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Abstract 
Cross-sectional research indicates that cannabis use is associated with cognitive and 
neuroanatomical damage, particularly when used regularly during development. The 
timing of use-related impacts on cognition and brain structure remains unclear. This 
dissertation includes two studies to characterize the longitudinal (1) neurocognitive 
profile and (2) white matter microstructure of young adult cannabis users who initiated 
use during adolescence. Cannabis users were assessed on a comprehensive 
neurocognitive battery and Diffusion Tensor Imaging (DTI) protocol at baseline and at a 
2-year follow-up. In Study 1, cannabis users had stable deficits in verbal learning and 
memory as well as planning ability, and a stable relative strength in processing speed at 
baseline and follow-up. Deficits in spatial working memory and motivated decision-
making observed at baseline recovered to control-level performance at follow-up. 
Heavier and earlier use of cannabis during adolescence was associated with decline in 
verbal learning and memory performance over time. In Study 2, change in white matter 
microstructure between time points was observed. Cannabis users exhibited reduced 
white matter microstructure organization in the central and parietal regions of the 
superior longitudinal fasciculus, left superior frontal gyrus, corticospinal tract, right 
anterior thalamic radiation, and in the posterior cingulum; cannabis users demonstrated 
increased white matter microstructure in the left anterior corpus callosum and left 
thalamic white matter. The findings suggest that continued heavy cannabis use during 
adolescence and young adulthood disrupts ongoing development of white matter 
microstructure. White matter microstructure changes were generally unrelated to 
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cognitive performance, and future research is needed to clarify their functional 
significance. Potential mechanisms and implications of the findings are discussed.  
 
   v 
 
Table of Contents 
List of Tables ............................................................................................................................ vii 
List of Figures ........................................................................................................................... ix 
General Introduction .............................................................................................................. 1 
Study 1: Longitudinal Neurocognitive Profile of Young Adult Cannabis Users .. 6 
1.1 Hypotheses .............................................................................................................................. 20 
1.2 Methods .................................................................................................................................... 20 
1.2.1 Sample .............................................................................................................................................. 20 
1.2.2 Procedure ........................................................................................................................................ 23 
1.2.3 Measures .......................................................................................................................................... 25 
1.2.3.1 Neurocognitive Battery ....................................................................................................................... 25 
1.2.3.2 Substance Use .......................................................................................................................................... 33 
1.2.4 Statistical Approach .................................................................................................................... 34 
1.3 Results ...................................................................................................................................... 38 
1.3.1 Baseline ............................................................................................................................................ 38 
1.3.1.1 Sample Characteristics ........................................................................................................................ 38 
1.3.1.2 Substance Use Characteristics .......................................................................................................... 39 
1.3.1.3 Baseline Group Differences in Neurocognitive Performance ............................................. 40 
1.3.1.4 Baseline Neurocognitive Performance and Substance Use ................................................. 44 
1.3.1.5 Baseline Demographic Characteristics and Cognitive Performance in Follow-up 
sample  ........................................................................................................................................................................ 46 
1.3.2 Follow-up ........................................................................................................................................ 48 
1.3.2.1 Sample Characteristics ........................................................................................................................ 48 
1.3.2.2 Substance Use Characteristics .......................................................................................................... 48 
1.3.2.3 Group Differences in Neurocognitive Performance at Follow-Up.................................... 49 
1.3.2.4 Hierarchical Regression within Cannabis Users ...................................................................... 63 
1.4 Discussion ............................................................................................................................... 71 
   vi 
 
2 Study 2: Longitudinal Changes in White Matter Microstructure in Young 
Adult Cannabis Users ............................................................................................................ 81 
2.1 Hypotheses .............................................................................................................................. 87 
2.2 Methods .................................................................................................................................... 87 
2.2.1 Sample .............................................................................................................................................. 87 
2.2.2 Procedure ........................................................................................................................................ 90 
2.2.3 Measures .......................................................................................................................................... 91 
2.2.3.1 Neurocognitive Battery ....................................................................................................................... 91 
2.2.3.2 Substance Use .......................................................................................................................................... 91 
2.2.4 MRI Data Acquisition and Processing .................................................................................. 92 
2.2.5 Statistical Approach .................................................................................................................... 94 
2.3 Results ...................................................................................................................................... 99 
2.3.1 Sample Characteristics .............................................................................................................. 99 
2.3.2 Substance Use Characteristics ............................................................................................. 100 
2.3.3 Baseline Differences in White Matter Microstructure Between Groups ............ 101 
2.3.4 Baseline White Matter Microstructure Behavioral Correlates............................... 104 
2.3.5 Follow-up Differences in White Matter Microstructure Between Groups ........ 105 
2.3.6 Follow-up White Matter Microstructure Behavioral Correlates ........................... 107 
2.4 Discussion ............................................................................................................................. 112 
3 General Conclusions and Future Directions .......................................................... 120 
4 Tables................................................................................................................................... 129 
5 References .......................................................................................................................... 162 
   vii 
 
List of Tables 
 
Table 1. Study 1 Demographic and substance use characteristics of cannabis users and controls at baseline 
and follow-up ..................................................................................................................................... 129 
Table 2. DSM-IV-TR Diagnoses at study initiation and follow-up, as assessed by the K-SADS-PL. .......... 131 
Table 3. Substance Use Disorder Symptoms baseline and follow-up. ......................................................... 132 
Table 4. Lifetime other drug usage in cannabis users and controls at baseline and follow-up .................. 134 
Table 5. Iowa Gabling Task (IGT) deck contingencies. .............................................................................. 135 
Table 6. Baseline neuropsychological cognitive composite scores. ............................................................ 136 
Table 7. Baseline neuropsychological battery scores. ................................................................................ 137 
Table 8. Partial correlations between baseline cognitive performance and substance use variables in 
cannabis users (n = 36). .................................................................................................................... 140 
Table 9. Baseline demographic and substance use characteristics between participants who returned for 
follow-up assessment and those who dropped out of the study at follow-up, separated by controls and 
cannabis users.................................................................................................................................... 142 
Table 10. Baseline and follow-up neuropsychological cognitive composite scores for participants who 
completed the follow-up assessment (controls n = 29) and (cannabis users n = 26). ....................... 143 
Table 11. Baseline and Follow-up neuropsychological battery scores for participants who completed the 
follow-up assessment (controls n = 29) and (cannabis users n = 26). .............................................. 144 
Table 12. Partial correlations between follow-up cognitive performance and cannabis use measures in 
cognitive measures in cannabis users (n = 26). ................................................................................. 147 
Table 13. Hierarchical multiple regression analyses: Cannabis use at baseline assessment predicting 
follow-up RAVLT Trial 1-5 performance within cannabis users. ...................................................... 149 
Table 14. Hierarchical multiple regression analyses: Age of cannabis use initiation predicting follow-up 
forward digit span performance within cannabis users. .................................................................... 150 
Table 15. Hierarchical multiple regression analyses: Age of cannabis use initiation predicting learning and 
memory performance within cannabis users. ..................................................................................... 151 
Table 16. Hierarchical multiple regression analyses: Age of cannabis use initiation predicting Iowa 
Gambling Task performance within cannabis users. ......................................................................... 153 
Table 17. Study 2: Demographic and substance use characteristics of cannabis users and controls at 
baseline and follow-up. ...................................................................................................................... 154 
Table 18. DSM-IV-TR Diagnoses at baseline and follow-up, as assessed by the K-SADS-PL. .................. 156 
Table 19. Other drug usage in cannabis users and controls at baseline and follow-up.............................. 157 
   viii 
 
Table 20. Baseline group differences in fractional anisotropy (FA) and radial diffusivity (RD). ............... 158 
Table 21. Partial correlations between cognitive and substance use variables and mean FA in cannabis 
users > controls baseline cluster. ...................................................................................................... 159 
Table 22. Analysis of 2-year change in fractional anisotropy and radial diffusivity. ................................. 160 
Table 23. Correlations between cognitive and substance use variables and mean FA-change cluster values.
 ........................................................................................................................................................... 161 
 
   ix 
 
List of Figures 
 
Figure 1. Learning and memory composite score change between baseline and follow-up. ......................... 51 
Figure 2. RAVLT performance across trials at baseline and follow-up for cannabis users and controls. ..... 53 
Figure 3. RAVLT Trial 1 words recalled change between baseline and follow-up. ..................................... 54 
Figure 4. DRT reaction time on 500 ms 8,000 ms delay condition change between baseline and follow-up.
 ............................................................................................................................................................. 56 
Figure 5. Average moves to complete 3-move trials change between baseline and follow-up. .................... 57 
Figure 6. Change between baseline and follow-up on first move initiation time for 4-move problems. ....... 58 
Figure 7. IGT good minus bad deck choices across blocks at baseline and follow-up.................................. 59 
Figure 8. IGT Deck selections at baseline and follow-up for cannabis users and controls. .......................... 62 
Figure 9. Scatterplot of follow-up RAVLT Trial 1-5 performance by baseline total hits in the past year. ... 65 
Figure 10. Scatterplot of follow-up Digit Span Forward performance by age of cannabis use onset. .......... 67 
Figure 11. RAVLT scatterplots of follow-up performance by age of cannabis use onset. ............................ 69 
Figure 12. Scatterplot of follow-up IGT deck 2 choices by age of cannabis use onset. ................................ 70 
Figure 13. Cannabis user > Control FA, Control > Cannabis user RD. Voxelwise analysis of baseline group 
difference and 2-year change in fractional anisotropy and radial diffusivity. .................................... 102 
Figure 14. Control > Cannabis user FA, Cannabis user > Control RD. Voxelwise analysis of 2-year change 
in fractional anisotropy and radial diffusivity. ................................................................................... 103 
Figure 15. Scatterplot of baseline total # of drinks in the past year by mean FA in cannabis users > controls 
baseline cluster in the right genu and forceps minor of the CC. ........................................................ 104 
Figure 16. Scatterplot of baseline IGT disadvantageous deck2 choices by mean FA in cannabis 
users>controls baseline cluster in the right genu and forceps minor of the CC. ................................ 105 
Figure 17. Scatterplot of total number of hits at follow-up, controlling for baseline hits, by mean FA-change 
in controls > cannabis users cluster in the left SLF/CC forceps major. ............................................. 108 
Figure 18. Scatterplot of total number of hits at follow-up, controlling for baseline hits, by mean FA-change 
in controls>cannabis users cluster in the left CST.. ........................................................................... 108 
   x 
 
Figure 19. Scatterplot of motor speed composite scores, controlling for baseline motor speed performance, 
by mean FA-change in controls > cannabis users cluster in the right ATR. ...................................... 109 
Figure 20. Scatterplot of IGT total good choices, controlling for baseline total good choices, by mean FA-
change in controls > cannabis users cluster in the left SFG white matter. ......................................... 110 
Figure 21. Scatterplot of IGT advantageous deck 4 choices, controlling for baseline deck 4 choices, by 
mean FA-change in controls > cannabis users cluster in the left SFG white matter. ......................... 111 
Figure 22. Scatterplot of IGT disadvantageous deck choices, controlling for baseline total good choices, by 
mean FA-change in controls > cannabis users cluster in the left SFG white matter. ......................... 111 
 
 
   1 
 
General Introduction 
Cannabis is experiencing its moment in the spotlight in the United States. At the 
time of this writing, 23 states and the District of Columbia have legalized cannabis use 
for medical use, and 4 states have legalized cannabis for both medical and recreational 
use. Political, social, and legal debates about cannabis‟s legal status continue (Volkow, 
Baler, Compton, & Weiss, 2014), and ongoing changes to its legal status across the 
United States are likely. 
In the context of its uncertain and changing legal status, cannabis has consistently 
been the most commonly used “illicit” substance in the United States (Substance Abuse 
and Mental Health Services Administration, 2014). Among high school juniors and 
seniors reporting no problems associated with substance use, 14% of students said they 
had used cannabis during their lifetime (Falck, Nahhas, Li, & Carlson, 2012). Among 
12
th
 grade students, 6.5% report daily cannabis use (Johnston et al., 2013).  
Along with the high prevalence of cannabis use, adolescents and young adults 
report decreased perceived risk and disapproval of cannabis use (Johnston, Bachman, & 
Schulenberg, 2012; Johnston et al., 2013; Substance Abuse and Mental Health Services 
Administration, 2014). Historically, attitude change toward cannabis use has coincided 
with increased prevalence of use (Johnston et al., 2012). Higher levels of cannabis use in 
adolescents and young adults are associated with individuals‟ approval of cannabis use as 
well as the perception of approval among one‟s peers and parents (LaBrie, Hummer, & 
Lac, 2011; Wu, Swartz, Brady, & Hoyle, 2015). Medical and recreational cannabis laws 
are potential factors causing decreased perception of risk, which contributes to an 
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increase in cannabis use. Decreased perception of risk (Schuermeyer et al., 2014; Wall et 
al., 2011) and increased cannabis use (Cerdá, Wall, Keyes, Galea, & Hasin, 2012; 
Harper, Strumpf, & Kaufman, 2012) have been found in states with medical cannabis 
laws. However, establishing a causal link between newly enacted laws and shifts in 
perception and use requires further research (Wall et al., 2012).  
Given attitude changes, changes in the legal status of cannabis, and cannabis‟s 
continued popularity, cannabis use among young people is likely to be an important and 
enduring public health concern. A growing body of research is dedicated to 
understanding possible long-term consequences of cannabis use during adolescence and 
young adulthood (Volkow, Baler, et al., 2014). Adolescence and young adulthood have 
been targeted because they are important periods of maturation and change in the brain, 
with reorganization of cortical connections, corticolimbic interactions, and 
neurotransmitter systems (Colby, Van Horn, & Sowell, 2011; Gogtay & Thompson, 
2010; Gogtay et al., 2004; O‟Hare & Sowell, 2008; Rice & Barone, 2000). Chronic 
cannabis use during adolescence has the potential to alter brain structure and function as 
well as cognitive performance through disruption of the endogenous cannabinoid system 
that is widely distributed throughout the brain. 
The endocannabinoid system plays an important role in prenatal central nervous 
system development (Galve-Roperh, Palazuelos, Aguado, & Guzmán, 2009) and cortical 
development during adolescence, with peak endocannabinoid receptor expression and 
binding capacity in the striatum, limbic system, and ventral midbrain noted during 
adolescence (Rodriguez de Fonseca, Ramos, Bonnin, & Fernández-Ruiz, 1993). Cannabis 
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acts directly on the brain by binding to receptors in the endocannabinoid system. The 
endocannabinoid system broadly regulates synaptic transmission by inhibiting 
neurotransmitter release at axon terminals (Howlett et al., 2002; Szabo & Schlicker, 
2005), causing both excitatory and inhibitory downstream effects relative to the function 
of the inhibited neurotransmitter (i.e., glutamate, GABA, dopamine, serotonin, 
acetylcholine; Freund, Katona, & Piomelli, 2003). The endocannabinoid system plays a 
large role in synaptic plasticity by promoting or inhibiting neurotransmission across a 
wide range of brain regions (Heifets & Castillo, 2009; Trezza et al., 2012), and altering 
its function during important windows of neural development could result in long-lasting 
changes in brain structure and function. 
Endocannabinoid receptors are broadly distributed throughout the brain, in the 
prefrontal cortex, hippocampus, basal ganglia, thalamus, hypothalamus, and cerebellum 
(Freund et al., 2003; Herkenham et al., 1990; Viveros, Llorente, Moreno, & Marco, 
2005). These regions contribute to a variety of cognitive functions, including behavioral 
inhibition, learning and memory, attention, planning, self-monitoring, decision-making, 
motor processes, as well as appetite and sleep regulation (Lezak, Howieson, & Loring, 
2004; Spear, 2000; Viveros et al., 2005). Chronic cannabis use disrupts the 
endocannabinoid system through downregulation of endocannabinoid receptors in 
cortical brain regions (Hirvonen et al., 2012), and altering endocannabinoid-mediated 
synaptic transmission (Heifets & Castillo, 2009). Disruption of the endocannabinoid 
system during adolescence, as opposed to adulthood, is associated with long-term 
changes in brain structure, neurochemical signaling, and cognitive performance, both in 
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animal models (e.g., Bambico, Nguyen, Katz, & Gobbi, 2010; Gleason, Birnbaum, 
Shukla, & Ghose, 2012; Pistis et al., 2004; Raver, Haughwout, & Keller, 2013; Rubino et 
al., 2009; Schneider & Koch, 2003, 2007; Schneider, Schömig, & Leweke, 2008; 
Stopponi et al., 2014) and in humans (e.g., Battisti et al., 2010; Ehrenreich et al., 1999; 
Fontes et al., 2011; Lisdahl, Gilbart, Wright, & Shollenbarger, 2013; Meier et al., 2012; 
Pope et al., 2003; Solowij et al., 2012; Wagner, Becker, Gouzoulis-Mayfrank, & 
Daumann, 2010). The purported effects of endocannabinoid system disruption during 
adolescence and young adulthood include long-term changes in serotonin (Bambico et 
al., 2010; Best & Regehr, 2008) and dopamine (Kowal, Colzato, & Hommel, 2011; Pistis 
et al., 2004; Schneider & Koch, 2003) signaling, as well as changes in emotionality 
(Schneider & Koch, 2003; Trezza et al., 2012), IQ (Meier et al., 2012; Pope et al., 2003), 
memory and learning (Cha, White, Kuhn, Wilson, & Swartzwelder, 2006; Jager & 
Ramsey, 2008; Quinn et al., 2008; Realini, Rubino, & Parolaro, 2009; Schneider & Koch, 
2003, 2007; Wagner et al., 2010), inhibitory control (Realini et al., 2009; Schneider & 
Koch, 2003), and executive functioning (Battisti, Roodenrys, Johnstone, Pesa, et al., 
2010; Fontes et al., 2011; Solowij et al., 2012). Neuroplastic changes resulting from 
chronic cannabis use initiated in adolescence could drive long-term structural and 
functional organization of the brain in adulthood, affecting cognition, emotional 
functioning, and behavioral regulation beyond the period of acute intoxication. 
The aims of this dissertation are to characterize the neurocognitive and 
neuroanatomical profiles associated with sustained cannabis use during adolescence and 
young adulthood. Two studies are presented. Study 1 characterizes the baseline profile 
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and longitudinal changes in neurocognitive functioning within a cohort of adolescent-
onset cannabis users assessed at two time points during early adulthood. Study 2 
characterizes the baseline profile and longitudinal changes in measures of brain white 
matter microstructure within this same group of cannabis users, and then explores 
associations between the neurocognitive and neuroanatomical profiles and longitudinal 
change within cannabis users.  
By examining both cognitive performance and brain structure, the scientific 
community can reach a greater understanding about the cognitive and neurobiological 
vulnerabilities associated with adolescent-onset and young adult cannabis use. Consensus 
in the scientific community can help to inform the public debate about the legality of 
cannabis use, and more clearly define the actual risks associated with use.  
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1 Study 1: Longitudinal Neurocognitive Profile of Young Adult Cannabis 
Users 
Cannabis use during adolescence and young adulthood is associated with 
disruptions in select cognitive domains outside of the time period of acute intoxication. 
Defining a cognitive profile among cannabis users outside of the period of acute 
intoxication, while still in the context of regular use, approximates how regular cannabis 
use impacts day-to-day cognitive function. The majority of research with adolescent and 
young adult cannabis users has employed cross-sectional research methods to assess 
regular cannabis users outside of the period of acute intoxication to characterize the 
relative strengths and weaknesses associated with regular cannabis use. An overview of 
this literature by cognitive domain is provided below. Fewer studies have used 
longitudinal methods, and a summary of this more limited literature is also provided. 
Attention. Attention is a cognitive ability that underpins many skills, including 
various aspects of executive functioning, learning and memory, and processing speed. 
Attention is a complicated construct, but can be succinctly described as a process that 
relates to one‟s ability to perceive salient information in the environment, allocate 
attentional resources, and respond to the environment and feedback appropriately 
(Anderson, Laurent, & Yantis, 2011; Desimone & Duncan, 1995). Adolescent and young 
adult cannabis users have demonstrated poorer sustained attention and reduced accuracy 
during sustained attention conditions (Dougherty et al., 2013; Jacobsen, Mencl, 
Westerveld, & Pugh, 2004) compared to controls. Slowed reaction times on measures of 
sustained attention and mental tracking have been noted among earlier-onset cannabis 
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users (15-16 years old; Ehrenreich et al., 1999; Fontes et al., 2011), young adult cannabis 
users (Lisdahl & Price, 2012), and young adults with greater cannabis use (Bolla, Brown, 
Eldreth, Tate, & Cadet, 2002). Slowed reaction times during sustained attention tasks 
may represent deficits in processing speed or may reflect participants‟ greater efforts to 
maintain performance at high levels of accuracy. 
Diminished performance on attentional tasks persists into periods of abstinence as 
well. After one month of abstinence, decreased attentional accuracy was assocated with 
increased cannabis use in young adult cannabis users (Bolla et al., 2002). However, the 
findings are equivocal when it comes to longer periods of abstinence. Reduced sustained 
attention accuracy has been noted in adolescent cannabis users compared to controls after 
three months of abstinence (Hanson et al., 2010), while no deficits were observed in 
another study among a different cohort of cannabis users after at least three months of 
abstinence (Fried, Watkinson, & Gray, 2005). 
Processing speed. The domain of processing speed has considerable overlap with 
attentional ability. For the purposes of this overview, processing speed refers to quick 
mental manipulation and recruitment of effective strategies during task performance. 
Measures that are thought to reflect processing speed, at least in part, include sequencing 
tasks (e.g., Trail Making Test) and coding tasks (e.g., Digit Symbol Coding). This 
domain has also been termed “complex attention” by Tapert and colleagues (Hanson et 
al., 2010; Lisdahl & Price, 2012; Medina et al., 2007; Tapert, Granholm, Leedy, & 
Brown, 2002). 
   8 
 
In the context of regular cannabis use, current users demonstrate slowed 
processing speed performance relative to controls (Fried et al., 2005), and greater slowing 
associated with greater cannabis use (Bolla et al., 2002; Lisdahl & Price, 2012; Medina et 
al., 2007). A longitudinal study that followed adolescents with substance use disorders 
over 8 years noted that greater cannabis use during the follow-up period was associated 
with poorer complex attention/processing speed performance at follow-up (Tapert et al., 
2002). Evidence indicates that cannabis users demonstrate slowed and relatively less 
accurate processing speed performance during early abstinence periods of one week 
(Lisdahl & Price, 2012) and one month (Medina et al., 2007), but that these relative 
impairments are no longer evident after three months of abstinence (Fried et al., 2005). 
Executive functioning. Executive functioning encompasses a range of cognitive 
abilities and skills, including cognitive inhibition, cognitive flexibility, verbal fluency, 
decision-making, planning, and self-organization. 
Cognitive Inhibition. Cognitive inhibition refers to the capacity to rapidly inhibit 
prepotent or initiated responses when required to by the environment or a particular 
task‟s demands. Cognitive inhibition performance has been noted to be relatively 
impaired in cannabis using adolescents (Lisdahl & Price, 2012), young adults (Bolla et 
al., 2002; Gruber, Sagar, Dahlgren, Racine, & Lukas, 2012), young adult males (Pope & 
Yurgelun-Todd, 1996) and early-onset users (Battisti, Roodenrys, Johnstone, Pesa, et al., 
2010; Fontes et al., 2011; Gruber, Sagar, et al., 2012). While many studies report 
cognitive inhibition impairment among cannabis users, other studies have failed to find 
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the relationship (J. E. Grant, Chamberlain, Schreiber, & Odlaug, 2012; Pope et al., 2003; 
Takagi, Lubman, et al., 2011).  
Cognitive Flexibility. This cognitive domain refers to one‟s ability to flexibly shift 
between different cognitive sets and adapt performance based on feedback from the 
environment or changing task goals (e.g., Wisconsin Card Sort Test: WCST; Lezak et al., 
2004). In the context of regular use, cannabis users demonstrate poorer overall set-
shifting performance (Bolla et al., 2002; Gruber et al., 2012; Pope & Yurgelun-Todd, 
1996). Cannabis users demonstrate a greater tendency to perseverate (Lane, Cherek, 
Tcheremissine, Steinberg, & Sharon, 2007; Pope & Yurgelun-Todd, 1996) and make 
more errors (Dougherty et al., 2013; Lane et al., 2007) in their test-taking approach. As 
has been described in other domains, early-onset use is associated with worse 
performance (Fontes et al., 2011; Gruber, Sagar, et al., 2012). However, no impairments 
in WCST performance were noted in adult early-onset users after 1 month of abstinence 
(Pope et al., 2003), suggesting that cognitive flexibility can recover after prolonged 
abstinence in early-onset user cannabis users, but is impaired in the context of regular 
use. 
Verbal Fluency. Performance on measures of fluency, the ability to employ 
effective strategies to quickly generate words according to task rules, indicates that 
cannabis users typically do not show alterations (Lisdahl & Price, 2012; Pope et al., 
2003). However, users may demonstrate impaired verbal fluency in the context of lower 
IQ estimates (Pope & Yurgelun-Todd, 1996).  
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Decision-Making. A variety of task paradigms measure different aspects of 
decision-making. This overview focuses on reward-related decision-making in the 
context of unknown contingencies that are learned from feedback on prior selections 
(e.g., Iowa Gambling Task, IGT; Bechara et al., 2001), reward-related decision-making 
with unknown outcomes (e.g., Cambridge Gambling Task, CGT; J. E. Grant et al., 2012), 
and impulsive decision-making (e.g., Two Choice Impulsivity Paradigm, TCIP, 
Information Sampling Test, IST; Dougherty et al., 2013; Solowij et al., 2012).  
Decision-making has not been extensively assessed in adolescent and young adult 
cannabis users. Among adult cannabis users, poorer IGT decision-making performance is 
observed after both acute use and extended periods of abstinence (Bolla et al., 2002; 
Ernst et al., 2003; Verdejo-García, Rivas-Pérez, Vilar-López, & Pérez-García, 2007; 
Whitlow et al., 2004). In younger cannabis users, some evidence indicates that cannabis 
users are more prone to risky choices associated with greater likelihood of punishment on 
the CGT (J. E. Grant et al., 2012). However, other studies have not reported this pattern 
of findings with IGT performance (Dougherty et al., 2013; Gonzalez et al., 2012). While 
group differences are not always observed, poorer task performance on the IGT has been 
associated with increased cannabis substance use disorder symptoms (Gonzalez et al., 
2012) and cannabis-related problems (Gonzalez, Schuster, Mermelstein, & Diviak, 2015). 
Findings among cannabis users reflect the decision-making deficits reported among other 
substance using populations (Fernández-Serrano, Pérez-García, & Verdejo-García, 2011; 
Goudriaan, Grekin, & Sher, 2007; Hanson, Luciana, & Sullwold, 2008; Verdejo-García, 
Rivas-Pérez, et al., 2007; Verdejo-García, Benbrook, et al., 2007). 
   11 
 
Studies to dismantle the psychological processes underlying decision-making on 
the IGT, which includes a component of learning about reward contingencies from 
feedback about earlier choices, have indicated that adult cannabis users allocate more 
attention to gains and recent outcomes (Yechiam, Busemeyer, Stout, & Bechara, 2005) 
and demonstrate less consistency and are less sensitive to losses (Fridberg et al., 2010). 
Reliance on recent and salient reward information can contribute to poorer overall 
decision-making strategies on tasks where a more conservative strategy is advantageous. 
This hypothesis is supported by cannabis users‟ performance on tasks assessing 
impulsive decision-making. When given the choice between receiving smaller rewards 
after a 5-second wait or larger rewards after a 15-second wait, adolescent cannabis users 
exhibit preference for shorter reward delays over longer delay intervals (Dougherty et al., 
2013). Cannabis users demonstrate faster and more impulsive decision-making relative to 
controls, a pattern of responding associated with poorer task performance overall (Clark, 
Roiser, Robbins, & Sahakian, 2009; Solowij et al., 2012). Longer duration of cannabis 
use and earlier age of cannabis use onset is associated with more impulsive decision-
making (Solowij et al., 2012). 
 Planning and self-organization. Measures of planning and self-organization 
assess one‟s ability to develop effective strategies and to execute plans to accomplish a 
set goal (Fernández-Serrano et al., 2011; Luciana, Collins, Olson, & Schissel, 2009). This 
domain can be assessed with more traditional measures of planning, including Tower of 
London-like tasks that measure immediate planning ability, or with measures of 
prospective memory, assessing future planning ability. Few studies have investigated 
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immediate planning ability among cannabis users. Diminished planning on the Tower of 
London (TOL) has been observed among acutely intoxicated cannabis users (McClure, 
Stitzer, & Vandrey, 2012; Ramaekers et al., 2006), as well as non-acutely high current 
users (Epstein & Kumra, 2015; J. E. Grant et al., 2012). After a month of abstinence, 
however, planning performance was equivalent to that of controls (Medina et al., 2007). 
Prospective memory refers to the memory processes employed in everyday 
contexts to remember to perform future actions or intentions (e.g., remembering to run 
errands after work; Bartholomew, Holroyd, & Heffernan, 2010; McHale & Hunt, 2008). 
Cannabis users demonstrate poorer prospective memory when compared to controls on 
measures of event-based prospective memory (i.e., when asked to complete a task after a 
specific event happens; Bartholomew et al., 2010; McHale & Hunt, 2008), and time-
based prospective memory (i.e., when asked to remember to complete a task at a certain 
time; McHale & Hunt, 2008; Montgomery et al., 2012).  
 Spatial working memory. The short-term storage and manipulation of on-line 
visuospatial information is an important component of establishing new learning and 
memory (Jonides et al., 2008). No deficits have been noted among cannabis users, as 
compared to controls, on a spatial span test (Harvey, Sellman, Porter, & Frampton, 2007) 
or a visual n-back task (Ehrenreich et al., 1999). However, on a more complex spatial 
working memory task (CANTAB spatial working memory test), which requires 
individuals to search for tokens that are hidden within an array of boxes without returning 
to previously visited boxes, current regular cannabis users demonstrated poorer 
   13 
 
performance than non-regular users (Harvey et al., 2007). Regular cannabis users have 
demonstrated poorer organization and less consistency than non-regular users. 
 Spatial memory. Visuospatial memory refers to the recall and reproduction of 
visual information after the information is off-line and not actively rehearsed in working 
memory. This is assessed after a delay period during which the information is 
consolidated then recalled from memory. One study with male young adult heavy 
cannabis users found that users demonstrated poorer delayed visuospatial memory 
relative to males who used less cannabis (Pope & Yurgelun-Todd, 1996). However, 
several studies have found no differences between cannabis users and controls on 
measures of visuospatial memory (Bolla et al., 2002; Macher & Earleywine, 2012; 
Mahmood, Jacobus, Bava, Scarlett, & Tapert, 2010; McHale & Hunt, 2008; Medina et 
al., 2007; Pope et al., 2003).  
Verbal working memory. Verbal working memory is the verbal analog of spatial 
working memory, referring to the maintenance and manipulation of on-line information. 
This ability is commonly assessed by measuring the number of bits of information a 
person can hold in mind and repeat back (digits, letters). Limited evidence supports a 
disruption in verbal working memory processes in young adult cannabis users (Hanson et 
al., 2010; Medina et al., 2007), with the majority of evidence finding no disruption in 
cannabis using samples (Cuttler et al., 2012; Fried et al., 2005; Macher & Earleywine, 
2012; Pope & Yurgelun-Todd, 1996).  
Verbal memory. Verbal memory refers to the recall and recognition of 
previously presented verbal information after the information is not actively rehearsed 
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(Lezak et al., 2004). Research in cannabis users has commonly used list-learning 
measures to assess verbal learning and memory. These tests consist of a list of target 
words that are read to participants multiple times during a learning stage of testing. 
Recall of the target words is measured immediately after the participant recalls a 
distractor list of words as well as after a time delay, typically 20-30 minutes after the 
learning stage.  
Performance during the learning/encoding stage has been reported to be impaired 
in cannabis-using adolescents (Harvey et al., 2007) and young adults (Gonzalez et al., 
2012; Hanson et al., 2010; Pope & Yurgelun-Todd, 1996; Solowij et al., 2011). Harvey et 
al. (2007) found that greater cannabis use predicting worse performance on the learning 
trials of regular cannabis users. Many studies have reported that after a time delay, 
cannabis users demonstrate poorer performance under different abstinence conditions, 
including short-term abstinence (Cuttler et al., 2012; Gonzalez et al., 2012; Hanson et al., 
2010; Pope & Yurgelun-Todd, 1996; Solowij, Jones, et al., 2011; Takagi, Yücel, et al., 
2011), and periods of abstinence of at least 28 days (Bolla et al., 2002; Hanson et al., 
2010). Learning deficits exhibited by users are subtle, with users typically producing 1-2 
fewer words than controls. Similar to the findings with list learning, cannabis users 
demonstrate impairments in story learning and memory tasks after at least 3 weeks of 
abstinence (Medina et al., 2007; Schwartz, Gruenewald, Klitzner, & Fedio, 1989).  
While this is a relatively robust finding in the literature, not all studies have 
reported deficits in list learning associated with cannabis use (Bava, Jacobus, Mahmood, 
Yang, & Tapert, 2010; Lisdahl & Price, 2012; Pope et al., 2003; Schwartz et al., 1989). 
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Further, motivation to perform well appears to play an important role in overall task 
performance within cannabis users but not controls, with increased motivation 
ameliorating performance deficits among cannabis users (Macher & Earleywine, 2012). 
A meta-analysis examining the cognitive effects of cannabis use specifically addressed 
these conflicting cognitive findings with respect to adult cannabis users (Grant et al., 
2003). A reliable negative effect was observed in the domains of verbal learning, 
recognition, and recall among cannabis users (Cohen‟s d = -.21).  
Poorer list-learning performance has been associated with a variety of cannabis 
use characteristics among users (Wagner et al., 2010). Poorer performance on learning 
trials was associated with higher lifetime doses of cannabis and longer durations of 
regular use. Performance on memory trials was associated with frequency of use, lifetime 
dose, and duration of use. Associations between cannabis use and performance, and the 
consistency of performance deficits noted, provide compelling evidence for disruptions in 
verbal memory in adolescent and young adult cannabis users.  
Longitudinal Findings 
Longitudinal methods have been less commonly used to examine the cognitive 
correlates of cannabis use. To determine if cognitive deficits persist into periods of 
abstinence, researchers have assessed cannabis users after up to 3 months of abstinence 
(Fried et al., 2005; Hanson et al., 2010; Medina et al., 2007). Only three longitudinal 
studies have assessed cannabis users at more than one time point over a period of years 
(Jacobus, Squeglia, Sorg, Nguyen-Louie, & Tapert, 2014; Meier et al., 2012; Tait, 
Mackinnon, & Christensen, 2011), and Meier et al. (2012) is the only study to 
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prospectively assess cannabis users prior to initiation of use. Given the limitations in the 
literature, the causal role of cannabis use in the development of cognitive deficits remains 
unclear. Prospective studies are needed to better approximate causal effects.  
The only longitudinal study to assess cannabis users prior to initiation of cannabis 
use included participants from the Dunedin Multidisciplinary Health and Development 
Study, a birth cohort of 1,037 participants, who were assessed over 38 years on a range of 
health and cognitive measures (Meier et al., 2012). Participants completed IQ assessment 
prior to cannabis initiation for the majority of cannabis using subjects. At age 38, 
participants were re-assessed on measures of IQ, and also tested on measures of verbal 
learning and memory, sustained and divided attention, and processing speed. Participants 
who did not use cannabis demonstrated stable IQ estimates throughout their lives while 
those who developed cannabis dependence at any point prior to age 38 demonstrated a 
decrease in IQ by about 6 points. Similarly, participants who used cannabis regularly (at 
least 4 days per week) demonstrated IQ declines as well. Those who initiated cannabis 
use prior to age 18 demonstrated an apparently greater IQ decline than those who 
initiated use later in life (Meier et al., 2012). Furthermore, among early-onset former 
persistent cannabis users, reduction in cannabis use in the year prior to testing had no 
effect on the IQ decrease. In contrast, adult-onset persistent cannabis users demonstrated 
no IQ decline regardless of current use patterns. Thus, age of cannabis use onset 
primarily accounted for the IQ decline among cannabis dependent participants. Broader 
neuropsychological performance was not explored in relation to age of initiation. This 
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study is the strongest evidence to date that use initiated during adolescence is associated 
long-term cognitive decline. 
Two other longitudinal studies assessed cannabis users after participants had 
already initiated use (Jacobus et al., 2015; Tait et al., 2011). Tait et al. (2011) followed a 
young adult cohort of cannabis users, aged 20-24 at baseline, at 4-year intervals for two 
follow-up assessments of verbal learning and memory, associative memory, working 
memory, and processing speed. Reported amount of cannabis use at baseline varied 
between abstinence and regular use. Cannabis users with different trajectories of use 
differed in their immediate free recall skills, with persistent heavy users (at least weekly 
use) demonstrating poorer immediate recall while former heavy and former light users 
demonstrated task performance equivalent to that of controls. There was also a trend for 
current light users (~monthly use) to demonstrate diminished immediate recall compared 
to former light users. Cannabis user and non-user groups‟ task performance was 
equivalent on other cognitive measures of associative memory, working memory, and 
processing speed. These results indicate that verbal memory is a select cognitive domain 
that is diminished in the context of regular use, but that performance in young adulthood 
may be improved after prolonged abstinence.  
The second longitudinal study to assess users after initiation followed 16-19 year 
old adolescent alcohol+cannabis users over a follow-up interval of 3 years (Jacobus, 
Squeglia, Bava, & Tapert, 2013; Jacobus et al., 2015). Participants were assessed at 1.5-
year intervals for 3 time points (i.e., assessment at baseline, 18 months, 3 years). Global 
neuropsychological performance, which was a calculated as a composite score of 
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attention, processing speed, verbal memory, visuospatial function, and executive function 
measures, was equivalent between the alcohol+cannabis users and non-substance using 
controls. Global neuropsychological performance was lower among alcohol+cannabis 
participants, relative to participants who only used alcohol, at the second assessment, but 
the group difference no longer remained at the third assessment (Jacobus, Squeglia, Bava, 
et al., 2013). A follow-up analysis explored performance differences between groups 
across the separate tasks that composed the global neuropsychological composite. 
Alcohol+cannabis users demonstrated poorer performance relative to controls in the 
domains of processing speed/complex attention, verbal working memory, verbal learning, 
verbal memory, and visuospatial functioning at the 1.5 year follow-up (Jacobus et al., 
2015), though only deficits in verbal working memory, verbal learning, and verbal 
memory were noted at the 3-year follow-up assessment. Verbal working memory and 
memory deficits were noted at all 3 assessments, with only verbal learning emerging as 
an area of weakness over time. Of note, earlier age of cannabis use onset was associated 
with worsened performance on measures of processing speed and sequencing at the 3-
year follow-up assessment. 
Summary 
In sum, adolescent and young adult cannabis users demonstrate impairment across 
a range of cognitive domains within cross-sectional studies. Subtle deficits in the 
domains of attention, processing speed, various aspects of executive functioning, and 
verbal memory are most consistently associated with cannabis use. Across cognitive 
domains, early age of cannabis use initiation is associated with poorer task performance. 
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The relationship between cannabis use and impairments in cognitive control, visuospatial 
memory, and verbal working memory is not a robust finding among adolescent and 
young adult cannabis users.  
Few longitudinal studies have examined neurocognitive performance of cannabis 
users over time. Only one study to date has prospectively assessed cannabis users prior to 
cannabis use initiation (Meier et al., 2012). Global neuropsychological impairment 
among adult persistent cannabis users and IQ decline was associated with both persistent 
cannabis use as well as younger age of cannabis use initiation. This compelling research 
points to deficits by the age of 38, but does not address whether impairments are 
detectable at an earlier age. Two other longitudinal studies suggest subtle but detectable 
impairments evidenced at an earlier age in the domains of working memory and verbal 
memory, while other domains of cognitive function are spared (Jacobus et al., 2015; Tait 
et al., 2011). Cessation of use appears to be associated with recovery of cognitive 
performance among young adult users but not adult users (Meier et al., 2012). This may 
represent greater cognitive resilience among younger users, which becomes less robust as 
cannabis users age. 
The present study builds on the limited longitudinal research within cannabis 
users to examine the association between cannabis use and cognition over time in order to 
clarify how use over time may influence cognitive performance. A sample of chronic 
daily adolescent-onset cannabis users was assessed on a comprehensive 
neuropsychological battery and their performance was compared to that of non-using 
controls. It should be stated at the outset that an interpretive difficulty is introduced by 
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the fact that the cannabis users were not substance naïve at baseline. The following 
hypotheses are examined: 
1.1 Hypotheses 
Baseline 
It was predicted that cannabis users would exhibit diminished performance on measures 
of attention, processing speed, executive functioning, and verbal memory relative to non-
cannabis using controls. 
Follow-up 
Cannabis users were expected to continue to exhibit the same deficits evident at baseline. 
Because cannabis use patterns were not expected to stay uniform within the cannabis user 
sample, it was predicted that those who continued to use cannabis most heavily and/or 
frequently would demonstrate greater cognitive deficits relative to those who decreased 
use during the follow-up interval. An earlier age of cannabis use initiation was expected 
to be associated with diminished cognitive performance at baseline and over time. 
1.2 Methods 
1.2.1 Sample 
Forty cannabis users, ages 19-20, were initially recruited into this longitudinal study. 
Initial cannabis use onset was required to be prior to age 17 given that adolescent onset of 
use has been associated with greater functional impairments (Ehrenreich et al., 1999; 
Fontes et al., 2011; Gruber, Dahlgren, Sagar, Gönenç, & Lukas, 2014; Lisdahl et al., 
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2013). Inclusion criteria specified that cannabis users reported using at least 5x/week. 
Two cannabis users reported use at a lower frequency (3-4x/week) and were allowed in 
the recruited sample by error. To maximize sample size, all participants in the recruited 
sample were included in the current analyses, with 90% of users reporting using 5+ times 
per week. Cannabis users were excluded if they reported daily cigarette use, or if alcohol 
use was reported to exceed 4 drinks for females and 5 drinks for males on more than 2 
occasions per week. The current sample is a minor expansion of the cannabis user sample 
reported previously (Becker, Collins, & Luciana, 2014), including 1 cannabis user who 
met criteria for alcohol dependence. Alcohol use was examined in relation to cognitive 
performance for all participants.  
Thirty-five non-drug using control participants were selected from a larger 
longitudinal study exploring adolescent brain development. At initial study recruitment, 
controls were excluded if they met current or past Axis I DSM-IV-TR (American 
Psychiatric Association, 2000) criteria for any psychiatric disorder. Therefore, additional 
exclusion criteria were applied. Controls were also excluded if they reported cannabis use 
more than once monthly, and/or if they endorsed any other illicit substance use.  
General inclusion criteria for all participants included being a native English 
speaker, right-handed, with normal/corrected-to-normal vision and hearing. Exclusion 
criteria included any contraindicates to MRI scanning, any reported history of 
neurological problems or head injury, intellectual disability, or current pregnancy. All 
participants were recruited through university advertisements, and all were monetarily 
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compensated. Participants provided informed consent. The University of Minnesota's 
Institutional Review Board approved the protocol. 
Of the 40 cannabis users initially screened for the study, 2 were excluded because 
their reported cannabis use was less than an average of 3x/week for the prior year. One 
cannabis user was excluded because of a reported history of seizures. Thirty-seven 
cannabis users completed the baseline assessment following screening. One cannabis user 
was excluded from the final sample due to missing data (see below). Table 1 reports 
sample characteristics for the cannabis user (n = 36) and control (n = 35) samples. 
At baseline, cannabis user and control samples were matched for age, IQ, and 
demographic background. Because of sample inclusion requirements, controls exhibited 
no psychopathology at study initiation. Cannabis users exhibited minimal 
psychopathology outside of substance use disorders (Table 2). Within substance use 
disorders, cannabis users exhibited more symptoms related to problematic cannabis use 
than problematic alcohol use (Table 3), and self-reported substance use patterns indicate 
that cannabis was the primary drug used within the cannabis users (Table 4). 
Of the 72 participants who initially participated in the study, 58 participants (27 
cannabis users and 31 controls) returned for a two-year follow-up assessment. The 
retention rate of 80% for the follow-up sample is within the range of those reported 
among other longitudinal studies with cannabis users (89% for wave 2 reported in Tait et 
al., 2011; 64% for the final sample included in Jacobus et al., 2015, Jacobus, J, personal 
communication, August 5, 2015). Five cannabis users were not interested in participating, 
2 could not be contacted, and 2 had moved and were unavailable for assessment. Of the 
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control participants, 1 was not interested in participating, 2 could not be contacted, 1 had 
moved, and 2 failed to return for unknown reasons. One cannabis user and 2 control 
participants were excluded from follow-up analyses due to missing alcohol use data. 
Table 1 reflects sample characteristics for included participants at follow-up. Participants 
returned after approximately a two-year interval (cannabis users M = 2.35 years, SD = 
0.31; control M = 2.22 years, SD = 0.49), with no significant group difference in time 
interval to follow-up. 
During both baseline and follow-up assessments, all participants, including 
cannabis users, were asked to refrain from drug use for at least 24 hours before testing so 
as not to be acutely high during the assessment, though participants who reported 12-to-
24 hours of abstinence were accepted. Longer periods of abstinence were not required to 
avoid assessing individuals in the midst of drug withdrawal and because a goal of the 
study was to capture functional capacities in the context of active use. Formal drug 
testing was not implemented due to budgetary limitations and given that the study did not 
require long-term cannabis abstinence. 
1.2.2 Procedure 
At study enrollment, interested participants completed brief telephone interviews 
as a screen for study eligibility. Eligible participants were invited to complete a more in-
depth in-person screening assessment to verify inclusion and exclusion criteria. 
Participants completed an in-person structured interview, the Kiddie-Schedule for 
Affective Disorders and Schizophrenia Present and Lifetime Version (K-SADS-PL: 
Kaufman et al., 1997) to assess for recent and past histories of affective, psychotic, 
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childhood developmental, and behavioral disorders. The benefit of using the K-SADS to 
assess psychopathology in young adults is that it captures past histories of childhood 
disorders while also providing an in-depth assessment of DSM-IV-based adult 
psychopathology. Current (recent) ratings were based on the previous 2 months for non-
substance use related disorders and the previous 6 months for substance use disorders. 
Intelligence was estimated using the Vocabulary and Matrix Reasoning subtests of the 
Wechsler Abbreviated Scale of Intelligence (WASI: Wechsler, 1999). Participants 
completed detailed health and demographic questionnaires. Handedness was verified 
using the Edinburgh Handedness Inventory (Oldfield, 1971). Participants who met 
inclusion criteria returned for a second assessment, which included magnetic resonance 
imaging (MRI) scans as well as behavioral questionnaires and a comprehensive 
neurocognitive battery. The neurocognitive battery was designed to capture a broad array 
of functions in the domains of motor function, processing speed, attention, spatial and 
verbal memory, and executive functioning skills. Together, these measures took several 
hours to complete. 
During the follow-up assessment, the same procedure was used. General health 
and IQ measures (K-SADS-PL, WASI, Health and demographic measures, Edinburgh 
Handedness Inventory) were collected at follow-up to measure change since initial 
enrollment. No participants were excluded after initial study enrollment. At follow-up, 
the K-SADS-PL assessed for symptom presence during the follow-up interval, and did 
not assess for lifetime presence of psychopathology. 
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1.2.3 Measures 
1.2.3.1 Neurocognitive Battery 
Motor Function 
Finger Tapping Test (Lezak et al., 2004). This test measured bimanual motor 
speed. Participants tapped a key as many times as possible within a 10-second period. 
Three trials were administered for each hand, and the number of taps per trial was 
recorded. The average of all three trials per hand is reported. 
Grooved Pegboard (Lafayette Instruments, 1989). This test measured 
psychomotor bimanual dexterity and speed. Participants were presented with a flat board 
containing rows of holes and small metal „pegs‟ that fit into the holes on the board. The 
pegs were shaped so that one side is square. Each peg had to be correctly manipulated in 
order to fit the holes. Under timed conditions, participants used the pegs to fill the holes 
on the board using first the right (dominant) hand, then the left (non-dominant) hand. 
Accuracy and response time are reported. 
Processing Speed 
Digit Symbol (WAIS-III Digit Symbol; Wechsler, 1997). This test measured 
psychomotor speed, sustained attention, scanning ability, and the ability to quickly learn 
associations between numbers and symbols (Sattler & Ryan, 2009). This test was 
administered according to WAIS-III standardized procedures. Specifically, participants 
were presented with a piece of paper with rows containing blank squares below randomly 
assigned numbers from 1 to 9. Participants were asked to assign symbols to the spaces 
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below the numbered boxes according to a key that pairs each number with a unique 
symbol. The total score represents the total correct number of items completed within 120 
seconds, out of a total possible score of 133. 
Letter Cancellation Task (Lezak et al., 2004). This task measured immediate 
attention and vigilance under timed conditions. Participants viewed a piece of paper on 
which were printed rows of capitalized letters. They were instructed to work as quickly 
and as accurately as possible and to cross out all occurrences of the letters „E‟ and „C‟. 
Time-to-completion and numbers of errors (commission and omission) are reported. 
Verbal Fluency 
Controlled Oral Word Association Test (COWAT; Delis, Kramer, Kaplan, & 
Ober, 2000; Lezak et al., 2004). The COWAT assessed expressive speech fluency as well 
as rule maintenance and response monitoring. Standardized administration procedures 
using the target letters F, A, and S were employed. The total score for each participant 
represents the total number of words generated across all three trials after deductions for 
rule violations, which include set-loss errors (i.e., words not beginning with target letters) 
and perseverations (i.e., saying the same word more than once). Total correct words and 
numbers of errors are reported. 
Verbal Attention and Working Memory 
Digit Span (WAIS–III Digit Span; Wechsler, 1997). This test measured 
immediate recall of auditory verbal information. Digit span forward and digit span 
backward conditions were administered according to WAIS-III standardized procedures. 
Participants were read sequences of digits, and were then asked to repeat the sequence as 
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presented (digits forward) or in the reverse order (digits backward). Participants were 
administered successively more difficult levels, with one digit added to the sequence at 
every level. The maximum number of digits correctly recalled is reported for both the 
digit span forward and backward conditions. 
Verbal Learning and Memory 
Rey Auditory Verbal Learning Test (RAVLT; Lezak et al., 2004; A. Rey, 1993). 
This test measured acquisition, storage, and retrieval of verbal information. During the 
learning phase, participants were first read and asked to recall a list of 15 words. This 
procedure was repeated four additional times to yield the number of items correctly 
recalled on trials 1-5. This learning phase assessed the participant‟s immediate learning 
and temporary storage of verbal information. Following the learning trials, participants 
were then read and asked to recall a new list of 15 words (interference trial). The 
interference trial assessed immediate learning of new information, and was presented 
only once. Following the interference trial, participants were then asked to freely recall as 
many words as they could from the first list (immediate recall) and again following a 30-
minute delay (delayed recall). The immediate recall trial assessed learning recall when 
the items are not actively rehearsed in working memory. Performance on the delayed 
recall trial represented learning that has been consolidated into memory. The number of 
words recalled during the learning trials, interference trial, immediate recall, and delayed 
recall trials are reported. Intrusion (recall of non-list words) and perseverative (repeated 
responses) errors are also tabulated. These variables are standard for this task. 
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Additional learning and memory variables were calculated to characterize 
performance in a more nuanced manner. The amount of information recalled after 
consolidation was calculated as the percentage of words recalled during the 30-minute 
delay relative to the number of words recalled during the last of the five learning trials 
([Trial 7/Trial 5] × 100; Takagi, Yücel, et al., 2011). Retroactive interference (trial 5 vs. 
immediate recall) and proactive interference (trial 1 vs. interference) were also examined 
(Takagi, Yücel, et al., 2011). Retroactive interference refers to later learning disrupting 
the recall of previously learned information, whereas proactive interference refers to 
earlier learning disrupting the recall of information learned later.  
Spatial Memory 
Spatial Working Memory (SWM CANTAB; Owen, Downes, Sahakian, Polkey, & 
Robbins, 1990). This test measured spatial working memory, self-monitoring, and 
behavioral self-organization. Using a computerized touch-screen, participants searched 
for tokens hidden inside an array of boxes. The task was organized into 4, 6 and 8 box 
problems, with increased box number corresponding to increased task difficulty. 
Participants viewed the array of boxes on the screen and were instructed that at any one 
time, there was a single token hidden inside one of the boxes. Their task was to search 
until they found it, at which point the next token was hidden. Once a given box yielded a 
token, that box was not used to hide the token again during the trial. Returning to a box 
after a token had already been found within it constituted an error. Every box was used 
once on every trial; thus, the total number of tokens to be found during each trial 
corresponded to the number of boxes on the screen. A “between-search” error was 
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recorded when participants returned to a box in which a token had already been found. A 
strategy score was also tabulated. The strategy score, based on responses to 6- and 8-item 
searches, reflected the participant‟s tendency to search through available locations in an 
organized manner (Owen et al., 1990). A high score represented poorer use of an 
organized search strategy. Total between-search error score (sum of errors on 4-, 6-, 8-
move problems), as well as strategy scores, are the variables of interest. 
Spatial Delayed Response Task (DRT; Luciana & Collins, 1997; Luciana, Collins, 
& Depue, 1998). This computerized task measured working memory for the locations of 
spatial targets. During the task, participants were seated with their head in a chin-
forehead rest such that the computer monitor is 27 cm from their eyes. During each of 48 
trials, the participants first observed a black “+” central fixation point on a computer 
monitor (0.63 × 0.63) for 3 seconds. Next, a black “*” visual cue appeared in their 
peripheral vision, within a 360 circumference, for 200 ms. After the peripheral visual 
cue, the cue and fixation point disappeared, and the screen blackened for randomly 
interspersed delay intervals of 500 or 8,000 ms. After the delay interval, the participant 
indicated the remembered location of the cue by touching that area of the screen with a 
touch-pen device (FastPoint Technologies, Inc.). Visual cues were presented at 4 
different locations in each of 4 quadrants for the 2 delay conditions. Visual cue 
eccentricities were 10 to minimize the use of edge or center cues and ensure cues did not 
fall within the participant‟s blind spot, and locations of 0, 90, 180, and 270 were not 
included to minimize the use of spatial referencing to exact vertical and horizontal 
positions. 
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A block of 16 “no delay” trials (during which the target appeared but remained 
on-screen) was also administered prior to the delay trials to measure basic perceptual and 
visuomotor abilities independent of memory. Average accuracy (in millimeters) and 
response times (in milliseconds) are reported for each condition. 
Planning 
Tower of London (TOL CANTAB; Owen et al., 1990). This test measured 
planning ability. The task consisted of a problem-solving block and a yoked following 
block. During the problem-solving block, participants viewed two displays of colored 
balls, presented simultaneously, on a computer screen. One of these displays was the 
target, and the second was the participant‟s workspace. Using a computerized touch-
screen, participants moved the colored balls within their own workspace to match the 
target display (problem-solving block). Participants were told at the start of each 
problem-solving trial that the trial should be completed in X number of moves, where X 
was the minimum number of moves required to achieve a perfect solution. This 
instruction was provided to encourage participants to plan their moves to achieve perfect 
solutions. The total number of problems in which participants responded with the 
minimum number of moves is recorded and expressed as a proportion of total possible 
perfect solutions. Participants were instructed not to make the first move until they knew 
which balls to move and were encouraged to solve the problem correctly on the first try. 
The time from presentation of the problem to starting to solve the problem (planning 
time) is reported.  
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During the yoked following block, participants were instructed to repeat moves 
that were executed by the computer. Unbeknownst to the participant, the computer-
generated moves on the yoked following block replicated the exact moves that the 
participant made during the problem-solving block trials. Participants‟ response times 
during yoked following trials provided measures of basic motor speed in the absence of 
planning and/or problem solving. For each trial, first move initiation (or planning) time 
was the time between the presentation of the problem and the execution of the first move 
minus the initiation time from the yoked following block trial. First move initiation time, 
percent perfect solutions, and average moves on 2-, 3-, 4-, and 5-move problems are 
examined. 
The CANTAB battery, from which this task is derived, was updated in the course 
of the project. At their baseline assessment, controls completed a version of the task that 
contained problems that could be solved in 2-, 3-, 4-, and 5-moves, presented in that 
order. At follow-up, 27 controls completed the updated version of the task that contained 
2-, 3-, 4-, 5- and 6-move problems, while 4 received the earlier version. Cannabis users 
completed the second updated version (2- to 6-move problems) at both time points. To 
harmonize scoring between the groups and assessment time points, only scores from the 
2- to 5-move problems were included in the analyses.  
Motivated Decision-Making 
Iowa Gambling Task (IGT: Bechara, Damasio, Damasio, & Anderson, 1994). 
This task measured motivated decision-making ability. Participants completed a 
computerized version of the IGT during which they selected from among four decks of 
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cards varying in their amounts of monetary reward and punishment (Table 5; Bechara et 
al., 1994). Participants worked to earn real money (maximum of $5). For each selection 
from Decks 1 or 2 (the “disadvantageous/bad decks”), participants won $0.25 but also 
incurred losses so that over 20 selections from these decks, participants incurred a net 
loss of $1.25. Decks 1 and 2 differed in the frequency and magnitude of punishment: 
Deck 1 contained frequent (50% of cards) but smaller ($0.35-$0.90) punishments, 
whereas Deck 2 contained less frequent (10% of cards) but much larger ($3.00-$3.25) 
punishments. For each selection from Decks 3 or 4 (the “advantageous/good decks”), 
participants won either $0.10 or $0.15 and the losses were organized so that over 20 
selections from these decks, participants accrued a net gain of $1.25. Similar to the 
disadvantageous decks, the two advantageous decks differed from each other in the 
frequency of punishment: Deck 3 contained frequent (50% of cards) but smaller ($0.05-
$0.20) punishments, and Deck 4 contained less frequent (10% of cards) but larger 
punishments ($0.60-$0.65). The decks were presented in order from left to right on the 
computer screen at baseline, then the order of the decks was shuffled at the follow-up 
assessment to minimize practice effects.  
For analysis, trials (n = 100) were divided into 5 blocks with 20 trials per block. 
For each block, the number of choices from disadvantageous decks was subtracted from 
number of choices from advantageous decks. Thus, values above “0” correspond to 
relatively advantageous choices. In addition, the actual numbers of selections made from 
each deck were tabulated across the full task to analyze choice preferences. 
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1.2.3.2 Substance Use 
Amount and frequency of substance use were assessed with the K-SADS-PL 
interview at baseline and at follow-up for cannabis users and controls. Controls selected 
from the larger database were included in these analyses if they reported minimal 
cannabis use (no more than once monthly) and no other illicit substance use. Substance 
use patterns within the cannabis users were more variable, as inclusion criteria did not 
require abstinence from non-cannabis illicit substances. Therefore, multiple measures 
were employed to characterize substance use patterns in cannabis users.  
An in-house interview questionnaire based on guidelines provided by the NIAAA 
was implemented at baseline and follow-up to assess detailed frequency and quantity of 
alcohol and cannabis use among cannabis users. This measure assessed frequency of use, 
typical number of hits per use occasion, and largest number of hits consumed in 24 hours, 
each of which was assessed for the prior 12 months and prior 30 days. Total number of 
hits within the last 12 months was calculated as a product of the number of occasions a 
participant used cannabis during the past year and the typical number of hits used per 
occasion, capturing both the frequency and quantity of cannabis use patterns. 
At baseline and follow-up, cannabis users completed the Personal Experience 
Inventory (Henley & Winters, 1989) to assess other substance use. The PEI measures the 
frequency of substance use within the last 12 months on a 5-point scale (never, 1-5 times, 
6-20 times, 21-49 times, 50-99 times, 100+ times). Non-cannabis drug use for the 12 
months prior to each assessment was calculated by summing the frequency ratings across 
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illicit drug classes (psychedelics, cocaine, amphetamines, barbiturates, tranquilizers, 
heroin, narcotics, steroids, inhalants, and recreation use of prescription drugs).  
All participants completed the Achenbach‟s Adult Self-Report (ASR; Achenbach 
& Rescorla, 2003) questionnaire, yielding substance use scales of self-reported daily 
tobacco use, number of days drunk, and days using drugs (other than alcohol or tobacco) 
for the previous 6 months.  
1.2.4 Statistical Approach 
Data were analyzed using the Statistical Package for the Social Sciences (SPSS 
Inc., Chicago, IL, USA), Windows version 20. Data were screened for outliers and 
influential data points. Distributions of all variables were examined and variables that did 
not meet the assumptions for parametric analysis were square root transformed, including 
error variables for the Letter Cancellation, RAVLT, and COWAT, substance use 
variables from the ASR, and total number of cannabis hits within the past year for 
cannabis users. Chi-square tests were used to compare nominal variables (i.e., sex) 
between cannabis users and controls. Mann-Whitney U analyses assessed for group 
differences in substance use characteristics given that variances were unequal between 
groups.  
 In order to characterize cognitive performance, both cognitive composite scores 
and separate task variables were examined. Composite scales were created in a two-step 
process by first selecting measures according to known cognitive domains (Lezak et al., 
2004), then refining composites according to internal reliability analyses (Delis, 
Jacobson, Bondi, Hamilton, & Salmon, 2003). This method is consistent with several 
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other studies examining cognitive performance among adolescent and young adult 
substance users (Hanson & Luciana, 2010; Hanson et al., 2010; Jacobus et al., 2014; 
Medina et al., 2007, 2009). Individual neuropsychological test variables were converted 
to z-scores based on the whole sample of participants at both time points (n = 126). Z-
scores were transformed such that higher scores represented better performance across all 
variables. Next, the individual test z-scores were averaged to form the final composite 
score for each cognitive domain. Internal consistencies of the composite scores were 
assessed using Cronbach‟s  coefficient.  
 Six cognitive composites were created: (1) Processing speed ( = 0.60; Letter 
Cancellation time, Digit Symbol total correct, COWAT total correct words); (2) Verbal 
learning and memory ( = 0.91; RAVLT trial 1-5 total words, RAVLT immediate recall, 
RAVLT delayed recall); (3) Spatial working memory and planning ( = 0.73; SWM 
strategy score, SWM total errors, TOL % perfect solutions, TOL total average moves); 
(4) Motor speed ( = 0.91; Finger Tapping dominant hand taps, Finger Tapping non-
dominant hand taps); (5) Motor dexterity ( = 0.82; Grooved Pegboard dominant hand 
time, Grooved Pegboard non-dominant hand time). 
For all reported analyses, alpha levels equal to or below 0.05 were considered 
statistically significant, and alpha levels at or below 0.10 were considered trend effects. 
Baseline 
Univariate and repeated measures analyses of variance (ANCOVA) assessed for 
group differences in the same way as the earlier report (Becker et al., 2014). The 
Greenhouse-Geisser method was used to adjust the degrees of freedom where appropriate 
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(Greenhouse & Geisser, 1959). Sex, IQ, and alcohol use were covaried in all group 
comparisons. Alcohol use was quantified as an average of two alcohol use variables that 
were z-scored across the whole sample (controls and cannabis users). The first alcohol 
use variable was calculated by multiplying the participants‟ self-reported average 
drinking occasions per week and the average number of alcoholic drinks per occasion for 
the previous 6 months, as assessed by direct K-SADS-PL interview (occasions per week 
× number of drinks); responses were coded on an ordinal scale for occasions per week (1 
= 0 occasions, 2 = 1-2 occasions, 3 = 3+ occasions) and number of drinks (1 = 0 drinks, 
2 = 1-2 drinks, 3 = 3+ drinks). Ordinal scaling was used because the responses were 
derived from ordinal ratings on the K-SADS-PL interview. The second alcohol use 
variable was the number of days that the participant reported being drunk in the last 6 
months, as assessed by the ASR questionnaire.  
Due to the study‟s inclusion criteria, controls had no history of tobacco use or 
non-alcohol-related drug use. For cannabis users, illicit drug use was calculated from 
responses on the PEI.  Patterns of daily tobacco use were quantified by responses to 
questions from the ASR and K-SADS. Levels of alcohol, tobacco, and other drug use 
differed between groups, but alcohol use was the only variable that could be used in 
between-group analyses. The contributions of tobacco and other drug use to cognition in 
the cannabis users were examined within cannabis users using partial correlations to 
explore the extent to which other substance use contributed to performance where group 
differences were observed. Alcohol, tobacco, drug use, and cannabis use variables were 
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correlated with task performance in cannabis users, controlling for sex, IQ, and other 
substance use.  
To ensure that the sample of participants who returned for follow-up assessment 
was equivalent to the full baseline sample, Univariate ANOVA and Mann-Whitney U 
analyses assessed for group differences between participants who returned for follow-up 
assessment and participants who were lost to follow-up. These analyses were conducted 
separately for control and cannabis user samples. 
Follow-up 
Repeated measures ANCOVA was used to characterize change between baseline 
and follow-up performance. This approach examined differences between groups on 
cognitive performance, as well as the group  time interaction effect. The Greenhouse-
Geisser method was used to adjust the degrees of freedom where appropriate. Repeated 
measures ANCOVA is most appropriate when samples are well-balanced, have the same 
number of time points, and when time interval to follow-up time is generally consistent 
(Taris, 2000). Each of these conditions is satisfied in the current sample. Repeated 
measures ANCOVA was also used to be consistent with the limited existing literature 
characterizing change in cognitive performance in cannabis users given that others have 
used this approach (Hanson et al., 2010; Jacobus, Squeglia, Bava, et al., 2013; Jacobus, 
Squeglia, Infante, Bava, & Tapert, 2013; Jacobus et al., 2015, 2014; Tait et al., 2011). All 
repeated measures ANCOVAs covaried time interval to follow-up, sex, IQ, and average 
alcohol use during time interval to follow-up. Average alcohol use was quantified in the 
same manner as described above, as an average of two alcohol use variables (occasions 
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per week  number of drinks, number of days that the participant reported being drunk in 
the last 6 months) that were z-scored across the whole sample at baseline and follow-up 
(controls and cannabis users). The resulting estimates of average alcohol use at baseline 
and follow-up were averaged to create a measure of average alcohol use during baseline 
and follow-up. Estimates of average alcohol use did not change over time (t(53) = -1.00, 
p = .321). 
Within the cannabis user group, hierarchical regression analyses, as described in 
the results section, explored whether cannabis use factors were associated with greater or 
less than predicted change in cognitive performance from baseline to follow-up. 
1.3 Results 
1.3.1 Baseline 
1.3.1.1 Sample Characteristics 
Demographic information and participant characteristics are presented in Table 1. 
Samples were matched on age, ethnicity/racial identity, educational attainment, and IQ. 
Both samples performed in the high average range of IQ performance, which is consistent 
with similar studies comparing non-substance users and substance users in a college 
population (Croft, Mackay, Mills, & Gruzelier, 2001; Hanson et al., 2008). There were 
significantly more males among cannabis users. This is consistent with the sex 
distribution of cannabis users in this age range (Substance Abuse and Mental Health 
Services Administration, 2013). 
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Given selection procedures, controls had no full-syndrome psychopathology at 
baseline. Outside of substance use disorders, cannabis users reported little 
psychopathology (Table 2). One cannabis user participant met criteria for current Bipolar 
Disorder NOS; another met criteria for past Bipolar Disorder NOS. Both disorders were 
diagnosed based on episodic hypomania. This finding is consistent with the reported 
comorbidity between substance use disorders and bipolar disorder (Perlis et al., 2004; 
Wilens et al., 2008). Other psychological disorders evident in cannabis users included 
past Oppositional Defiant Disorder (n = 2) and past Specific Phobia (n = 1). To assess if 
comorbid psychopathology contributed to the between groups findings, data were 
analyzed with and without inclusion of these individuals. 
1.3.1.2 Substance Use Characteristics 
Cannabis users had significantly higher average alcohol use (p < .001; Table 1). 
Further, as would be expected from national norms among cannabis users (Substance 
Abuse and Mental Health Services Administration, 2013), users had greater tobacco use, 
days drunk, and days using drugs in the last 6 months compared to controls. Despite 
differences from the control sample, cannabis users reported relatively little substance use 
outside of cannabis and alcohol. The majority of cannabis users had tried other drugs 
fewer than 5 times (See Table 4). As a result of exclusion criteria, controls reported no 
cannabis use beyond 1x/month. Cannabis users reported a mean age of initiation of 
regular cannabis use during mid-adolescence (M = 15.24, SD = 1.23) with a range from 
13 to 18 years. Cannabis users reported nearly daily cannabis use during the past 30 days, 
with a self-reported average of 262.69 hits within the last 30 days; however, there was 
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considerable variability in the number of total hits, with a standard deviation of 200.41, 
and a range of 45-750.  
DSM-IV-TR substance use disorder diagnostic characteristics. Almost all 
cannabis users met criteria for current and/or past cannabis substance use disorder (Table 
2) and many met criteria for current and/or past alcohol abuse. Substance use symptom 
patterns were examined in detail to clarify symptom expression related to alcohol, 
cannabis, and other drug use (Table 3). Cannabis users exhibited fewer symptoms related 
to alcohol use (M = 0.97, SD = 1.24 current symptoms per person; M = 1.30, SD = 1.53 
past symptoms per person) than related to cannabis use (M = 4.14, SD = 1.92 current 
symptoms per person, U = 125, p < .001; M = 4.35, SD = 1.83 past symptoms per 
person, U = 142.0, p < .001). No substance use disorder symptoms related to other drug 
use were expressed among cannabis users or controls. As a result of exclusion criteria, 
controls exhibited very few symptoms related to alcohol use (M = 0.11, SD = 0.32 
current symptoms per person; M = 0.03, SD = 0.17 past symptoms per person), and no 
symptoms related to other drug use. 
1.3.1.3 Baseline Group Differences in Neurocognitive Performance 
Tables 6 and 7 present neurocognitive data for cognitive composites and specific 
task variables (marginal means and standard errors) as well as relevant statistics for each 
group. Major findings will be summarized here within the text. 
Motor Function 
Groups were equivalent on the motor speed and motor dexterity cognitive 
composites. No laterality differences emerged between groups (Group  Hand 
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interactions in repeated measures ANCOVA). When task variables were analyzed 
separately, there was a trend for cannabis users to demonstrate faster motor speed on 
dominant hand Finger Tapping. Groups had equivalent performance on non-dominant 
hand Finger Tapping and on the Grooved Pegboard.  
Processing Speed 
Cannabis users exhibited better performance on the processing speed composite 
relative to controls. Task by task analyses revealed that cannabis users exhibited faster 
Letter Cancellation completion times. Omission and commission errors were equivalent 
between groups, and completion times were uncorrelated with overall errors in both 
groups. Groups did not differ in their Digit Symbol performance. Cannabis users 
displayed greater verbal fluency than controls, producing more correct responses on the 
COWAT. Cannabis users also made greater set-loss errors than controls. A marginal 
positive partial correlation was observed between correct COWAT responses and set-loss 
errors among cannabis users (r(31) = .293, p = .098) but not controls (r(30) = .018, p = 
.922), controlling for sex, IQ, and alcohol use. No group difference was noted for 
perseverative errors. 
Verbal Learning and Memory 
The groups were equivalent on Digit Span forward performance. Cannabis users 
recalled marginally fewer digits on the digits backward condition of the task.  
Controls performed better than cannabis users on the verbal learning and memory 
cognitive composite. A repeated measures ANCOVA was used to analyze all RAVLT 
trials, with RAVLT trial (learning trials 1-5, interference trial, immediate recall, and 
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delayed recall) as a within subjects factor and group as a between subjects factor. A main 
effect of time, F(4.949, 326.62) = 2.861, p = .016, ηp
2 
= .04, group, F(1, 66) = 6.25, p = 
.015, ηp
2 
= .09, and a Group  Trial interaction, F(4.949, 326.62) = 2.375, p = .039, ηp
2 
= 
.04, emerged. Follow-up one-way ANCOVAs revealed that there was a trend for 
cannabis users to recall fewer words on trials 4 and 5. Cannabis users performed worse 
than controls on the interference trial. Following the interference trial, cannabis users 
demonstrated poorer immediate recall as well as poorer 30-minute delayed recall relative 
to controls. Cannabis users exhibited a lower percent of learning after consolidation, F(1, 
66) = 6.84, p = .011, ηp
2 
= .09 (cannabis user M = 77.68%, SE = 3.13; control M = 
90.87%, SE = 3.19). There was a trend for cannabis users to show greater proactive 
interference than controls (Trial 1 vs. Interference Trial), Group  Trial interaction F(1, 
66) = 2.90, p = .093, ηp
2 
= .04. No Group  Trial interaction emerged for retroactive 
interference (Trial 5 vs. Immediate Recall).  
There was a trend for cannabis users to produce more intrusion errors during 
learning trials. The number of perseverative errors during list learning was equivalent 
between groups. 
Spatial Memory 
Groups demonstrated equivalent performance on the spatial working memory and 
planning composite. 
No significant group differences were evident on the SWM test in relation to 
memory errors or strategy score.  
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On the Spatial Delayed Response Task (DRT), groups were equivalent in their 
accuracies and response latencies for the no delay condition, indicating that the basic 
sensorimotor functions required for the task were similar between groups. Cannabis users 
demonstrated a trend toward decreased accuracy on the 500 ms delay condition, and a 
significant effect of decreased accuracy on the 8,000 ms delay condition. Cannabis users 
had significantly longer response latencies (slower performance) after both 500 ms and 
8,000 ms delays. Accuracy and response latencies were uncorrelated in cannabis users 
and controls for the 500 ms (cannabis user r(31) = -.176, p = .327; control r(30) = -.157, 
p = .390) and 8,000 ms (cannabis user r(31) = -.184, p = .305; control r(30) = -.109, p = 
.551) delay conditions, controlling for sex, IQ, and alcohol use. 
Planning 
Cannabis users produced fewer perfect solutions on the Tower of London (TOL) 
task, indicating that they made more moves than necessary to achieve accurate 
performance. When task difficulty levels were examined, cannabis users made 
significantly more moves than controls to complete 3-move problems, which are 
considered to be relatively easy. Cannabis users had marginally slower initiation times 
during 2-move problems, and faster initiation times during 5-move problems. 
Motivated Decision-Making 
On the Iowa Gambling Task (IGT), total good minus bad choices over five blocks 
of the task were examined with block as the within subjects factor and group as the 
between subjects factor in a repeated measures ANCOVA. This approach is standard for 
the task (Bechara et al., 2001; Fridberg et al., 2010; Verdejo-García, Benbrook, et al., 
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2007). A marginal Group  Block interaction, F(3.08,200.19) = 2.214, p = 0.086, ηp
2 
= 
0.03, and a significant main effect of group, F(1,65) = 9.19, p = 0.003, ηp
2 
= 0.12, were 
observed. Across the task, cannabis users made fewer advantageous choices. Follow-up 
one-way ANCOVAs revealed a marginal group difference on Blocks 2 and 3, and a 
significant group difference on Blocks 4 and 5, with cannabis users making fewer 
advantageous deck selections on all blocks. Analyses of deck choices revealed that 
cannabis users made significantly more choices from disadvantageous Decks 1 and 2 than 
controls, and marginally fewer choices than controls from advantageous Decks 3 and 4 
(deck contingencies described in Table 5). 
1.3.1.4 Baseline Neurocognitive Performance and Substance Use 
For all significant group effects described above, alcohol, tobacco, non-cannabis 
drug, and cannabis use measures were each separately examined for associations with 
task performance within cannabis users (Table 8). Substance use measures were 
uncorrelated with one another (Table 8).  
Cannabis. Earlier age of cannabis use initiation was correlated with slower 
reaction time on the 500 ms and 8,000 ms delay conditions of the DRT, and greater 
average moves on 3-move problems for the TOL.  
Greater use in the past year (total # hits) was correlated with greater errors on the 
500 ms condition of the DRT and faster initiation times on 5-move TOL problems. 
Greater use was marginally correlated with recall of fewer words during the interference 
trial of the RAVLT. Other cannabis use variables, including number of days participants 
used cannabis in the past year and past 30 days, and total number of hits in the past 30 
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days, were not significantly correlated with the cognitive performance measures that 
distinguished cannabis users from controls. 
Alcohol. For the verbal learning and memory composite, learning and recall 
measures of the RAVLT, errors made within the 8,000 ms delay condition of the delayed 
response task, and TOL average moves on 3-move problems, greater alcohol use was 
unexpectedly associated with better task performance in cannabis users. There was a 
trend for greater alcohol use to be associated with faster reaction times on the 8,000 ms 
delay condition of the DRT and higher percent perfect solutions on the TOL. Alcohol use 
was not significantly correlated with other task performance variables.  
Tobacco. Cognitive performance was not significantly correlated with tobacco 
use within cannabis users.  
Non-cannabis drug use. Greater non-cannabis drug use was unexpectedly 
correlated with a higher percentage of learned words recalled after a delay on the RAVLT 
as well as faster initiation times (decreased planning) on 5-move TOL problems. There 
was a trend for greater non-cannabis drug use to be correlated with poorer processing 
speed composite scores, fewer errors on the COWAT, and better performance on the 
delayed recall on the RAVLT.  
Impact of Comorbid Psychopathology 
Significant group differences as described above remained unchanged when 
cannabis users with psychopathology outside of SUDs (n = 5) were excluded. 
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1.3.1.5 Baseline Demographic Characteristics and Cognitive 
Performance in Follow-up sample 
To ensure that the subset of participants who returned for follow-up was 
representative of the full sample assessed at baseline, demographic and substance use 
characteristics were compared between participants who returned for follow-up versus 
those who did not. 
Follow-up Sample: Baseline Sample Characteristics (Table 9) 
Participants who returned for follow-up assessment and participants who did not 
return were equivalent in age, ethnicity/racial identity, and IQ. Controls were equivalent 
in sex; among cannabis users, there was a trend for more males to be in the follow-up 
sample relative to those who did not return for follow-up. Cannabis users were matched 
on educational achievement, though there was a trend for controls who returned for 
follow-up assessment to have somewhat lower educational achievement at baseline, 
which was not fully accounted for by age (F(1, 31) = 6.676, p = .015, ηp
2 
=
 
.18, with age 
covaried). 
The follow-up sample and participants lost to follow-up were equivalent on 
alcohol and tobacco use. In controls, both samples were equivalent on drug use. In the 
cannabis user sample, those who returned for follow-up assessment endorsed fewer 
occasions of drug use during the past 6 months (at baseline), and marginally fewer 
cannabis use occasions when compared to those who did not return for the follow-up 
assessment. Both samples reported equivalent age of cannabis use initiation, and total 
number of hits within the last 3 and 12 months.  
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Follow-up Sample: Baseline Neurocognitive Performance 
Significant baseline group differences remained largely unchanged when the 
sample was reduced to participants who completed the follow-up assessment (see Table 
11, which reports the baseline marginal mean and standard errors for task variables 
among the participants who returned for the follow-up assessment). 
On the Finger Tapping Test, the trend for cannabis users to display a greater 
number of taps with the dominant hand became fully significant, F(1, 50) = 4.17, p = 
.046, ηp
2 
= .08. There was no longer a significant or marginal group difference in spatial 
DRT errors made during the 500 ms (p = .266, ηp
2 
= .03) or 8,000 ms (p = .123, ηp
2 
= 
.05) delay conditions of the task. The trends for cannabis users to recall fewer words on 
the RAVLT Trial 4 (p = .277, ηp
2 
= .02) and Trial 5 (p = .193, ηp
2 
= .03) were no longer 
significant. On the Tower of London, the trend for cannabis users to display slower 
initiation time on 2-move problems became fully significant, F(1, 50) = 5.253, p = .026, 
ηp
2 
= .10, and the finding that cannabis users had faster initiation times on 5-move 
problems was no longer significant (p = .273, ηp
2 
= .02). The trend for cannabis users to 
have lower IGT good-bad choices during block 2 was no longer significant (p = .110, ηp
2 
= .05). The trend for cannabis users to make fewer choices from Deck 3 became fully 
significant F(1, 50) = 4.70, p = .035, ηp
2 
= .09.  
Given the smaller sample size in these follow-up analyses, a reduction in power to 
detect group differences cannot be ruled out. Comparing baseline differences between 
groups within the full sample at baseline yields a power estimate of 0.54 to detect the 
medium effect size observed among significant and trend group differences at baseline 
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(average ηp
2 
= 0.088 in whole sample), whereas the power estimate was reduced to 0.41 
to detect a medium effect size in the reduced sample.  
1.3.2 Follow-up 
1.3.2.1 Sample Characteristics 
Demographic information and participant characteristics at follow-up are 
presented in Table 1. Demographic characteristics mirrored those found at baseline.  
1.3.2.2 Substance Use Characteristics 
At follow-up, cannabis users continued to report significantly higher alcohol use, 
tobacco use, and days using drugs than controls (see Tables 1 and 4). Cannabis users 
continued to report relatively little substance use outside of cannabis and alcohol use, and 
control subjects reported minimal experimentation with cannabis and no other substance 
use (Table 4).  
Increased occasions using alcohol per week (responses coded on an ordinal scale 
for occasions per week, 1 = 0 occasions, 2 = 1-2 occasions, 3 = 3+ occasions) were 
reported among controls, t(28) = -3.087, p = .005 (baseline M = 1.72, SD = 0.53, follow-
up M = 2.03, SD = 0.50) and cannabis users, t(25) = -6.325, p < .001 (baseline M = 2.19, 
SD = 0.49; follow-up M = 2.81, SD = 0.49). Controls reported an increase in the quantity 
of alcohol consumed on a typical occasion of use (number of drinks, 1 = 0 drinks, 2 = 1-
2 drinks, 3 = 3+ drinks), t(28) = -3.087, p = .005 (baseline M = 2.17, SD = 0.89, follow-
up M = 2.55, SD = 0.78) and cannabis users reported no change in the typical quantity of 
alcohol consumed per use occasion. Alcohol use occasions per week × quantity of use 
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was marginally increased at follow-up among controls, t(28) = -2.015, p = .054 (baseline 
M = 4.14, SD = 2.37; follow-up M = 5.14, SD = 2.37), and cannabis users, t(26) = -
6.261, p < .001 (baseline M = 6.48, SD = 1.67; follow-up M = 8.35, SD = 1.92). No 
significant change was reported on average days drunk in the past 6 months. Participants 
reported no significant change in tobacco use per day in the past 6 months. 
Cannabis users reported a decreased number of days using cannabis in the past 
year, t(25) = 3.266, p = .003, and in the past 30 days, t(25) = 4.133, p < .001 at follow-up 
versus baseline (Table 1). Despite the decline in use, regular use continued to be reported 
by the majority of cannabis users (median use occasions in past year = 287.90 [range of 
0-365], and past 30 days = 19.25 [range of 0-30]). The average number of hits per day 
did not change between time points, though considerable variability remained among 
participants. No significant change was noted in the typical number of cannabis hits per 
occasion used. Cannabis users reported a decrease in the number of days using drugs in 
the past 6 months, t(23) = 2.167, p = .041, while no significant change was noted in 
controls‟ reported days using drugs other than alcohol. 
1.3.2.3 Group Differences in Neurocognitive Performance at Follow-Up 
(Tables 10 and 11) 
Repeated measures ANCOVAs, with cognitive variables as a within subjects 
factor, group status as a between-subjects factor, and the covariates of IQ, sex, time 
interval to follow-up, and average alcohol use during baseline and follow-up, were used 
to measure change between baseline and follow-up for each of the cognitive measures. 
Main effects of group would suggest differences between groups, regardless of time 
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point. Main effects of time would suggest differences between time points, regardless of 
group. Group  Time interactions suggest that the groups differ either in their baseline or 
follow-up performance or in the magnitude of change over time. Significant and marginal 
interactions were followed-up with one- or two-way ANCOVAs, with the nuisance 
covariates of IQ, sex, time interval to follow-up, and average alcohol use within time 
point. All cognitive composite scores and task variables were analyzed to mirror the 
statistical approach at baseline. Only marginal and significant group or Group  Time 
interactions will be described below. 
Motor Function 
A marginal Group  Time interaction for the dominant hand completion time on 
the grooved pegboard task was found, but follow-up one-way ANCOVAs indicated that 
there were no significant group differences at both baseline, F(1, 50) = 0.131, p = .719, 
ηp
2 
< .00, and follow-up, F(1, 50) = 2.562, p = .116, ηp
2 
= .05. The effect size at follow 
up was higher than at baseline with findings approaching significance, which may 
account for the interaction. A main effect of time was not significant for controls (p = 
.606, ηp
2 
= .01) or cannabis users (p = .970, ηp
2 
< .00) when groups were analyzed 
separately.  
Processing Speed 
Cannabis users performed better relative to controls on the processing speed 
composite regardless of time point.  
A main effect of group on Letter Cancellation completion time indicated that 
cannabis users demonstrated faster completion times than controls. A marginal Group  
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Time interaction on Letter Cancellation omission errors was found, but follow-up one-
way ANCOVAs indicated that groups were equivalent at both baseline, F(1, 50) = 0.085, 
p = .771, ηp
2 
< .00, and follow-up, F(1, 50) = 1.300, p = .260, ηp
2 
= .03. A main effect of 
time was not significant for controls (p = .697, ηp
2 
= .01) or cannabis users (p = .225, ηp
2 
= .06) when groups were analyzed separately. A main effect of time point was observed 
for total correct words generated on the COWAT, F(1, 49) = 4.202, p = .046, ηp
2 
= .08, 
with more words generated at follow-up than at baseline. 
Verbal Learning and Memory 
There was a marginal main effect of group on the verbal learning and memory 
composite, with cannabis users demonstrating poorer performance than controls 
regardless of time point (Figure 1).  
 
Figure 1. Learning and memory composite score change between baseline and follow-
up. Error bars represent standard errors. Means reported are marginal means, controlling 
for interval, sex, IQ, and average alcohol use at baseline and follow-up. 
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Follow-up RAVLT task variables were examined using a repeated measures 
ANCOVA, with RAVLT trial (number of words recalled on learning trials 1-5, 
interference trial, immediate recall, and delayed recall) as a within subjects factor and 
group status as a between-subjects factor. This analysis includes interference trial 
performance, whereas the composite excludes that trial. At follow-up, main effects of 
RAVLT trial (p = .169, ηp
2 
= .03), group (p = .632, ηp
2 
= .01), and a Group  RAVLT 
trial interaction (p = .346, ηp
2 
= 02) were all non-significant (Figure 2).  
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Figure 2. RAVLT performance across trials at baseline and follow-up for cannabis users 
and controls. Error bars represent standard errors. Means reported are marginal means, 
controlling for interval, sex, IQ, and average alcohol use at baseline and follow-up. 
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Post-hoc analyses examined individual RAVLT trials with a repeated measures 
ANCOVA, with time point as a within subjects variable and group as a between-subjects 
variable (main effects of group and Group  Time interactions are reported in Table 11). 
A marginal Group  Time interaction on Trial 1 was followed-up with one-way 
ANCOVAs to examine baseline and follow-up performance. Groups demonstrated 
equivalent performance at baseline, F(1, 50) = 0.590, p = .446, ηp
2 
= .01, but were 
significantly different at follow-up, with cannabis users recalling fewer words than 
controls at follow-up, F(1, 50) = 10.407, p = .002, ηp
2 
= .17 (Figure 3). A marginal main 
effect of time was observed within cannabis users (p = .071, ηp
2 
= .15), but not controls 
(p = .425, ηp
2 
= .03) when groups were analyzed separately. 
 
Figure 3. RAVLT Trial 1 words recalled change between baseline and follow-up. Error 
bars represent standard errors. Means reported are marginal means, controlling for 
interval, sex, IQ, and average alcohol use at baseline and follow-up. 
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users. A main effect of group was observed for total intrusions during learning trials was 
observed, with cannabis users making more errors. 
Spatial Memory 
There was a trend main effect of group on the spatial working memory and 
planning composite, with cannabis users demonstrating poorer performance than 
controls. 
A main effect of time point was observed on the DRT for errors on the no delay 
condition, F(1, 49) = 4.477, p = .039, ηp
2 
= .08, with more errors at follow-up than at 
baseline, though when groups were analyzed separately, this effect was only significant 
in cannabis users (p = .025, ηp
2 
= .21) and not controls (p = .819, ηp
2 
< .00). A main 
effect of group and a Group  Time interaction were observed for reaction time on the 
500 and 8,000 ms delay conditions. Follow-up analyses indicated that cannabis users had 
greater reaction times than controls at baseline, 500 ms: F(1, 50) = 14.16, p < .000, ηp
2 
= 
.22; 8,000 ms: F(1, 50) = 12.722, p = .001, ηp
2 
=. 20, but had equivalent performance at 
follow-up, 500 ms: F(1, 50) = .687, p = .411, ηp
2 
= .01; 8,000 ms: F(1, 50) = 0.550, p = 
.462, ηp
2 
= .01 (Figure 4). Main effect of time was not significant for either group in both 
conditions when groups were analyzed separately. 
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Figure 4. DRT reaction time on 500 ms 8,000 ms delay condition change between 
baseline and follow-up. Error bars represent standard errors. Means reported are marginal 
means, controlling for interval sex, IQ, and average alcohol use at baseline and follow-
up. 
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A main effect of group was found for the TOL percent perfect solutions, with 
cannabis users performing worse than controls overall. Examination of separate difficulty 
levels of the TOL revealed a main effect of group and a significant Group  Time 
interaction for average moves to complete 3-move trials (Figure 5). Cannabis users 
required more moves to complete these trials accurately at baseline, F(1, 49) = 6.074, p = 
.017, ηp
2 
= .11, and at follow-up, F(1, 50) = 4.383, p = .041, ηp
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Figure 5. Average moves to complete 3-move trials change between baseline and follow-
up. Error bars represent standard errors. Means reported are marginal means, controlling 
for interval, sex, IQ, and average alcohol use at baseline and follow-up. 
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interaction on first move initiation time was observed for 4-move problems. Groups did 
not significantly differ at baseline, F(1, 49) = 1.077, p = .304, ηp
2 
= .11, but were 
significantly different at follow-up, F(1, 48) = 4.332, p = .043, ηp
2 
= .08, with cannabis 
users demonstrating faster initiation times than controls (Figure 6). 
 
Figure 6. Change between baseline and follow-up on first move initiation time for 4-
move problems. Error bars represent standard errors. Means reported are marginal means, 
controlling for interval, sex, IQ, and average alcohol use at baseline and follow-up. 
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Block  Group interaction, F(2.80, 125.86) = 3.692, p = .016, ηp
2 
= .08, were observed, 
whereas main effects of IGT block or group, or Time  IGT block or Group  Time  
IGT block interactions were not observed (Figure 7).  
 
Figure 7. IGT good minus bad deck choices across blocks at baseline and follow-up. 
Error bars represent standard errors. Means reported are marginal means, controlling for 
interval, sex, IQ, and average alcohol use at baseline and follow-up. 
 
To more fully understand the interactions, a repeated measures ANCOVA, with 
IGT block and time point as within subjects factors, was repeated for each group 
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separately. Both groups demonstrated a main effect of time (controls: F(1, 20) = 5.165, p 
= .034, ηp
2 
= .20; cannabis users: F(1, 21) = 6.396, p = .020, ηp
2 
= .23), demonstrating 
improvement between baseline and follow-up, and cannabis users demonstrated a Time 
Point  Interval interaction, F(1, 21) = 8.621, p = .008, ηp
2 
= .29, whereas controls did 
not show this effect (p = .789, ηp
2 
< .00). Greater advantageous choices at follow-up were 
associated with shorter time interval to follow-up only among cannabis users (cannabis 
rpartial = -.595, p = .004; controls rpartial = -.178, p = .439), controlling for IQ, sex, and 
average alcohol use.  
To characterize group differences at follow-up, a repeated measures ANCOVA 
with IGT block as a within subjects factor and group status as a between-subjects 
variable. Main effects of IGT block (p = .961, ηp
2 
< .00), group (p = .409, ηp
2 
= .02), and 
a Group  IGT Block interaction (p = .261, ηp
2 
= .03) were all non-significant. Groups 
differed at baseline but showed equivalent performance at follow-up. 
To explore performance change between baseline and follow-up across blocks, 
repeated measures ANCOVAs were performed with time point (baseline and follow-up) 
as a within subjects factor and group as a between-subjects factors (main effects of group 
and Group  Time interactions are reported in Table 11). Significant and marginal main 
effects of time were observed for Block 1 F(1,45) = 7.781, p = .008, ηp
2 
= .15, Block 2 
F(1,45) = 7.691, p = .008, ηp
2 
= .15, Block 3, F(1,45) = 3.956, p = .053, ηp
2 
= .08, and 
Block 5, F(1,45) = 6.859, p = .012, ηp
2 
= .13, all indicating better performance at follow-
up relative to baseline. When groups were analyzed separately, only cannabis users 
demonstrated a main effect of time across the majority of blocks (cannabis user Block 1: 
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p = .009, ηp
2 
= .28; Block 2: p = .041, ηp
2 
= .18; Block 4: p = .005, ηp
2 
= .33; Block 5: p 
= .014, ηp
2 
= .25), and controls did not (control Block 1: p = .814, ηp
2 
< .00; Block 2: p = 
.122, ηp
2 
= .12; Block 4: p = .182, ηp
2 
= .09; Block 5: p = .121, ηp
2 
= .12). Cannabis users 
and controls had equivalent Block 1 performance at both baseline (p = .693, ηp
2 
< .00) 
and follow-up (p = .136, ηp
2 
= .02). On Blocks 4 and 5, cannabis users made fewer 
choices from good decks than controls at baseline, but cannabis users and controls had 
equivalent performance at follow-up, (Block 4: p = .455, ηp
2 
= .01; Block 5: p = .917, ηp
2 
< .00). Overall, analyses revealed that group differences at baseline accounted for the 
interactions observed in the omnibus repeated measures ANCOVA, and that groups had 
equivalent performance at follow-up. Cannabis users showed more improvement over 
time than controls. 
Examination of specific deck selections (deck contingencies described in Table 5; 
main effects of group and Group  Time interactions reported in Table 11; Figure 8) 
revealed a main effect of time for choices from Deck 1, F(1,45) = 6.663, p = .013, ηp
2 
= 
.13, and Deck 2, F(1,45) = 7.920, p = .007, ηp
2 
= .15, indicating that participants made 
fewer choices from the two disadvantageous decks at follow-up compared to baseline. 
However, when groups were considered separately, only cannabis users had a main effect 
of time (cannabis user Deck 1: p = .006, ηp
2 
= .31, Deck 2: p = .026, ηp
2 
= .22; control 
Deck 1: p = .733, ηp
2 
< .00; Deck 2: p = .391, ηp
2 
= .04). 
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Figure 8. IGT Deck selections at baseline and follow-up for cannabis users and controls. 
Error bars represent standard errors. Means reported are marginal means, controlling for 
interval, sex, IQ, and average alcohol use at baseline and follow-up. 
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Influence of Abstinence or Reduced Use at Follow-up 
While the majority of the cannabis user sample reported continued heavy 
cannabis use at follow-up, 2 cannabis users reported occasional use (< 20 hits in past 
year) and 1 user reported abstinence during the follow-up assessment. Significant 
findings from the repeated measures ANCOVAs remained largely unchanged when these 
cannabis users who reported markedly reduced cannabis use at follow-up (n = 3) were 
excluded. Marginal main effects of group on the verbal learning and memory composite, 
F(1,46) = 4.316, p = .043, ηp
2 
= .09, and RAVLT Trial 1, F(1,46) = 5.185, p = .027, ηp
2 
= .10, became fully significant, as did the Group  Time interactions for the average 
reaction time on the DRT 500 ms condition, F(1,46) = 4.470, p = .040, ηp
2 
= .09, and 
total good deck selections on the IGT, F(1,42) = 4.342, p = .043, ηp
2 
= .09. The main 
effect of group on IGT Deck 4 choices was reduced to a trend, F(1,42) = 2.808, p = .100, 
ηp
2 
= .06. The direction of findings remained unchanged in all analyses. 
1.3.2.4 Hierarchical Regression within Cannabis Users 
Hierarchical regression analyses were conducted to examine the prediction of 
cognitive task performance at follow-up from cannabis use characteristics within the 
cannabis users, above and beyond what would be expected given their baseline 
performance. Baseline cognitive performance, time interval to follow-up, sex, IQ, and 
average alcohol use during baseline and follow-up were entered in the first step as 
nuisance variables. Cannabis use predictors of interest were entered in the second step, 
and included the total number of hits within the last 12 months and age of cannabis use 
onset. Both cannabis use variables are the most commonly reported in the adolescent and 
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young adult cannabis user literature. Change in R
2 
at each step was explored to assess 
predictors‟ contribution to model fit. Separate regression analyses with the cognitive 
composites and all cognitive measure variables as dependent variables were conducted. 
Analyses in which cannabis use predictors contributed to a significant portion of the 
dependent variable‟s variance are described below. To represent the association between 
follow-up cognitive performance and cannabis use across the entire cognitive battery, 
partial correlations between all follow-up cognitive performance measures and the 
cannabis use variable of interest, controlling for the covariates described above, are 
reported in Table 12. 
Baseline Cannabis Use Predicting Cognition at Follow-up 
In this set of analyses, the cannabis use variable of interest was the total number 
of hits reported at baseline. The dependent variable was follow-up cognitive 
performance. Baseline cognitive performance, time interval to follow-up, sex, IQ, and 
average alcohol use during baseline and follow-up were entered in the first step as 
nuisance variables.  
Verbal learning and memory.  A higher number of total hits reported at baseline 
was significantly associated with fewer words recalled during the RAVLT learning trials 
at follow-up (rpartial = -.514, p = .014; Figure 9; Table 13 provides full hierarchical 
regression model). A follow-up partial correlation analysis within the follow-up cannabis 
user sample found that baseline total number of hits within the last 12 months was not 
correlated with trial 1-5 total words recalled at baseline, with sex, IQ, and average 
alcohol use at baseline covaried (rpartial = .055, p = .813). 
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Figure 9. Scatterplot of follow-up RAVLT Trial 1-5 performance by baseline total hits in 
the past year. Partial regression plot controlling for baseline cognitive performance, 
interval, sex, IQ, and average alcohol use at baseline and follow-up. 
 
Follow-up Cannabis Use Predicting Cognition at Follow-up 
Next, the cannabis use variable of interest was the total number of hits reported at 
follow-up. Follow-up total number of hits within the last year was regressed on baseline 
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were saved and used as the cannabis use variable of interest representing the variance 
attributed to cannabis use at follow-up, controlling for baseline use. In the regression 
model predicting follow-up cognitive performance, baseline cognitive performance, 
interval between assessments, sex, IQ, and average alcohol use between baseline and 
follow-up were was entered in the first step, and the unstandardized residual of follow-up 
regressed on baseline total number of hits within the last year was entered in the second 
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Processing speed. Within the whole cannabis user group, a higher number of 
total hits reported at follow-up was significantly associated with better follow-up 
processing speed (rpartial = .501, p = .021), and verbal fluency (rpartial = .521, p = .016). 
However, these relationships were reduced to non-significance after removal of two 
influential data points (Table 12).  
Age of Cannabis Use Onset Predicting Cognition at Follow-up 
Next, the age of cannabis use onset was examined in relation to follow-up 
cognitive performance. For each task variable, follow-up cognitive performance was 
predicted, using hierarchical regression analyses, with baseline cognitive performance, 
time interval to follow-up, sex, IQ, and average alcohol use at baseline and follow-up 
entered in Step 1, and age of cannabis use onset entered in Step 2.  
Verbal learning and memory. A later age of cannabis use onset was associated 
with better performance on forward digit span at follow-up (rpartial = .479, p = .028; 
Figure 10; Table 14 for full regression model). A follow-up partial correlation analysis 
within the follow-up cannabis user sample found that age of regular cannabis use onset 
was not significantly associated with baseline forward digit span, with sex, IQ, and 
average alcohol use at baseline covaried (rpartial = .126, p = .587). 
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Figure 10. Scatterplot of follow-up Digit Span Forward performance by age of cannabis 
use onset. Partial regression plot controlling for baseline cognitive performance, interval, 
sex, IQ, and average alcohol use at baseline and follow-up. 
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performance (b* = .302, p = .057; Table 15). As reported in section 1.3.1.4 above, age of 
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composite score at baseline in a partial correlation controlling for sex, IQ, alcohol, 
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trials, trials 1-5, (rpartial = .530, p = .013), delayed recall (rpartial = .560, p = .008), and 
percentage of learned words recalled after consolidation (rpartial = .503, p = .020). See 
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Table 15 for full regression models and Figure 11. Higher alcohol use marginally 
predicted better delayed recall performance (b* = .248, p = .086; Table 15). Within the 
full cannabis sample at baseline, age of cannabis use onset was not correlated with 
delayed recall performance or percentage of learned words recalled after consolidation 
(Table 8). A follow-up partial correlation within the follow-up cannabis user sample 
found that age of regular cannabis use onset was marginally associated with trial 1-5 total 
words at baseline, with sex, IQ, and average alcohol use at baseline covaried (rpartial = 
.381, p = .089), showing the same directional relationship observed at follow-up. 
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Figure 11. RAVLT scatterplots of follow-up performance by age of cannabis use onset. Partial regression plot controlling for baseline 
delayed recall performance, interval, sex, IQ, and average alcohol use at baseline and follow-up. 
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Planning. Within the whole cannabis user group, a later age of cannabis use onset 
was associated with a greater percentage of perfect solutions (rpartial = .485, p = .030), and 
better performance on 5-move problems (rpartial = -.450, p = .047). However, these 
relationships were reduced to non-significance after removal of an influential data point 
(Table 12).  
Motivated decision-making. There was a trend association between an earlier 
age of onset and fewer choices from disadvantageous Deck 2 at follow-up (rpartial = -.406, 
p = .076; Table 16; Figure 12). A follow-up partial correlation, controlling for sex, IQ, 
and average alcohol use at baseline, indicated that Deck 2 selections at baseline were not 
associated with age of cannabis use onset (rpartial = -.026, p = .912). 
 
Figure 12. Scatterplot of follow-up IGT deck 2 choices by age of cannabis use onset. 
Partial regression plot controlling for baseline deck 2 choices, interval, sex, IQ, and 
average alcohol use at baseline and follow-up. 
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1.4 Discussion 
This study assessed neuropsychological performance among a sample of young 
adult heavy cannabis users, then re-assessed neuropsychological performance after two 
years of continued heavy use within the majority of the sample. The study sample is 
largely overlapping with that used in a prior analysis of baseline neurocognitive 
performance (Becker et al., 2014), and the baseline results in the present analysis mirror 
those of the earlier paper. As predicted, cannabis users demonstrated relative weaknesses 
in the domains of verbal learning and memory, spatial working memory, spatial planning, 
and motivated decision-making at baseline when compared to non-using 
demographically-matched controls. These findings are consistent with cross-sectional 
studies that find deficits in the domains of abstract reasoning, decision-making, and 
verbal memory in young adult users (Bossong, Jager, Bhattacharyya, & Allen, 2014; 
Crean, Crane, & Mason, 2011; Lisdahl et al., 2013; Solowij & Battisti, 2008). Beyond 
cannabis user samples, neuropsychological impairments in episodic memory and 
decision-making are generally found among substance using samples, while more 
specific impairments are noted in the domains of planning and prospective memory 
among cannabis users (reviewed in Fernández-Serrano, Pérez-García, & Verdejo-García, 
2011). The baseline cognitive profile of cannabis users shares many of the common 
deficits noted among substance using populations as well as the specific deficits more 
commonly found among cannabis users. Further, the relative deficits noted were not 
accounted for by the impact of other substance use, since alcohol use and non-cannabis 
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drug use were either unrelated to performance or associated with better performance on 
measures that distinguished the groups. 
Unexpectedly, cannabis users exhibited a relative strength in the domains of 
verbal fluency and processing speed, strengths not typically noted among cannabis users. 
Processing speed/complex attention (Croft et al., 2001; Fried et al., 2005; Lisdahl & 
Price, 2012; Medina et al., 2007; Winward, Hanson, Tapert, & Brown, 2014) and verbal 
fluency (Fernández-Serrano et al., 2011) are among the domains commonly reported to 
be diminished among cannabis users, and are generally noted to be impaired among 
substance using populations. However, cannabis users in the current sample demonstrated 
high average IQs, which is a sample characteristic not typically noted among cannabis 
user samples that demonstrate lower processing speed performance (Fernández-Serrano 
et al., 2011; Lisdahl & Price, 2012; Medina et al., 2007). This difference in general 
intellectual ability may account for the discrepancy between the current findings and 
those reported in other cannabis user samples. The notable cognitive strengths displayed 
by the current sample make the findings of cognitive deficits relative to control 
participants all the more striking. Despite these strengths, selective impairments in 
important cognitive domains emerged among users. 
At follow-up, cannabis users continued to report regular and heavy cannabis use 
in general. It was expected that the neuropsychological deficits observed at baseline 
would persist at follow-up given the continued high level of use among cannabis users. 
This hypothesis was only partially supported. As expected, the relative cognitive deficits 
observed in the domains of planning and delayed verbal memory remained stable at 
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follow-up, suggesting that these are stable cognitive vulnerabilities associated with 
continued cannabis use during young adulthood. When analyses were restricted to 
cannabis users who continued regular and heavy cannabis use, the group difference in 
verbal learning and memory became more pronounced. Poorer verbal memory 
performance is the most robust finding that characterizes non-acutely high cannabis 
users‟ neurocognitive profile both in the context of regular use and after periods of 
sustained abstinence (Bolla et al., 2002; Cuttler et al., 2012; Gonzalez et al., 2012; I. 
Grant et al., 2003; Hanson & Luciana, 2010; Hanson et al., 2010; Harvey et al., 2007; 
Jacobsen, Pugh, Constable, Westerveld, & Mencl, 2007; Medina et al., 2007; Pope & 
Yurgelun-Todd, 1996; Schwartz et al., 1989; Solowij, Jones, et al., 2011; Tait et al., 
2011; Takagi, Yücel, et al., 2011; Wagner et al., 2010). The verbal learning and memory 
task is good measure of internal motivation and effortful performance. Participants must 
develop and use efficient strategies to facilitate learning and memory recall. A high level 
of cognitive control and self-organization that relies on coordinated frontal and medial 
temporal mechanisms is required for successful encoding and retrieval of information 
(Long, Oztekin, & Badre, 2010).While cannabis users in this study acquired learning at 
the same rate and magnitude as controls, they exhibited greater loss of information after 
learning consolidation at both time points. This pattern is consistent with the use of less 
efficient strategies rather than disruptions in consolidation.  
Alterations in cognitive and neural efficiency could emerge from cannabinoid-
mediated neuroplastic changes among chronic users. Chronic cannabinoid exposure 
induces a variety of changes in synaptic transmission across different neurotransmitters 
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and brain regions, notably within the prefrontal cortex and limbic system (Bossong et al., 
2014; Heifets & Castillo, 2009; Lubman, Cheetham, & Yücel, 2015). Functionally, 
chronic cannabis use is associated with activation of alternative brain regions in the 
context of control-level task performance on fMRI and ERP studies (Battisti, Roodenrys, 
Johnstone, Respondek, et al., 2010; Harding et al., 2012; Tapert et al., 2007), with earlier 
age of onset associated with greater alterations. The finding that extent and age of 
cannabis use were associated with poorer verbal learning and memory performance over 
time provides further support for this interpretation. Recruitment of alternative pathways 
may provide compensatory, but less efficient, functional networks. Less efficient 
networks may be overly taxed during more complex and effortful tasks, producing poorer 
performance.  
While fewer studies have examined planning ability among cannabis users, a 
general trend has emerged that planning ability is diminished in the context of regular use 
(Epstein & Kumra, 2015; J. E. Grant et al., 2012; McHale & Hunt, 2008; Montgomery et 
al., 2012). Cannabis users‟ performance on the planning task was impaired only on the 
relatively easy 3-move problems. These problems are less complex than subsequent 
trials, and can be completed using perceptual rather than representational cues. Typically, 
less than optimal performance on relatively easy tasks in the context of normal 
performance on more challenging tasks is interpreted as a motivational deficit, (Lezak et 
al., 2004), where effort-based resources are more strongly allocated to more challenging 
relative to less challenging problems.  
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The finding that cannabis users‟ performance improved to control-level 
performance on measures of spatial working memory and motivated decision-making 
was unexpected. Baseline performance deficits noted among cannabis users in these 
domains were consistent with cross-sectional evidence of spatial working memory 
(Harvey et al., 2007) and motivated decision-making (Fridberg et al., 2010; Yechiam et 
al., 2005) deficits among cannabis users. However, this literature is limited by a total lack 
of longitudinal assessment of both domains. The current findings suggest that with 
repeated experience with both tasks, cannabis users‟ performance recovers to control-
level performance, even in the context of continued cannabis use. Cannabis users 
continued regular use, but reported an overall decline in use from baseline to follow-up. It 
is possible that the reduction in use resulted in the improvements noted on these two 
tasks, though dose-dependent relationships between change in use and performance 
change were not observed at follow-up. Cross-sectional studies find that after reduction 
or cessation of use, some cognitive performance deficits in young adults resolve (Fried et 
al., 2005; Medina et al., 2007). Longitudinal evidence also supports some recovery of 
cognitive function in the context of continued use. A recently-reported longitudinal study 
that followed young adult alcohol+cannabis users, similar to the current study, found that 
along with reductions in cannabis use, deficits in processing speed/complex attention and 
visuospatial construction reported at a 1.5 year follow-up had resolved to control-level 
performance by the 3-year follow-up (Jacobus et al., 2015). Further longitudinal research 
is needed to replicate these findings and clarify if decreased use is the mechanism driving 
these findings.  
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Another possible mechanism accounting for the recovery in performance on 
certain cognitive tasks could be “behavioral tolerance” to the effects of cannabis with 
sustained use. In acute administrations, regular cannabis users display better performance 
relative to occasional cannabis users on measures of attention (Desrosiers, Ramaekers, 
Chauchard, Gorelick, & Huestis, 2015; Ramaekers, Kauert, Theunissen, Toennes, & 
Moeller, 2009; Theunissen et al., 2012), and measures of road-tracking control while 
driving (Bosker et al., 2012). As described above, chronic cannabis use is associated with 
activation of alternative functional networks during cognitive task performance. 
Alternative and compensatory networks may be sufficient to support performance when 
completing simpler tasks (Hart, Van Gorp, Haney, Foltin, & Fischman, 2001). More 
complex tasks that require more cognitive resources may remain vulnerable to the acute 
effects of cannabis, since performance on more complex and effortful tasks of executive 
functioning remains diminished among both regular and occasional users when acutely 
intoxicated (Ramaekers et al., 2009; Theunissen et al., 2012). The link between 
behavioral tolerance and recovery of cognitive performance on select measures reported 
in this study, including spatial working memory and motivated decision-making, is 
speculative and more longitudinal research is needed to examine this potential 
relationship. 
Beyond observing stable deficits, I expected that continued and heavy cannabis 
use would be associated with cognitive decline over time. However, this relationship was 
not observed. Cannabis users demonstrated control-level performance during the follow-
up assessment across many measures of the neurocognitive battery, and no new areas of 
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weakness emerged at follow-up. While these findings were unexpected, they are largely 
consistent with those reported by Jacobus and colleagues (2015), who found stable 
working memory and verbal memory deficits at all assessments, with only verbal 
learning performance worsening over time. Neither Jacobus et al. (2015) nor the current 
study support the hypothesis that widespread cognitive impairments develop over a 2-3 
year period in the context of sustained cannabis use during early adulthood. Instead, 
select cognitive impairments in verbal learning and memory and executive functioning, 
noted at baseline, persist over the follow-up interval, while relative deficits in other 
cognitive domains improve to control-level performance by follow-up.  
Examination of cannabis use patterns revealed that cannabis use during 
adolescence, rather than young adulthood, exerted an impact on neurocognitive 
performance at follow-up, specifically in the domain of verbal learning and memory. 
Extent of cannabis use at baseline, and not the time to follow-up interval, was associated 
with diminished follow-up verbal learning performance. Similarly, as expected, earlier 
age of regular cannabis use was associated with poorer verbal working memory and 
verbal learning and memory performance. Extent and age of regular use were not 
associated with these measures at baseline, with the exception of a marginal relationship 
between verbal working memory and age of use, and the majority of measures only 
emerged as predictors of performance decline over time. These findings support the 
current theory that the magnitude and timing of adolescent cannabis use plays an 
important role in the trajectory of neural development and cognitive performance over 
time, irrespective of continued use patterns during young adulthood (Lisdahl et al., 2013). 
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This theory has been supported by longitudinal evidence linking earlier cannabis use with 
poorer processing speed and sequencing ability during young adulthood (Jacobus et al., 
2015) and greater IQ decline during adulthood (Meier et al., 2012), as well as cross-
sectional evidence that earlier use is associated with poorer IQ (Pope et al., 2003), 
attention (Ehrenreich et al., 1999), visual search (Huestegge, Radach, & Kunert, 2009), 
verbal fluency (Gruber, Sagar, et al., 2012), and executive functioning performance 
(Battisti, Roodenrys, Johnstone, Pesa, et al., 2010; Fontes et al., 2011; Gruber, Dahlgren, 
Sagar, Gönenç, & Killgore, 2012; Gruber, Sagar, et al., 2012). While this association was 
expected, the current study is the first to document this finding longitudinally in the 
domain of verbal learning and memory. Given that learning and memory is the 
neurocognitive domain most commonly impaired among cannabis users, this is an 
important contribution to the current understanding of adolescent cannabis use. 
Though the current study‟s findings are suggestive of selective patterns of 
impairment that emerge as a consequence of use and replicate findings reported in the 
literature, cause-effect associations cannot be determined because users were not assessed 
prior to initiation of use. It could be that premorbid levels of function were impaired in 
cannabis users prior to use onset. Cognitive vulnerabilities may contribute to early 
initiation and continued cannabis use, which then manifest in later testing (Iacono, 
Malone, & McGue, 2008). Parsing the causes from effects of substance use is very 
challenging, and further research is need to dismantle the general liabilities associated 
with substance use and the specific effects caused by regular use.  
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Important limitations must be noted for the current study. To provide a full view 
of the data and replicate other studies, the statistical comparisons in this study were not 
corrected for multiple comparisons. Many of the findings interpreted as significant in the 
present study would not remain if more rigorous statistical thresholding was employed. 
Another limitation of the current study is the overrepresentation of males in the 
cannabis user sample, which is consistent with the sex distribution of cannabis users in 
the United States (Substance Abuse and Mental Health Services Administration, 2014). 
Sex was controlled in all statistical analyses; however, findings cannot be readily 
generalized to female marijuana users. A further limitation that it is difficult to quantify 
the precise level of cannabis exposure given that the potency of cannabis is not standard. 
While there was an attempt to quantify it by calculating number of hits, this measure does 
not address potency or the amount of drug ingested during a hit. Drug testing was not 
employed to quantify cannabis exposure at the time of testing or confirm levels of 
reported use. Multiple interview and self-report measures were used to assess substance 
use characteristics, and the level of detail that participants conveyed regarding their use 
patterns was convincing in terms of the likelihood that they were, indeed, heavy cannabis 
users, an assumption validated by their reports of symptoms of cannabis dependence. A 
related limitation is that the majority of the cannabis user sample demonstrated 
homogenous use patterns at both baseline and follow-up, reducing the ability to detect 
dose-response associations over time.  
Additionally, while cannabis users were not acutely high during testing, the 
possibility that the cognitive differences observed in this sample are due to residual 
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effects of cannabis use cannot be ruled out. That said, given that performance was largely 
unimpaired, this potential limitation appears unlikely unless residual effects of cannabis 
confer cognitive advantages. The current assessment provides a comprehensive cognitive 
profile of otherwise high functioning individuals in the context of current cannabis use. 
This profile allows us to make real-world inferences about how regular and sustained 
cannabis use might impact cognition. In order to minimize potential confounds, high 
functioning individuals were recruited, with comparable education and IQ to other young 
adult controls, and a low level of psychopathology. While this feature of the study can be 
considered a strength since the sample of users represents college-aged individuals who 
heavily use the drug, it may limit generalizability to other cannabis-using samples who 
evidence more externalizing behavior, less education, and more psychopathology. The 
expectation is that they would show greater levels of impairment. Another possible 
concern is that cannabis users were in active states of withdrawal during testing, affecting 
the results. Cannabis users were asked to abstain for at least a 24 hours period prior to the 
assessment, but were accepted if they reported abstinence for at least 12 hours prior to 
assessment. This possibility appears unlikely given the normative psychomotor 
performance and relative strength in processing speed exhibited by cannabis users at both 
time points, which is inconsistent with behaviors that individuals in the midst of cannabis 
withdrawal demonstrate (Haney et al., 2001).  
While these behavioral findings add to the growing corpus of longitudinal studies 
of cannabis-using individuals, they would be incomplete without consideration of how 
neural systems are impacted by use. The next study addresses this issue.  
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2  Study 2: Longitudinal Changes in White Matter Microstructure in Young 
Adult Cannabis Users 
This chapter focuses on longitudinal changes in white matter microstructure in the 
sample of adolescent-onset young adult cannabis users discussed in the first study. White 
matter microstructure is important to examine in this sample because it is a measure of 
brain connectivity and organization, and disruptions in connectivity may underlie the 
behavioral deficits discussed in Study 1. Very few studies have examined the 
neurobiological underpinnings of behavioral deficits noted among cannabis users, and a 
clear biological mechanism driving the deficits is lacking in the literature. White matter is 
one potential mechanism driving these differences among adolescent-onset cannabis 
users.  
Adolescence and young adulthood are critical periods of neural maturation, 
during which there is reorganization of cortical connections, an increase in the fidelity of 
corticolimbic interactions, and neurochemical changes that promote adaptive behavioral 
regulation (Colby et al., 2011; Giedd, 2004; O‟Hare & Sowell, 2008; Wahlstrom, Collins, 
White, & Luciana, 2010). Grey matter develops along a nonlinear trajectory, with peak 
proliferation prior to puberty, then gradual grey matter decline and pruning during 
adolescence and young adulthood, extending into the 30s (Giedd, 2004; Giedd et al., 
1999; Gogtay et al., 2004; Pfefferbaum et al., 1994; Sowell et al., 2003; Sowell, 
Thompson, Tessner, & Toga, 2001). In contrast, white matter volume develops linearly 
from childhood to adolescence (Giedd et al., 1999; Paus et al., 2001), following a 
posterior-inferior to anterior-superior developmental trajectory (Colby et al., 2011; 
   82 
 
Sowell, Thompson, Holmes, Jernigan, & Toga, 1999) and does not reach its peak until 
adulthood, between the mid-30s and 40s (Bartzokis et al., 2001; Sowell et al., 2003; 
Westlye et al., 2010). White matter improves the efficiency of signal conduction between 
brain regions, and its development is associated with improved cognitive control and 
executive functioning performance during adolescence (Peters et al., 2014; Treit, Chen, 
Rasmussen, & Beaulieu, 2013). 
Diffusion Tensor Imaging (DTI) is a sensitive neuroimaging technique that 
characterizes white matter microstructure, and yields measures of the directional 
organization of white matter (fractional anisotropy: FA), averaged water diffusion in all 
directions (mean diffusivity: MD), and water diffusion perpendicular to the primary fiber 
orientation (radial diffusivity: RD). In general, increases in FA and decreases in MD and 
RD are observed in major white matter fiber tracts throughout adolescence and extending 
into adulthood. Reduction in RD has been associated with increased myelination and 
axonal packing in animal models (Budde et al., 2007; Song et al., 2003, 2005), and age-
related changes in FA in humans are often attributed to decreased RD (Giorgio et al., 
2008; Lebel & Beaulieu, 2011; Lebel, Walker, Leemans, Phillips, & Beaulieu, 2008). 
The biological mechanisms that drive MD changes are less clear.  
Estimates of peak development of white matter microstructure vary between ages 
20-42 (Kochunov et al., 2012; Lebel et al., 2012; Schmithorst & Yuan, 2010; Westlye et 
al., 2010). There is considerable regional variability in the maturational timing of white 
matter microstructure, with earlier maturation in commissural and projection white matter 
tracts, and later development during adolescence and young adulthood in the association 
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tracts (Ashtari et al., 2007; Kochunov et al., 2012; Lebel & Beaulieu, 2011; Lebel et al., 
2008).  
As is the case with other active periods of brain development (Fride, 2008; 
Huizink, 2014; Linnet et al., 2003), substance use during adolescence and young 
adulthood may interfere with normative development, altering the structural integrity and 
function of the adult brain. A growing literature suggests there are neurocognitive deficits 
and neuroanatomical alterations among adolescent and young adult cannabis users 
relative to non-users. Behaviorally, cannabis use in adolescence and young adulthood is 
most commonly associated with relative deficits in verbal learning and memory, 
decision-making, and executive functioning (reviewed in Study 1). 
Neuroimaging studies find alterations in brain structure and function associated 
with use. Reduced hippocampal (Ashtari et al., 2011; Demirakca et al., 2011; Filbey, 
McQueeny, Kadamangudi, Bice, & Ketcherside, 2015; Lorenzetti et al., 2014; Schacht, 
Hutchison, & Filbey, 2012; Yücel et al., 2008), parahippocampal gyrus (Battistella et al., 
2014; Matochik, Eldreth, Cadet, & Bolla, 2005), orbital frontal (Battistella et al., 2014; 
Churchwell, Lopez-Larson, & Yurgelun-Todd, 2010; Filbey et al., 2014), and increased 
cerebellum (Battistella et al., 2014; Cousijn et al., 2012; Medina, Nagel, & Tapert, 2010) 
gray matter volumes are among the more consistent findings within cannabis users. 
Alterations in amygdala gray matter are also reported, but the direction of alterations 
varies between reports (Gilman et al., 2014; Lorenzetti et al., 2014; Schacht et al., 2012; 
Yücel et al., 2008). The degree to which groups are matched on the potential confounds 
of sex, age, and other substance use varies between studies. One notable recent study 
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found no group differences between cannabis users and controls, who were matched on 
alcohol use, on measures of gray matter morphology in the nucleus accumbens, 
amygdala, hippocampus, and cerebellum, suggesting alcohol use or other confounds may 
significantly contribute to reported group differences (Weiland et al., 2015). Further, 
findings across studies suggest cannabis use likely exerts only a modest effect on gray 
matter volume, indicating that large sample sizes may be needed to detect a true effect 
(Weiland et al., 2015).  
Among MRI and positron emission tomography (PET) studies of functional 
relationships among brain regions, cannabis users demonstrate altered patterns of brain 
activity when compared to non-using controls, particularly within the prefrontal cortex 
(Batalla et al., 2013), orbitofrontal network (Filbey et al., 2014), prefrontal and 
occipitoparietal cortex (Harding et al., 2012), and frontal-subcortical network (Filbey & 
Yezhuvath, 2013). A potential mechanism driving these differences may be disruption of 
white matter fiber tracts that support signaling between neurons within and across neural 
nodes. Cannabinoid receptors are widely distributed in white matter fiber tracts (Romero 
et al., 1997), and exhibit higher binding capacity in white matter structures during 
development as opposed to adulthood (Romero et al., 1997; Zalesky et al., 2012). 
Disruption of the endocannabinoid system during development could alter white matter 
development, and, in turn, the efficiency of neural signaling.  
The direction of alterations in white matter volume in a variety of cortical and 
subcortical regions has been inconsistently reported in cannabis users, with one group 
finding increased density of white matter associated with the left parahippocampal and 
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fusiform gyri and lower density in left parietal lobe white matter (Matochik et al., 2005), 
and a second group noting cerebellar white matter volume reduction in cannabis users 
(Solowij, Yücel, et al., 2011). Other studies find no association between cannabis use and 
the extent or volume of white matter (Block et al., 2000; Cousijn et al., 2012; Jager et al., 
2007), making it difficult to draw general conclusions from the existing studies. Measures 
of white matter volume or extent derived from T1 weighted structural MRI scans may not 
be sufficiently sensitive to subtle alterations in white matter microstructure that impact 
information processing.  
DTI has the potential to address this limitation given that white matter 
organization can be examined at the microstructural level. DTI studies indicate that 
cannabis users demonstrate altered white matter organization, although, again, there are 
inconsistencies across studies in the direction of MRI-measured changes. Most studies 
indicate that FA is lower in various white matter regions in cannabis users. Some DTI 
reports include findings of increased cannabis user RD and MD, also indicative of 
reduced white matter organization in cannabis users. DTI findings for cannabis users 
have involved widely scattered brain regions, including the superior longitudinal 
fasciculus (Ashtari et al., 2009; Bava et al., 2009; Thatcher, Pajtek, Chung, Terwilliger, 
& Clark, 2010; Yücel et al., 2010), arcuate fasciculus (Ashtari et al., 2009), frontal white 
matter adjacent to the anterior cingulate cortex (Gruber, Silveri, Dahlgren, & Yurgelun-
Todd, 2011) and hippocampus (Zalesky et al., 2012), internal capsule (Gruber et al., 
2014), and the rostrum (Arnone et al., 2008), genu (Gruber et al., 2014), and splenium 
(Zalesky et al., 2012) of the corpus callosum. Cannabis use may disrupt the 
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developmental trajectory of white matter organization since lower FA levels have been 
associated with an earlier age of cannabis use onset (Gruber et al., 2014, 2011).  
Not all DTI studies have found evidence for lower FA and/or greater RD and MD 
in cannabis users. Greater FA and lower RD have been reported in the forceps minor of 
the corpus callosum, a tract that connects the orbitofrontal cortices (Filbey et al., 2014), 
although years of use within the cannabis user group showed a curvilinear (quadratic) 
association with declining FA levels and rising RD levels. One early study found 
increased FA in cannabis users in white matter associated with medial frontal, cingulate, 
precentral, and parietal cortex, as well as decreased MD in cingulate and medial frontal 
white matter (Delisi et al., 2006). 
Though findings are compelling, this literature is comprised of cross-sectional 
designs, limiting interpretation of group-based differences. Longitudinal research may 
clarify some interpretative complexities, by assessing neural changes over time in relation 
to ongoing substance use. Recent longitudinal studies have explored white matter 
development associated with alcohol initiation (Luciana, Collins, Muetzel, & Lim, 2013), 
binge alcohol use with comorbid cannabis use (Jacobus, Squeglia, Bava, et al., 2013), and 
polysubstance use (Bava, Jacobus, Thayer, & Tapert, 2013). No longitudinal study to 
date has explored white matter microstructure specifically related to sustained cannabis 
use during young adulthood.  
This study examines change in measures of white matter microstructure across 
time as a function of cannabis use and in relation to substance use patterns and cognitive 
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performance. Young adult, regular cannabis users and control participants were assessed 
at two time points, with a two-year time interval between assessments.  
2.1 Hypotheses 
It was predicted that white matter organization, as measured by FA and RD, 
would be relatively diminished among cannabis users after multiple years of chronic use. 
Given the broadly distributed DTI findings to date, alterations were expected in frontal 
white matter as well as fiber tracts connecting frontal and posterior regions; hippocampal 
white matter; the corpus callosum; and cortical-subcortical projection fibers such as the 
corticospinal tract. Alterations in white matter organization were predicted to be 
correlated with amount of cannabis use in the follow-up interval within the cannabis user 
group. 
Correlation with Behavior 
Clusters that emerged as significantly different between groups are expected to 
correlate with cognitive performance within cannabis users, with better performance 
associated with greater white matter organization. I also expected that substance use 
patterns would be associated with white matter organization such that earlier use onset 
and greater use would be associated with poorer white matter organization. 
2.2 Methods 
2.2.1 Sample 
The sample of cannabis users included in this study is a reduced sample of the 
cannabis users included in Study 1 and included only those participants who completed 
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both baseline and follow-up assessments (Table 17). Thirty-seven cannabis users, ages 
19-20, were initially recruited into this longitudinal study. At study enrollment, cannabis 
users were recruited if they reported using cannabis at least 5 times per week for at least 1 
year; 1 cannabis user reported use at a lower rate (3-4 times per week, on average, during 
the prior year), but was retained in the sample. Initial cannabis use onset was required to 
prior to age 17. Cannabis users were excluded if they were daily cigarette smokers, or if 
alcohol use exceeded 4 drinks for females and 5 drinks for males on more than 2 
occasions per week. 
Of the cannabis users initially recruited into this longitudinal study, 27 cannabis 
users returned for follow-up assessment after a two-year interval. To maximize 
homogeneity of use patterns within users, 2 cannabis users were excluded from the 
current analysis because they reported cannabis use patterns markedly lower than the 
majority of the cannabis user sample (≤ 5 times in past 12 months). Twenty-three of the 
remaining 25 subjects (16 males, 7 females), aged 18 to 20 years (M = 19.45, SD = 0.66) 
generated artifact-free scanning data and comprised the final sample included in this 
study.  
The control sample differs from the control sample included in Study 1. Within 
the larger longitudinal study, all cannabis users were initially recruited and completed 
their baseline assessment during the controls‟ third follow-up assessment wave (Time 3) 
and completed their follow-up assessment during the controls‟ fourth assessment wave 
(Time 4). The cognitive comparisons reported above used the controls‟ initial (baseline, 
Time 1) assessment and their first follow-up (Time 2) so that the groups would be 
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matched on task experience. There was an MRI scanner upgrade during the second 
assessment wave (Time 2) of the larger longitudinal study, confounding comparison of 
MRI data collected before and after the scanner upgrade. Controls‟ baseline assessment 
(Time 1) was completed prior to the scanner upgrade, whereas cannabis users‟ 
assessment was completed after the upgrade (Time 3). To eliminate this confound for the 
analysis of imaging data, controls who were scanned after the scanner upgrade were 
selected from follow-up assessment waves (Time 2-Time 4) of the longitudinal study for 
the following analyses. For the purposes of reporting, the controls‟ assessments in the 
analyses are referred to as “baseline” and “follow-up,” respectively. Twenty-three control 
participants (16 males, 7 females) were selected from the larger longitudinal study of 
adolescent brain development. Controls were selected to match the cannabis users on sex, 
to reduce this potential confound when analyzing MRI data. This selection procedure 
required inclusion of participants from a wider age range (15-23 years old; M = 19.19, 
SD = 2.31), though the mean of age was equivalent between groups. Given this 
difference between groups, age was statistically controlled in all analyses. Controls were 
excluded from analyses if they endorsed more than minimal experimentation with 
cannabis at baseline (> 5 use occasions during their lifetime). All control participants who 
met these selection criteria were included in the sample. 
General inclusion criteria for all participants included being a native English 
speaker, right-handed, and with normal/corrected-to-normal vision and hearing. 
Exclusion criteria included any contraindications to MRI scanning, a reported history of 
neurological problems or significant head injury, intellectual disability, or current 
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pregnancy. Adult participants and parents of minors provided informed consent, and 
minors (those under age 18) assented to participate in the study. All participants were 
monetarily compensated. The University of Minnesota's Institutional Review Board 
approved the protocol.  
During both baseline and follow-up assessments, all participants, were asked to 
refrain from drug use for at least 24 hours before testing so as not to be acutely high 
during the assessment, though participants who reported 12 hours of abstinence were 
accepted. Longer periods of abstinence were not required to avoid assessing individuals 
in the midst of drug withdrawal and because a goal of the study was to capture functional 
capacities in the context of active use. Formal drug testing was not implemented due to 
budgetary limitations and given that the study did not require long-term cannabis 
abstinence. 
2.2.2 Procedure 
The procedure for assessment and study inclusion is detailed in Study 1 above 
(section 1.2.2). Inclusion criteria were verified during an initial visit by a demographic 
and health interview questionnaire, the Edinburgh Handedness Inventory (Oldfield, 
1971), the Wechsler Abbreviated Scale of Intelligence (WASI: Wechsler, 1999), and by 
structured diagnostic interviews (the Kiddie Schedule for Affective Disorders and 
Schizophrenia; Kaufman et al., 1997) administered to the participant as well as (for those 
under age 18) a parent. Participants who met inclusion criteria at study enrollment 
returned for a second assessment, which included MRI scans as well as a battery of 
neurocognitive tasks. The neurocognitive battery was designed to capture a broad array 
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of functions in the domains of motor function, processing speed, attention, spatial and 
verbal memory, and executive functioning skills. Together, these measures took several 
hours to complete. 
2.2.3 Measures 
2.2.3.1 Neurocognitive Battery 
The neurocognitive battery described in Study 1 (1.2.3.1) was employed for this 
study. Neurocognitive measures assessed the domains of motor function (Finger Tapping 
Test, Grooved Pegboard), processing speed (Digit Symbol, Letter Cancellation Task), 
verbal fluency (COWAT: Controlled Oral Word Association Test), verbal attention and 
working memory (Digit Span), verbal learning and memory (RAVLT: Rey Auditory 
Verbal Learning Test), spatial memory (SWM: Spatial Working Memory, DRT: Spatial 
Delayed Response Task), planning (TOL: Tower of London), and motivated decision-
making (IGT: Iowa Gambling Task). Please see section 1.2.3.1 above for full task 
descriptions. 
2.2.3.2 Substance Use 
At baseline and follow-up within the full sample, the frequency of substance use 
was assessed with the Personal Experience Inventory (Henley & Winters, 1989). The PEI 
measures the frequency of substance use within the last 12 months on a 5-point scale 
(never, 1-5 times, 6-20 times, 21-49 times, 50-99 times, 100+ times). Participants rated 
the frequency of substance use separately for each drug class (alcohol, cannabis, 
psychedelics, cocaine, amphetamines, barbiturates, tranquilizers, heroin, narcotics, 
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steroids, inhalants, and recreation use of prescription drugs). Non-cannabis drug use for 
the 12 months prior to each assessment was calculated by summing the frequency ratings 
across illicit drug classes. Controls selected from the larger database were included in 
these analyses if they reported minimal cannabis use (> 5 occasions of use) and no other 
illicit substance use. 
Participants older than 18 years of age completed Achenbach‟s Adult Self-Report 
(ASR; Achenbach & Rescorla, 2003) questionnaire, which yields substance use scales 
that consist of self-reported daily tobacco use, number of days drunk, and days using 
drugs (other than alcohol or tobacco) during the previous 6 months. Control participants 
younger than 18 years old completed the Youth Self-Report (YSR; Achenbach, 1991) 
questionnaire, which does not include substance use scales. All participants who 
completed the YSR reported no tobacco, alcohol, or other drug use during the K-SADS-
PL interview or the PEI. 
An in-house interview questionnaire based on guidelines provided by the NIAAA 
was implemented at baseline and follow-up to assess detailed frequency and quantity of 
alcohol and cannabis use among cannabis users. 
2.2.4 MRI Data Acquisition and Processing 
MRI data were collected on a Siemens 3T Tim Trio scanner (Siemens Medical 
Systems, Erlangen, Germany) using a twelve-channel array head coil at the University of 
Minnesota Center for Magnetic Resonance Research. The scanner and all scanning 
parameters were similar for both the control and cannabis-using samples at both time 
points reported here. Diffusion weighted data were acquired in the axial plane using a 
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dual spin echo, single-shot, pulsed-gradient, echo-planar imaging (EPI) sequence (TR = 
8500 msec., TE = 90 ms, 64 slices, no gap, FOV = 256 mm, voxel size = 2.0 × 2.0 × 2.0 
mm, b value = 1000 sec/mm2, GRAPPA iPAT = 2). The acquisition box was positioned 
to cover the cerebrum and as much of the cerebellum as possible. Thirty-six volumes 
were acquired in the diffusion scan: 6 non-diffusion-weighted volumes (b = 0) and 30 
diffusion-weighted volumes (b = 1000 sec/mm
2
), using gradient vectors distributed 
uniformly in 3-dimensional space according to an electrostatic repulsion algorithm (i.e., 
the “Jones30”; Jones, Horsfield, & Simmons, 1999). For off-line EPI geometric distortion 
correction, b0 field maps were constructed from gradient-echo images acquired using 
different echo times (TE = 4.62 ms and 7.08 ms; TR = 700 ms, flip angle = 90, 64 
slices, no gap, voxel size = 2.0 × 2.0 × 2.0 mm, FOV = 256 mm). 
Diffusion MRI data were processed using the FDT and TBSS packages in FSL 
(FMRIB Software Library v4.0.1, http://www.fmrib.ox.ac.uk/fsl, Smith et al., 2004). 
Each diffusion-weighted volume was corrected for head motion and eddy current 
distortions using an affine registration to the first b0 reference volume. The diffusion 
series was corrected for geometric distortion caused by magnetic field inhomogeneity 
using PRELUDE (Phase Region Expanding Labeler for Unwrapping Discrete Estimates) 
and FUGUE (FMRIB's Utility for geometrically Unwarping EPIs) in conjunction with 
the b0 field maps. Brain tissue was extracted using BET (Brain Extraction Tool). The 
diffusion tensor was fit at each voxel by submitting the preprocessed data from the b0 
reference volume and the 30 diffusion-weighted volumes to FSL’s DTIFIT. 
Diagonalization yields the eigenvectors (V1, V2, V3) and corresponding eigenvalues (L1, 
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L2, L3) of the diffusion tensor, which describe the directions and apparent magnitudes of 
water diffusion within each voxel. Three scalar variables were computed from these 
tensor components: mean diffusivity (MD), which is the average of L1, L2, and L3, and 
reflects average total diffusion; radial diffusivity (RD), which is the average of L2 and L3 
and reflects the magnitude of diffusion perpendicular to white matter tracts; and 
fractional anisotropy (FA), a variance measure that reflects how strongly water diffusion 
is restricted to the principle eigenvector and ranges from 0 (equivalent diffusion along 
V1, V2, and V3) to 1 (no diffusion along V2 and V3). 
Tract-Based Spatial Statistics (TBSS; Smith et al., 2006) was used to align the 
DTI scalar volumes so that voxelwise statistical analysis could be performed across 
participants and between time points. All FA volumes were aligned to a common space 
template using the nonlinear registration IRTK (Rueckert et al., 1999; 
www.doc.ic.ac.uk/~dr/software). The template was an average FA volume constructed 
from 72 participants drawn from the full research sample, aligned to 2 mm isotropic MNI 
voxel space (Luciana et al., 2013; Olson et al., 2009). MD and RD volumes were aligned 
to common space by applying the transformation matrices previously computed during 
the FA volume alignments. FA volumes were masked at a threshold of FA ≥ .15 to 
reduce partial volume effects, and the same voxel masks were applied to MD and RD 
volumes. FA, RD, and MD volumes were smoothed at 4 mm FWHM prior to statistical 
analysis.  
2.2.5 Statistical Approach 
Data were analyzed using the Statistical Package for the Social Sciences (SPSS 
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Inc., Chicago, IL, USA), Windows version 20. Scatterplots of residuals were examined to 
assess for normal distributions, and data were screened for outliers and influential data 
points. Distributions of all variables were examined. The total number of cannabis hits 
within the past year did not meet the assumptions for parametric analysis and was square 
root transformed. Chi-square tests were used to compare nominal variables (i.e., sex) 
between cannabis users and controls. Mann-Whitney U analyses assessed for group 
differences in substance use characteristics, in which variances were unequal between 
groups. 
To assess changes over time, common space DTI scalar volumes at follow-up 
were regressed on baseline volumes, yielding follow-up vs. baseline regression residuals 
for FA, RD, and MD. Preliminary analyses revealed that MD clusters had substantial 
overlap with RD clusters and did not identify unique areas of differential growth between 
groups. Given the substantial overlap between the two scalars, and that RD is more 
directly related to the maturational processes of interest in this study, including 
myelination, axonal packing, and age-related changes in FA (Budde et al., 2007; Giorgio 
et al., 2008; Lebel & Beaulieu, 2011; Lebel et al., 2008; Song et al., 2003, 2005), RD and 
FA were selected as the scalars of interest to reduce the number of statistical 
comparisons. 
SPM8 (www.fil.ion.ucl.ac.uk/spm/software/spm8) was used to perform voxelwise 
multiple regression analysis of the FA and RD follow-up vs. baseline residuals. 
Predictors in the multiple regression equations included group, sex, age at baseline, time 
interval between baseline and follow-up assessments, and average alcohol use (the mean 
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of baseline and follow-up PEI ratings for use in the past 12 months). Preliminary analyses 
were conducted using both baseline and follow-up PEI ratings for alcohol use in the past 
12 months, but no supra-threshold clusters were produced for the alcohol predictors. 
Accordingly, the final regression models were simplified to include a single alcohol 
covariate averaged across baseline and follow-up.  
To assess group differences at baseline, multiple regressions were performed on 
baseline FA and RD volumes with group, sex, age at baseline, and alcohol use at baseline 
(past 12 months) as predictors in the model.  
All regression analyses used an input voxelwise height threshold of p < .01 and 
cluster-level statistical thresholding at p ≤ .05 after family-wise error correction for 
multiple comparisons, as derived from random field theory (Worsley, Evans, Marrett, & 
Neelin, 1992).  
Correlation Between White Matter Microstructure and Substance Use Variables 
Mean FA within clusters was computed for the clusters that emerged in the 
baseline FA group difference and baseline to follow-up FA-change analyses. The mean 
FA cluster values at baseline were computed from the multiple regression analyses, 
which included the predictors of group, sex, age at baseline, and alcohol use during the 
past year at baseline. The mean FA-change cluster values were computed similarly from 
the multiple regression analyses, which included the predictors of group, sex, age at 
baseline, time interval between baseline and follow-up assessments, and average alcohol 
use at baseline and follow-up. 
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Mean FA cluster values were correlated with cannabis use variables within the 
cannabis user group, while controlling for variables of no interest. Cannabis use variables 
of interest were the age of regular cannabis use and total number of cannabis hits for past 
year. Cannabis use measures at baseline were regressed on sex and alcohol use during the 
past year. Residuals from these regressions were used as the outcome use variables and 
were correlated with the mean FA cluster values at baseline. Follow-up cannabis use 
measures were regressed on baseline cannabis use measures, sex, time interval between 
baseline and follow-up assessments, and average alcohol use in the past year. Residuals 
from these regressions were used as the outcome use variables and were correlated with 
the mean FA-change cluster values. 
For comparison, correlations were performed on follow-up measures of alcohol 
use (i.e., total number of drinks, controlling for interval time and sex as described above) 
and tobacco use, controlling for sex, time interval between baseline and follow-up, and 
average 12-month alcohol use. 
Correlation Between White Matter Microstructure and Cognitive Performance 
To determine the association between cognitive performance and the white matter 
findings, mean FA cluster values for the clusters that distinguished groups were 
correlated with cognitive performance within the cannabis user sample. Because the 
control sample was selected from later waves of the larger longitudinal study, controls 
and cannabis users differed in their prior exposure to the neurocognitive battery. For 
example, a control subject in this study may have completed the neurocognitive battery 1-
2 times prior to the “baseline” MRI assessment examined in these analyses, whereas the 
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cannabis users‟ baseline MRI assessment corresponds to their first neurocognitive 
assessment. Controls and cannabis users had different levels of experience with the tasks; 
therefore, a direct comparison between groups on task performance would have been 
confounded by different practice effects between groups.  
To reduce the number of statistical comparisons, cognitive composite scores were 
used to characterize cognitive performance. The 6 cognitive composites that were 
developed with the hybrid method described in 1.2.4, with scales first theoretically-
defined then refined with reliability analyses, were used for these analyses, specifically, 
(1) Processing speed (Letter Cancellation time, Digit Symbol total correct, COWAT total 
correct words); (2) Verbal learning and memory (RAVLT Trial 1-5 total words, RAVLT 
immediate recall, RAVLT delayed recall); (3) Spatial working memory and planning 
(SWM strategy score, SWM total errors, TOL % perfect solutions, Tower of London total 
average moves); (4) Motor speed (Finger Tapping dominant hand taps, Finger Tapping 
non-dominant hand taps); (5) Motor dexterity (Grooved Pegboard dominant hand time, 
Grooved Pegboard non-dominant hand time). Individual neuropsychological test 
variables were converted to z-scores based on the cannabis user sample participants 
included in this study‟s imaging analyses at both time points (n = 46). Z-scores were 
transformed such that higher scores represented better performance across all variables. 
The individual test z-scores were averaged to form the final composite score for each 
cognitive domain. Because the Iowa Gambling Task is not included in any of the 
cognitive composites, the separate task variables of deck choices and total good choices 
were examined as well.  
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Similar to the substance use correlations described above, mean FA cluster values 
were correlated with cognitive variables within the cannabis user group, while controlling 
for other predictors of no interest. For the baseline assessment, baseline cognitive 
performance was regressed on sex and alcohol use during the past year. Residuals from 
these regressions were used as the outcome use variables and were correlated with the 
mean FA cluster values at baseline. Follow-up cognitive performance was regressed on 
baseline cognitive performance, sex, time interval between baseline and follow-up 
assessments, and average alcohol use in the past year. Residuals from these regressions 
were used as the outcome use variables and were correlated with the mean FA-change 
cluster values. 
2.3 Results 
2.3.1 Sample Characteristics 
Demographic information and participant characteristics are presented in Table 
17. Groups were matched on sex distribution, ethnicity/racial identity, years of education, 
and estimated IQ. The study participants were largely Caucasian and had above average 
IQ estimates. Groups were matched in terms of mean age, though a larger age range 
characterized the control sample to balance the sex distribution across both groups. Time 
to follow-up assessment was equivalent between groups, with an overall mean interval of 
2.23 years (SD = 0.52). 
Minimal psychopathology was expressed within the sample. Among controls, 2 
participants reported past major depressive disorder at baseline and follow-up, 1 
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participant reported social phobia at follow-up, and 1 participant met criteria for alcohol 
abuse at follow-up (Table 18). Among cannabis users, 1 participant met criteria for 
bipolar disorder NOS at baseline and follow-up. Both disorders were diagnosed based on 
episodic hypomania. Other psychological disorders evident in cannabis users included 
past specific phobia at baseline (n = 1), past major depressive disorder at follow-up (n = 
1), and past generalized anxiety disorder at follow-up (n = 1). The majority of cannabis  
users met criteria for a cannabis use disorder at baseline and follow-up (Table 18), and a 
large portion of users met criteria for an alcohol use disorder, though alcohol abuse was 
more common than alcohol dependence, and symptom expression was lower for alcohol 
use disorders. 
2.3.2 Substance Use Characteristics 
All cannabis users reported consistent cannabis use prior to both the Time 1 and 
Time 2 assessments (see Table 17) Given the high prevalence of cannabis use in the 
general population, controls who had minimally experimented with cannabis use were 
included. Minimal experimentation with cannabis use was reported by 2 controls at the 
Time 1 assessment (both reported using cannabis 1-5 times in the past 12 months); at 
Time 2, n = 7 reported using 1-5 times in the past 12 months, n = 2 reported having 
transitioned into using 6-20 times in the past 12 months. Additionally, cannabis users 
reported greater alcohol use (Time 1 & Time 2 cannabis user Mdn use = 50-99 times in 
past 12 months) than controls (Time 1 Mdn use = never in the past 12 months; Time 2 
Mdn use = 21-49 times in past 12 months). Minimal non-cannabis drug use was reported 
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among cannabis users at baseline and follow-up (use ≤ 20) and controls (Time 1: no 
reported use; Time 2: ≤ 5 times; see Table 19).  
Cannabis users in this sample reported a mean age of initiation of regular 
cannabis use during mid-adolescence (M = 15.35, SD = 1.16). At baseline, cannabis 
users reported nearly daily cannabis use during the past 30 days. Cannabis use occasions 
had declined by follow-up, with cannabis users reporting fewer occasions of use in the 
past year (t(21) = 2.650, p = .015) and past month (t(21) = 3.626, p = .002). The total 
number of hits reported did not significantly differ between assessments. 
2.3.3 Baseline Differences in White Matter Microstructure Between 
Groups (Table 20) 
Analysis of FA group differences at baseline yielded one significant voxel cluster 
(2584 mm
3
), in which FA levels were unexpectedly greater for cannabis users than 
controls. This cluster covered the right side of the genu of the corpus callosum (CC), 
crossing over the CC midline to extend into the inferior part of the left genu. In terms of 
fiber tracts, the cluster overlapped the caudal forceps minor, with a much greater 
extension into the right hemisphere than the left (Figure 13, cluster color coded blue). 
Analysis of RD group differences at baseline yielded one trend-level voxel cluster 
(1640 mm
3
; trend level at clusterwise FWE p = .10), in which RD levels were 
unexpectedly greater for controls than cannabis users. The controls > cannabis users 
baseline RD cluster was located in the same corpus callosum region as the controls < 
cannabis users baseline FA cluster, but was smaller in size (Figure 13), cluster color 
coded yellow). No other significant group differences emerged as baseline.
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Figure 13. Cannabis user > Control FA, Control > Cannabis user RD. Voxelwise analysis of baseline group difference and 2-year change in fractional 
anisotropy and radial diffusivity. Multiple regression analyses controlled for covariates. Color coding indicates contrasts for multiple regression effects: 
blue = baseline FA, cannabis users > controls; yellow = baseline RD, cannabis users < controls; red = FA, cannabis users > controls; green = RD, 
cannabis users < controls. 
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Figure 14. Control > Cannabis user FA, Cannabis user > Control RD. Voxelwise analysis of 2-year change in fractional anisotropy and radial 
diffusivity. Multiple regression analyses controlled for age, sex, interval between baseline and follow-up, average alcohol use at baseline and follow-up. 
Color coding indicates contrasts for multiple regression effects: red = FA, controls > cannabis users; green = RD, controls < cannabis users. 
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2.3.4 Baseline White Matter Microstructure Behavioral Correlates 
Substance Use  
Greater FA in the cannabis user > controls right genu/forceps minor CC cluster 
was associated with fewer total drinks in the past year in cannabis users (Table 21; Figure 
15). 
 
Figure 15. Scatterplot of baseline total # of drinks in the past year by mean FA in 
cannabis users > controls baseline cluster in the right genu and forceps minor of the CC, 
controlling for sex and average alcohol use at baseline. 
 
This cluster was uncorrelated with measures of cannabis use or tobacco use.  
Neurocognitive Performance 
Motivated decision-making. Higher mean cluster FA was associated with fewer 
choices from the disadvantageous Deck 2 (Table 21; Figure 16).  
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Figure 16. Scatterplot of baseline IGT disadvantageous Deck 2 choices by mean FA in 
cannabis users > controls baseline cluster in the right genu and forceps minor of the CC, 
controlling for sex and alcohol use at baseline. 
 
Mean FA in the right genu and forceps minor of the CC was not correlated with 
other measures of the IGT or the cognitive composites. 
2.3.5 Follow-up Differences in White Matter Microstructure Between 
Groups 
Significant differences in two-year FA change between cannabis users and non-
using controls were identified in seven voxel clusters (see Table 22). In five of the 
clusters, the controls had more positive FA change than cannabis users over the two-year 
follow-up interval, which was the expected direction of effects (Figure 14), while the 
cannabis users had more positive FA change than controls for the remaining two clusters 
(Figure 13). The largest controls > cannabis user FA-change cluster (3864 mm
3
) was 
located in the right hemisphere primarily along the superior longitudinal fasciculus (SLF) 
adjacent to the precentral and postcentral gyri. It extended anteriorly into the junction 
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between the SLF and the corticospinal tract (CST). The next largest FA cluster (1632 
mm
3
) had its peak adjacent to the parietal operculum in the left hemisphere. The cluster 
followed the SLF adjacent to the supramarginal and angular gyri, extending into the 
forceps major of the CC near the anterior portion of the lateral occipital cortex; above the 
forceps major, it overlapped a caudodorsal portion of the inferior longitudinal fasciculus 
(ILF). The posterior portion of the third FA cluster (1464 mm
3
) was located in the white 
matter of the middle region of the superior frontal gyrus in the left hemisphere, while the 
anterior portion extended into the lateral anterior cingulum and anterior thalamic 
radiation (ATR) adjacent to the anterior superior frontal gyrus. Most of the fourth FA 
cluster (1232 mm
3
; trend level at clusterwise FWE p = .065) was located within the CST 
adjacent to the precentral and postcentral gyri in the left hemisphere, with the lateral 
aspect of the cluster extending into the SLF. The fifth controls > cannabis user FA-
change cluster (1208 mm
3
; trend level at clusterwise FWE p = .071) was adjacent to the 
inferior frontal gyrus (specifically, the frontal operculum) in the right hemisphere, with 
the medial aspect of the cluster overlapping the anterior thalamic radiation and the lateral 
aspect extending into the superior portion of the fronto-occipital fasciculus (FOF).  
More positive two-year FA change was observed for cannabis users than Controls 
within two clusters in the left hemisphere. One cluster (1808 mm
3
) was located primarily 
in anterior corpus callosum (posterior genu, rostral body), with a small overlap into the 
caudal anterior cingulum. The other cluster (1696 mm
3
) was located in posterior thalamus 
white matter. The medial aspect of this cluster overlapped the CST and the ATR, while 
the lateral aspect extended into the acoustic and optic radiations. 
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Radial Diffusivity 
In addition to the FA results, significant differences in two-year DTI change 
between cannabis users and Controls were identified in the analysis of RD data. It was 
generally expected that RD would decrease over time. RD change was more positive for 
cannabis users than Controls in a very large voxel cluster (6848 mm
3
) that extended over 
the posterior two-thirds of the right hemisphere, in white matter adjacent to precentral, 
postcentral, supramarginal, inferior parietal, precuneus, and posterior cingulate cortex. 
The cluster peak was located in the medial aspect of the cluster, which overlapped the 
posterior cingulum. The middle section of the cluster overlapped the CST, while the 
lateral aspect overlapped the SLF. Both of these cluster segments had substantial overlap 
with a similarly located controls > cannabis user FA-change cluster (note that increased 
FA often is accompanied by decreased RD; see Figure 14). RD change was more positive 
for controls than cannabis users in a left hemisphere voxel cluster (2368 mm
3
) located 
along the CST, with a peak in the posterior limb of the internal capsule. 
2.3.6 Follow-up White Matter Microstructure Behavioral Correlates  
Substance Use (Table 23) 
The number of cannabis hits in the past year during follow-up was negatively 
associated with the control > cannabis user mean FA-change clusters in the left SLF/CC 
forceps major (Figure 17) and left CST (Figure 18) within cannabis users, indicating that 
higher levels of reported cannabis use were associated with lower magnitudes of FA 
change over time. 
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Figure 17. Scatterplot of total number of hits at follow-up, controlling for baseline hits, 
by mean FA-change in controls > cannabis users cluster in the left SLF/CC forceps 
major. Analysis controlled for sex, interval between baseline and follow-up, and average 
baseline and follow-up alcohol use. 
 
 
Figure 18. Scatterplot of total number of hits at follow-up, controlling for baseline hits, 
by mean FA-change in controls > cannabis users cluster in the left CST. Analysis 
controlled for sex, interval between baseline and follow-up, and average baseline and 
follow-up alcohol use. 
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Age of cannabis use onset was not significantly correlated with cluster mean 
FA-change values. Total number of alcoholic drinks consumed in the past year and 
tobacco use measures were not correlated with any of the significant FA-change clusters. 
A secondary analysis explored the association between FA-change values and 
baseline number of hits, controlling for sex, interval, and average alcohol use (Table 23). 
A trend emerged for greater hits at baseline correlating with increased FA change in the 
right ATR controls > cannabis users cluster. No significant associations were noted. 
Neurocognitive Performance 
Motor speed. Better performance on the motor speed composite was positively 
correlated with increased FA-change within the control > cannabis user right ATR cluster 
(Figure 19).  
 
Figure 19. Scatterplot of motor speed composite scores, controlling for baseline motor 
speed performance, by mean FA-change in controls > cannabis users cluster in the right 
ATR. Analysis controlled for sex, interval between baseline and follow-up, and average 
baseline and follow-up alcohol use. 
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Motivated decision-making. Counter to prediction, increased FA-change was 
associated with fewer selections from advantageous decks on the IGT (Figure 20, Figure 
21), and more choices from the disadvantageous deck 1 (Figure 22).  
 
Figure 20. Scatterplot of IGT total good choices, controlling for baseline total good 
choices, by mean FA-change in controls > cannabis users cluster in the left SFG white 
matter. Analysis controlled for sex, interval between baseline and follow-up, and average 
baseline and follow-up alcohol use. 
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Figure 21. Scatterplot of IGT advantageous Deck 4 choices, controlling for baseline 
Deck 4 choices, by mean FA-change in controls > cannabis users cluster in the left SFG 
white matter. Analysis controlled for sex, interval between baseline and follow-up, and 
average baseline and follow-up alcohol use. Trend association, p = .069. 
 
 
Figure 22. Scatterplot of IGT disadvantageous deck choices, controlling for baseline 
total good choices, by mean FA-change in controls > cannabis users cluster in the left 
SFG white matter. Analysis controlled for sex, interval between baseline and follow-up, 
and average baseline and follow-up alcohol use. 
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FA-change clusters were not correlated with the motor dexterity, processing speed, 
verbal learning and memory, or spatial working memory cognitive composites. 
2.4 Discussion 
This study assessed changes in white matter microstructure over a 2-year period 
of continued heavy cannabis use in young adults who initiated use during adolescence. 
White matter microstructure is known to show continued developmental changes during 
this age period (Lebel et al., 2012). As predicted, FA-change was generally lower and 
RD-change was generally higher for cannabis users as compared to controls. Specifically, 
cannabis users showed less FA change in the central and parietal regions of the right and 
left SLF (extending into the temporal/parietal/occipital white matter junction region on 
the left), in white matter adjacent to the left superior frontal gyrus, in the left CST just 
medial to the SLF, and in the right anterior thalamic radiation lateral to the genu of the 
corpus callosum. A corresponding finding of more RD change for cannabis users 
overlapped the FA cluster in the right SLF, but encompassed a much larger white matter 
region that included adjacent medial structures such as the CST and posterior cingulum. 
These results were not accounted for by group differences at baseline. 
These deviations in the development of white matter microstructure were 
observed primarily in widely distributed cortical association fibers, which is consistent 
with findings from functional MRI and behavioral studies of cannabis users. Cognitive 
studies consistently find diminished cannabis user performance on tasks that require more 
effortful performance, such as were found for verbal memory in Study 1. In functional 
MRI studies, cannabis users tend to show a broader pattern of cortical activation, 
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recruiting alternative brain networks during task performance, as compared to non-
using controls (Block et al., 2002; Chang et al., 2006; Harding et al., 2012; Jacobsen et 
al., 2004; Kanayama et al., 2004; Padula et al., 2007; Schweinsburg et al., 2010; Tapert et 
al., 2007). Increased activation and recruitment of alternative information processing 
pathways by cannabis users may reflect imperfect functional compensation for subtle 
degradations in structural connectivity, such as those reported here.  
The hypothesis that white matter changes would be associated with substance use 
characteristics was partially supported. Decreased FA change in the left SLF (-38, -44, 
24) and CST (-16, -28, 50) clusters was associated with greater cannabis use hits during 
the follow-up period. Similar measures of alcohol and tobacco use did not correlate with 
FA change. Increased alcohol use at baseline was associated with the decreased FA in the 
right genu (4, 26, 4) cluster that distinguished between groups at baseline, but was not 
associated with FA-change over time. Thus, although the cannabis user group used more 
alcohol and tobacco than controls, only their cannabis use was associated in a continuous 
quantitative manner with FA change, thereby strengthening the inference that cannabis 
use itself was a primary factor underlying the observed group differences at follow-up. 
This finding contradicts the majority of existing longitudinal DTI studies that have not 
documented changes over time attributable to amount of cannabis use. Bava et al. (2013) 
reported a large number of DTI voxel clusters differentiating alcohol and cannabis users 
from non-users but found that results were driven by alcohol use over the 18-month 
follow-up period rather than cannabis use. Similarly, Jacobus et al. (2013) found that over 
a 3-year interval, a group of binge alcohol users and a group of combined binge alcohol 
and cannabis users differed from non-using controls in 15 voxel clusters, but with only 
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one exception, the clusters did not differentiate the two user groups. However, a 
smaller longitudinal DTI study (n = 16) on the initiation (rather than continuation) of 
heavy alcohol and cannabis use reported 20 clusters distributed throughout the brain that 
differentiated participants who initiated combined alcohol and cannabis use vs. alcohol 
use alone, with decreased FA shown almost exclusively by the combined alcohol and 
cannabis users over the 3-year follow-up period (Jacobus, Squeglia, Infante, et al., 2013). 
The current results are consistent with Jacobus, Squeglia, Infante, et al. (2013) in 
suggesting that brain white matter changes driven by heavy cannabis use during late 
adolescence and early adulthood can be detected by DTI despite the presence of 
concurrent heavy alcohol use. This is an important empirical demonstration, given that 
white matter development extends into the third decade of life (e.g., Lebel et al., 2012) 
and that cannabis use during adolescence and early adulthood has been found to have 
long-term impacts on cognitive functioning and brain structure and organization, both in 
animal models (e.g., Bambico, Nguyen, Katz, & Gobbi, 2010; Gleason, Birnbaum, 
Shukla, & Ghose, 2012; Pistis et al., 2004; Raver, Haughwout, & Keller, 2013; Rubino et 
al., 2009; Schneider & Koch, 2003, 2007; Schneider, Schömig, & Leweke, 2008; 
Stopponi et al., 2014) and in humans (e.g., Battisti et al., 2010; Ehrenreich et al., 1999; 
Fontes et al., 2011; Lisdahl, Gilbart, Wright, & Shollenbarger, 2013; Meier et al., 2012; 
Pope et al., 2003; Solowij et al., 2012; Wagner, Becker, Gouzoulis-Mayfrank, & 
Daumann, 2010).  
Contrary to predictions, several findings for the cannabis user group involved DTI 
changes generally associated with better white matter organization, i.e., increased FA and 
decreased RD. In the left hemisphere, more positive FA change was observed for 
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cannabis users in the anterior CC (posterior genu, rostral body) and posterior thalamic 
white matter. A corresponding decreased-RD cluster overlapped the posterior thalamic 
area and also extended medially into the CST. In analyses of baseline data, the medial CC 
genu region (caudal forceps minor tract) showed higher FA values and lower RD values 
in the cannabis user group. Filbey et al. (2014) also reported higher FA and lower RD for 
cannabis users in the forceps minor of the CC, and more generally an early study reported 
a similar pattern in several regions including the medial frontal white matter (Delisi et al., 
2006). Differences observed at baseline may reflect areas of compensation and relative 
strength in the cannabis user group, as higher FA in the region at baseline was associated 
with better task strategy on a measure of motivated decision-making. 
Interpretation of the functional relevance of FA increases and RD decreases in the 
cannabis user group over the 2-year follow-up period is complex. It was expected that 
FA-changes would map onto neurocognitive performance over time, such that increased 
FA would be associated with improved task performance. However, this association was 
only observed between the right ATR cluster and the motor speed composite. In contrast, 
advantageous IGT performance was negatively associated with increased FA-change in 
the left SFG white matter cluster. Other cognitive domains were unrelated to average FA-
change in the areas that distinguished groups. The overall pattern of findings did not 
support a strong association between cognitive performance and FA-change over time. 
This may be due to limitations inherent in the study design. The association between 
cognitive performance and white matter integrity was investigated only in those regions 
that distinguished between groups, and task performance was not analyzed in relation to 
whole-brain white matter integrity within cannabis users. It is possible that the regions  
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that differed between groups support cognitive functions not assessed in the cognitive 
battery employed, or that the behavioral alterations that are associated with these regions 
may emerge over time but are not detectable yet. As magnitude of cannabis use was 
associated with greater alterations, it is expected that continued use would lead to the 
emergence of these associations over time.  
In the absence of strong behavioral correlates, it is difficult to interpret the 
significance of the white matter deviations. This is a problem that is widespread in the 
cannabis user neuroimaging literature. Alterations (reductions or increases) are 
interpreted as negative when observed among cannabis users, yet few studies have been 
linked to behavioral correlates that substantiate those interpretations (Weiland et al., 
2015). Further research is needed to establish meaningful behavioral links with the 
observed alterations. 
Notably, the study findings are informative regarding the timing of use-related 
impacts on brain structure. At baseline, cannabis users had been heavily using cannabis 
for an average of two years. Group differences evident at the follow-up assessment were 
detectable after four or more years of continued heavy use. 
Unlike previous cross-sectional studies, no DTI differences were found between 
cannabis users and non-using controls in white matter tracts associated with core limbic 
structures such as the hippocampus (e.g., fimbria; Zalesky et al., 2012; Yücel et al., 2012) 
and amygdala (e.g., uncinate fasciculus; Jacobus, Squeglia, Infante, et al., 2013; Jacobus, 
Squeglia, Bava, et al., 2013; Shollenbarger, Price, Wieser, & Lisdahl, 2015), either at 
baseline or follow-up. These limbic structures are rich in endocannabinoid receptors, and 
cannabis exposure has been linked with hippocampal damage in animal models (Rubino 
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et al., 2009). Other studies may have had greater sensitivity to detect effects in these 
smaller tortuous white matter tracts due to the use of fiber tractography (Shollenbarger et 
al., 2015; Zalesky et al., 2012) and incorporation of substantially lower cluster-size 
thresholds in voxel-based analysis (Jacobus, Squeglia, Bava, et al., 2013; Jacobus, 
Squeglia, Infante, et al., 2013).  
Limitations of this study must be noted. The sample was relatively small and was 
comprised mostly of Caucasian participants. While the DTI results reported here were 
similar to those reported in other samples, additional research is needed among more 
racially and ethnically diverse samples to improve generalizability of the findings. 
Similarly, this sample of cannabis users is characterized by high average IQ estimates, 
which again limits the generalizability of findings and perhaps skews overall FA levels 
toward higher values (Navas-Sánchez et al., 2014). That said, these findings are sobering 
regarding potential impacts of chronic cannabis use across late adolescent development in 
an otherwise low-risk sample. An additional limitation with the sample is the greater 
range of ages in the control group relative to cannabis users. Groups were matched on 
mean age, and age was statistically controlled in analyses to mitigate potential 
confounding by age variance. Baseline age did not produce supra-threshold clusters in 
analyses of FA and RD change over the two-year follow-up period, which indicated that 
the group-wise DTI findings were not confounded significantly by the age range 
difference between groups.  
Perhaps more importantly, cannabis users and controls differed substantially in 
alcohol use, which is commonly observed in studies of adolescent and young adult 
cannabis users (e.g., Arnone et al., 2008; Bava et al., 2009, 2013; Gruber et al., 2014; 
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Jacobus, Squeglia, Infante, et al., 2013; Jacobus, Squeglia, Bava, et al., 2013; 
Shollenbarger et al., 2015; Thatcher, Pajtek, Chung, Terwilliger, & Clark, 2010b). To 
assess this sampling confound, past 12-month alcohol use at both baseline and follow-up 
were included in preliminary analyses of FA and RD change, which produced no supra-
threshold clusters for the two alcohol use variables. To provide statistical control for sub-
threshold differences, the average of the baseline and follow-up alcohol use variables 
were included in the final DTI analyses. The dose-dependent findings also indicated that 
cannabis use was the primary factor in the DTI cluster results, as mean values from 
several of the FA change clusters correlated with past 12-month cannabis use but not 
alcohol use. Nevertheless, the optimal design to detect and isolate longitudinal cannabis 
effects would employ contrasting groups that used alcohol at equivalent levels. 
As noted in Study 1, participants were asked be free of substance use for at least 
24 hours prior scanning, drug testing was not employed to verify reported levels of 
cannabis and other substance use among cannabis users and controls. Cannabis user and 
control participants completed multiple self-report and interview measures of substance 
use, and responses across measures were compared for reliability of information. While it 
is possible that participants endorsed false use levels, this appears unlikely given 
consistency of reports across measures within time points and across the follow-up 
interval. Further, cannabis users‟ self-reported level of cannabis use was supported by 
evidence of DSM-IV cannabis dependence in the sample as well as the neurocognitive 
impairments noted at baseline for these participants.  
Finally, while reports have described alterations in cerebellar white matter in 
cannabis users, the field-of-view placement did not allow for equivalent examination of 
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this region across participants. Therefore, the current study could not address the 
impact of cannabis use on cerebellar white matter development. 
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3 General Conclusions and Future Directions 
The two studies presented aimed to characterize the neurocognitive and 
neuroanatomical profiles associated with sustained cannabis use during adolescence and 
young adulthood in comparison to non-using controls. Cannabis is among the most 
commonly used drugs by adolescents and young adults, yet its effects in the developing 
brain are not well understood. It is important to better understand the cognitive and 
neurobiological vulnerabilities associated with cannabis use during the sensitive period of 
neurobehavioral development in adolescence. As the legal status of cannabis use 
continues to change, this research will ideally help to inform policy that can improve the 
public health of adolescents and young adults. 
In Study 1, the neurocognitive profile associated with cannabis use at baseline and 
follow-up was examined. Cannabis users demonstrated more widespread cognitive 
deficits at baseline than at follow-up in the domains of verbal learning and memory, 
spatial working memory, planning, and motivated decision-making. Continued cannabis 
use over the follow-up interval was not associated with a decline in cognitive 
performance over time. Instead, stable cognitive deficits remained in the domains of 
verbal learning and memory and planning ability, whereas performance on spatial 
working memory and motivated decision-making tasks recovered to control-level 
performance, and processing speed performance continued to be a relative strength within 
cannabis users.  
The overall profile of deficits that emerged at both time points indicates that 
motivation and effort may be mechanisms contributing to the cognitive vulnerabilities 
observed. Poorer performance on a relatively easy trial of the planning task, in the 
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context of normal performance on harder trials, suggests that diminished motivation 
may contribute to the cognitive profile of cannabis users. Cannabis users‟ neurocognitive 
performance can be enhanced with the use of motivational cues prior to task completion, 
whereas controls do not show this association (Macher & Earleywine, 2012), suggesting 
that internal motivation to sustain effortful performance is less robust among cannabis 
users. Increased internal motivation is needed to sustain effortful performance when there 
is no extrinsic reinforcement or reward (Ryan & Deci, 2000). Internal motivation relies 
on the subjective valuation of achieving success on a given task (Murayama, Matsumoto, 
Izuma, & Matsumoto, 2010), which is modulated by activity in the dopaminergic reward 
network, including endocannabinoid receptor-rich brain regions of the ventral tegmental 
area, nucleus accumbens, striatum, hippocampus, amygdala, and prefrontal cortex (Kable 
& Glimcher, 2007; Levy & Glimcher, 2011). Dopamine is hypothesized to be the primary 
transmitter that modulates the activity of the reward network, adapting and driving the 
relationship between motivation and behavior (Depue & Collins, 1999; Luciana, 
Wahlstrom, Porter, & Collins, 2012; Wahlstrom et al., 2010). Preclinical data indicate 
that the cannabinoid exposure may alter dopamine activity in the reward network, 
resulting in decreased motivation. Acute administration of cannabis increases dopamine 
release in the reward network (Tanda & Goldberg, 2003), while chronic administration 
produces a blunted dopamine response in the midbrain (Pistis et al., 2004). In humans, a 
pattern of chronic cannabis use is associated with reduced striatal dopamine synthesis and 
reactivity (Bloomfield, Morgan, Egerton, et al., 2014; Volkow, Wang, et al., 2014), with 
reduced striatal dopamine receptor binding associated with an earlier age of cannabis use 
initiation (Urban et al., 2012). Importantly, striatal dopamine synthesis capacity has been 
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inversely associated with apathy and amotivation among cannabis users (Bloomfield, 
Morgan, Kapur, Curran, & Howes, 2014). Together, the neurobiological alterations 
associated with chronic cannabinoid exposure likely contribute to diminished motivation 
for complex cognitive tasks. Diminished motivation could have drastic impacts on 
cannabis users‟ behavior, and may be important moderators of the deficits commonly 
observed. More research is needed to clarify the role of motivation in cognitive 
performance among cannabis users. 
Deficits in verbal learning and memory may be accounted for, in part, by lower 
motivation among users. It is also plausible that neural inefficiency is a mechanism 
driving poorer performance on more complex tasks. Cannabinoid-mediated neuroplastic 
changes in the context of chronic use (Heifets & Castillo, 2009) is associated with the 
recruitment of alternative and less efficient neural pathways (Harding et al., 2012). Less 
efficient pathways may be sufficient to compensate for cognitive deficits on simpler 
tasks, but be overly taxed on more complex tasks.  Neural inefficiency may manifest 
behaviorally in poorer performance on more effortful tasks, corresponding to the robust 
finding of verbal learning and memory deficits among cannabis users. 
The deficits in verbal learning and memory and planning noted in this study 
represent more stable features associated with continued use. Subtle but significant 
deficits were observed in these domains at both time points. Cannabis use characteristics 
of early and heavy use initiation during adolescence were associated with greater 
performance impairments among cannabis users at follow-up. The relationship emerged 
despite the cognitive strengths of users and general homogeneity of use characteristics in 
the cannabis user sample. This is consistent with theories that the timing and magnitude 
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of use during adolescence has far-reaching impacts on cognition throughout life 
(Lisdahl et al., 2013; Meier et al., 2012). The study extended the existing literature by 
documenting the emergence of these use characteristics‟ contributions to poorer learning 
and memory performance in a young adult sample.  
Unfortunately, this study does not resolve questions about the timing of the 
development of cognitive deficits in this sample, as select deficits were noted at baseline 
and persisted at follow-up. Notably, cannabis users in this sample had already initiated 
use at least a year prior to the baseline assessment, and premorbid differences between 
samples cannot be ruled out. More prospective research is needed to clarify the causal 
role of cannabis in cognitive deficits noted. 
The lack of more widespread cognitive deficits, or decline in cognitive 
performance between assessments, may be accounted for by the greater cognitive reserve 
in younger cannabis users as opposed to older users. As cannabis use extends into 
adulthood, underlying cognitive vulnerabilities may emerge among those with earlier and 
greater cannabis use during adolescence, and performance deficits in affected cognitive 
domains could become more striking. The declines that have been reported in the context 
of other longitudinal studies might be observed in this sample of cannabis users were 
assessed after a longer time period to follow-up. Future longitudinal research that follows 
users during emerging adulthood and indexes cognitive performance as a function of 
amount and age of cannabis use in adolescence would address this outstanding question. 
In Study 2, the underlying neuroanatomical profile of white matter microstructure 
was assessed at baseline and over the follow-up interval. The findings were consistent 
with cross-sectional DTI research indicating that heavy cannabis use is associated with 
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deleterious alterations in white matter microstructure within major fiber tracts, such 
as the superior longitudinal fasciculus, corticospinal tract, and corpus callosum. The 
deleterious alterations were not accounted for by baseline differences between groups and 
only emerged over the follow-up interval. The longitudinal study design extended the 
existing literature by assessing white matter microstructural change in the context of 
continuing regular cannabis use by high-functioning young adults. This design 
distinguished a small number of baseline DTI differences between cannabis users and 
non-using controls from a larger number of group differences in FA and RD change over 
time. The differences found suggest aberrant patterns of neurodevelopment as a 
consequence of heavy cannabis use. 
It was expected that the cognitive vulnerabilities noted in Study 1 would be 
associated with the FA-change clusters in Study 2, providing a link between the 
behavioral and neurobiological alterations. However, this direct association was largely 
not observed, and FA-change was associated with few behavioral correlates. Overall, the 
functional significance of the white matter microstructure differences between groups 
was not detected with the neurocognitive battery employed. Behavioral manifestations of 
disrupted white matter microstructure may manifest in subtler ways than would be 
detected by task performance at this time, but this underlying vulnerability may emerge 
in more pronounced cognitive deficits over time. By assessing young adult cannabis 
users, this study captures cannabis‟ impact in the context of ongoing refinement and 
remodeling of neural connections across broad association areas of the brain (Lebel et al., 
2012). As that maturational process slows and plateaus, cognitive processing efficiency 
may decline at a faster rate than in those with normative brain development. On the other 
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hand, the brain changes observed may represent neuroplastic changes that result in 
compensatory alternative brain organization, which ultimately yield equivalent task 
performance. Both possibilities are purely speculative at this point, and would require 
longer-term longitudinal studies to assess users over a longer time span, after brain 
development plateaus. 
Similarly, identifying the neurobiological underpinnings of the cognitive deficits 
observed in Study 1 also remains an outstanding research question. I expected that white 
matter microstructure disruptions would underlie the cognitive deficits typically noted in 
cannabis users, but this was not supported by the current studies. Given the lack of 
correlation between white matter microstructure and behavioral alterations noted in this 
study, I suggest that future research should employ different imaging methods to 
determine the link between the biological and behavioral findings. More inclusive 
methods assessing white matter across the whole brain of cannabis users, rather than 
within clusters that distinguished cannabis users from controls, may detect this 
association.  
It is also possible that neurobiological alterations not indexed with DTI underlie 
the cognitive alterations noted, such as molecular changes in neurotransmitter signaling. 
These more fine-grained alterations may not manifest in a broad index of white matter 
integrity, but are more likely to be detected with different imagining techniques that 
assess the chemical composition within brain regions (i.e., MRI spectroscopy: Muetzel et 
al., 2013). Each imaging technique has costs and benefits. The methods employed in the 
current studies allowed for comparison of white matter integrity between groups across 
the whole brain, whereas MRI spectroscopy assesses only a small portion of the brain. 
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However, the current results suggest more fine-grained imagining may be useful. A 
review of 8 MRI spectroscopy studies among cannabis users suggested that chronic 
cannabis use is associated with decreased neuronal viability and cannabinoid-mediated 
immunosuppression, supporting the hypothesis that exogenous cannabinoids are 
neurotoxic (Sneider, Mashhoon, & Silveri, 2013). However, in vitro and in vivo 
preclinical data support both a neuroprotective and neurotoxic profile of cannabinoids, 
(Sarne, Asaf, Fishbein, Gafni, & Keren, 2011). Further basic research is needed to clarify 
the complex role of the endocannabinoid system in the brain in general, during 
development, and how it can be disrupted through chronic cannabis use. 
This dissertation replicated findings that both cognitive and neurobiological 
alterations characterized young adult chronic cannabis users. Cognitive abilities are not 
expressed in a vacuum, and it is important to consider the larger implications of these 
findings. Cognitive abilities are expressed through complex, multidimensional, and 
interactive environments in daily life. Regardless of underlying mechanisms driving the 
alterations, subtle deficits in the domains of planning and verbal memory have the 
potential to have far-reaching effects on daily life, given that these cognitive domains 
support goal-attainment and new learning. Alterations in these abilities are likely to 
impact performance in a variety of real-world situations, including educational and 
workplace settings.  
One excellent illustration of how these cognitive deficits manifest in real-world 
settings was provided by Montgomery and colleagues (2012), who assessed young adult 
cannabis users and non-users as they played the role of an office worker in a non-
immersive virtual reality task. Participants completed tasks that approximated duties one 
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might perform in an office, providing a glimpse into the functional capabilities of 
participants in a cognitively demanding setting. Cannabis users performed worse overall, 
and their performance was most impaired on measures of planning (i.e., write a plan of 
action for a list of tasks one needed to accomplish in a logical order) and prospective 
memory (i.e., update a log for the outgoing mail, remember to turn off the coffee maker 
when someone arrived for a meeting). Logical organization and successful completion of 
tasks are important skills for success in all types of occupations, as well as countless 
valued activities in everyday life (e.g., volunteer activities, sports, hobbies, relationships, 
parenting). Further, even subtle deficits in learning and memory could impact users‟ 
ability to apprehend new information, build on existing knowledge bases, and advance 
their learning and education in school and the workplace. It is likely that the cognitive 
performance deficits that characterize cannabis users are reflected in a broad range of 
diminished real world achievement and functioning. 
Indeed, cannabis use is associated with lower educational achievement (Horwood 
et al., 2010; Medina et al., 2007) as well as poor psychosocial adjustment across a range 
of domains, including decreased life satisfaction, negative physical health consequences, 
and increased self-report of depression and anxiety, (Arseneault, Cannon, Witton, & 
Murray, 2004; Hall & Degenhardt, 2009; Hayatbakhsh et al., 2007; Patton et al., 2002; 
Rey et al., 2002). Ongoing research indicates that a broad range of risk factors predispose 
adolescents to initiate cannabis use, (Hayatbakhsh, Williams, Bor, & Najman, 2012), 
though, once initiated, cannabis use contributes to negative mental health and other poor 
psychosocial outcomes (Lynskey et al., 2003; Mcgee, Williams, Poulton, & Moffitt, 
2000; Patton et al., 2002). While the mechanisms driving the correlates with use are not 
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fully understood, altered cognitive abilities may be one contributor to overall 
diminished functioning and negative health outcomes. 
As legality questions are at the forefront in United States‟ political discussion, it is 
important to consider the actual risks that appear to be associated with cannabis use. The 
existing literature and, in part, this dissertation indicate that early and heavy use of 
cannabis is associated with a range of cognitive, neurobiological, and psychosocial risks. 
Thus, I support Krista Lisdahl‟s suggestion that young people “dare to delay” cannabis 
use during adolescence (Lisdahl et al., 2013), and wait until the window of increased 
developmental vulnerability closes to initiate use, if they choose to use at all. Crafting 
laws that reduce cannabis use during adolescence will be an important safeguard to 
mitigate the risks that are associated with that pattern of use. Further, focusing efforts and 
resources on early prevention of use and increased education to parents and adolescents 
about the risks associated with use are important steps to bridge the gap between the 
scientific community and those negatively impacted by use. 
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4 Tables 
Table 1. Study 1 Demographic and substance use characteristics of cannabis users and controls at baseline and follow-up 
Variable Control Cannabis User F, U, χ2  p 
Baseline characteristics     
n  35 36   
Age 19.40 (0.93) 19.51 (0.61) 0.37 0.55 
#Male/#Female 13/22 22/14 χ2 = 4.08 0.04* 
#Caucasian/#Other Ethnicity 27/8 31/5 χ2 = 0.95 0.33 
Years of education 13.26 (1.24) 13.26 (0.95) < 0.00 0.98 
Estimated Full Scale IQ
a
 114.85 (1.70) 114.40 (1.65) 0.03 0.86 
Vocabulary T-Score 62.16 (1.29) 60.71 (1.26) 0.62 0.44 
Matrix reasoning T-Score 54.56 (0.99) 55.65 (0.96) 0.60 0.44 
Alcohol use average -0.59 (0.69) 0.59 (0.75) 48.22* < 0.00** 
ASR substance use     
Past 6 months: Tobacco use per day 0.00 (0.00) 0.92 (1.53) U = 385.0 < 0.00** 
Past 6 months: Days drunk 5.37 (9.24) 25.21 (18.14) U = 143.5 < 0.00** 
Past 6 months: Days using drugs 0.14 (0.49) 145.20 (40.21) U = 0.00 < 0.00** 
Cannabis use
b
     
Age first used (years) – 15.24 (1.23)   
Past year: Days used – 333.86 (45.29)   
Past 30 days: Days used – 27.50 (3.88)   
Past year: Total # hits – 3256.97 (2307.04)   
Past 30 days: Total # hits – 262.69 (200.41)   
Follow-up characteristics      
n 29 26   
Years between assessments 2.22 (0.49) 2.36 (0.31) 1.60 0.21 
Age at follow-up 21.52 (0.90) 21.82 (0.76) 1.77 0.19 
#Male/#Female 10/19 19/7 χ2 =8.19 < 0.00** 
#Caucasian/#Other Ethnicity 23/6 22/4 χ2 = 0.26 0.61 
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Variable Control Cannabis User F, U, χ2  p 
Years of education 15.14 (1.13) 15.16 (2.72) < 0.00 0.97 
Estimated Full Scale IQ
a
 118.84 (1.54) 117.11 (1.63) 0.55 0.46 
Vocabulary T-Score 62.25 (1.25) 61.38 (1.33) 0.21 0.65 
Matrix reasoning T-Score 58.83 (0.90) 58.11 (0.96) 0.28 0.60 
Alcohol use average -0.51 (0.52) 0.58 (0.76) 39.57 < 0.00** 
ASR substance use     
Past 6 months: Tobacco use per day 0.00 (0.00) 2.03 (3.10) U = 130.5 < 0.00** 
Past 6 months: Days drunk 6.90 (9.84) 27.65 (22.56) U = 110.5 < 0.00** 
Past 6 months: Days using drugs 0.45 (0.91) 93.71 (67.37) U = 18.0 < 0.00** 
Cannabis use
b,c
     
Past year: Days used – 245.02 (134.92)   
Past 30 days: Days used – 18.28 (11.96)   
Past year: Total # hits – 2561.90 (2396.39)   
Past 30 days: Total # hits – 184.41 (204.75)   
Notes. Values represent means and standard deviation units, unless otherwise specified. Group comparisons using chi-square, Mann-Whitney U, or 
one-way analysis of variance are reported. ASR = Adult Self-Report. 
a
Marginal means and standard errors are presented, controlling for sex. 
b
Variables only included for cannabis users. 
c
Data unavailable for 1 cannabis user (n = 25). 
*p ≤  .05. **p ≤ .01. 
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Table 2. DSM-IV-TR Diagnoses at study initiation and follow-up, as assessed by the K-SADS-PL. The number of participants who met criteria for 
each disorder is reported. 
 Control  Cannabis 
 Baseline (n = 35) Follow-up (n = 29)  Baseline (n = 36) Follow-up (n = 26) 
Diagnosis Current 
 
Partial 
Remission Past Current 
Partial 
Remission Past 
 
Current 
Partial 
Remission Past Current 
Partial 
Remission Past 
Cannabis Dependence 0 0 - 0 0 -  19 1 - 15 5 - 
Cannabis Abuse 0 - 0 0 - 0  12 - 14 2 - 5 
Alcohol Dependence 0 0 - 0 1 -  1 0 - 3 1 - 
Alcohol Abuse 0 - 0 1 - 2  11 - 16 4 - 8 
Major Depressive 
Disorder 
0 - 0 0 - 0  0 - 0 0 - 2 
Bipolar NOS 0 - 0 0 - 0  1 - 1 1 - 1 
Oppositional Defiant 
Disorder 
0 - 0 0 - 0  0 - 2 NA - NA 
Specific Phobia 0 - 0 0 - 0  0 - 1 0 - 0 
Generalized Anxiety 
Disorder 
0 - 0 0 - 0  0 - 0 1 - 2 
Notes. NA = not assessed at follow-up. Current ratings are based on previous 6 months for substance use disorders, and on the previous 2 months for other 
diagnoses. At baseline, past ratings are based on lifetime symptom expression. At follow-up, past ratings are based on symptoms during follow-up interval
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Table 3. Substance Use Disorder Symptoms baseline and follow-up. The number of participants who reported each symptom is reported. 
 Control Cannabis User 
 Baseline Follow-up Baseline Follow-up 
Symptom Current
 
Past Current Past Current Past Current Past 
Alcohol         
Uses more than planned 0 0 1 2 0 1 7 7 
Recurrent negative physical consequences 3 1 5 9 17 19 5 15 
Recurrent use in dangerous situations 0 0 0 0 5 7 5 9 
Recurrent negative psychological consequences 0 0 1 1 2 3 1 1 
Recurrent negative occupational consequences 0 0 0 0 1 1 2 2 
Recurrent negative social consequences 0 0 1 1 2 5 2 2 
Recurrent negative legal consequences 0 0 0 1 0 1 0 0 
Recurrent failure to fulfill major role 0 0 0 0 0 2 2 3 
Important activities reduced for use 0 0 0 0 1 1 1 2 
Time consuming 0 0 0 0 2 1 5 5 
Tolerance 1 0 0 1 6 6 6 7 
Repeated attempts to quit 0 0 0 0 0 0 0 0 
Withdrawal 0 0 0 1 0 0 0 0 
Alcohol consumed to alleviate withdrawal 0 0 0 0 0 0 0 0 
Cannabis         
Uses more than planned 0 0 0 0 11 12 8 11 
Recurrent negative physical consequences 0 0 0 0 1 1 3 3 
Recurrent use in dangerous situations 0 0 0 0 24 26 18 19 
Recurrent negative psychological consequences 0 0 0 0 3 2 2 3 
Recurrent negative occupational consequences 0 0 0 0 13 13 4 4 
Recurrent negative social consequences 0 0 0 0 3 5 2 3 
Recurrent negative legal consequences 0 0 0 0 0 0 0 0 
Recurrent failure to fulfill major role 0 0 0 0 17 18 10 17 
Important activities reduced for use 0 0 0 0 7 9 4 5 
Time consuming 0 0 0 0 34 34 20 24 
Tolerance 0 0 0 0 20 19 18 21 
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 Control Cannabis User 
 Baseline Follow-up Baseline Follow-up 
Symptom Current
 
Past Current Past Current Past Current Past 
Repeated attempts to quit 0 0 0 0 6 7 4 5 
Withdrawal 0 0 0 0 8 9 6 11 
Cannabis consumed to alleviate withdrawal 0 0 0 0 1 1 0 2 
Note. Current ratings are based on previous 6 months. At baseline, past ratings are based on lifetime symptom expression. At follow-up, past 
ratings are based on symptoms during follow-up interval. 
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Table 4. Lifetime other drug usage in cannabis users and controls at baseline and follow-up. 
Number of participants who used each drug at different usage levels. Count includes lifetime use 
at baseline, and use in past 12 months at follow-up 
 
Control Cannabis 
Baseline Follow-up Baseline Follow-up 
 
n = 35 n = 29 n = 36 n = 26 
Cannabis
    No use 24 20 - 1 
1-5 times 10 5 - - 
6-20 times 1 4 - 1 
21-49 times - - - 1 
50-99 times - - - 6 
100+ times - - 37 17 
Psychedelics 
    No use 35 28 18 9 
1-5 times - 1 16 14 
6-20 times - - 2 2 
100+ times - - - 1 
Cocaine 
    No use 35 29 33 17 
1-5 times - - 2 9 
6-20 times - - 1 - 
Amphetamines 
    No use 35 29 29 20 
1-5 times - - 5 2 
6-20 times - - 1 4 
21-49 times - - 1 - 
Barbiturates 
    No use 35 29 31 25 
1-5 times - - 5 1 
Tranquilizers 
    No use 35 29 29 26 
1-5 times - - 7 - 
Heroin 
    No use 35 29 36 26 
Other narcotics 
    No use 35 29 23 20 
1-5 times - - 12 6 
21-49 times - - 1 - 
Steroids 
    No use 35 29 36 26 
Inhalants 
    No use 35 29 35 26 
1-5 times - - 1 - 
Prescription drugs 
    No use 35 28 27 21 
1-5 times - 1 9 4 
6-20 times - - - 1 
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Table 5. Iowa Gabling Task (IGT) deck contingencies. 
 Deck 1 Deck 2 Deck 3 Deck 4 
Win Amount $0.25 $0.25 $0.10 or $0.15 $0.10 or $0.15 
% of losses 50% 10% 50% 10% 
Range of losses $0.35 - $0.90 $3.00 - $3.25 $0.05 - $0.20 $0.60 - $0.65 
Net winnings after 20 
choices 
-$1.25 -$1.25 +1.25 +1.25 
Good vs. Bad Bad Bad Good Good 
Punishment Frequent Infrequent Frequent Infrequent 
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Table 6. Baseline neuropsychological cognitive composite scores. Cognitive composite scores represent average z-scores from component test 
variables. Higher performance indicates better performance. Means reported are marginal means, controlling for sex, IQ, and alcohol use.  
  Control Cannabis user    
Cognitive Composite Cronbach‟s  M (SE) M (SE) F p ηp
2 
Motor Speed 0.91 -0.317 (0.20)   0.197 (0.20)  2.614 .111 .04 
Motor Dexterity 0.82 -0.225 (0.17)  -0.046 (0.17)  0.440 .510 .01 
Processing Speed 0.60 -0.361 (0.13)   0.213 (0.13)  7.470 .008** .10 
Verbal Learning and Memory 0.91  0.231 (0.16)  -0.446 (0.16)  7.313 .009** .10 
Spatial Working Memory and Planning 0.73  0.002 (0.13)  -0.236 (0.13)  1.333 .253 .02 
**p ≤ .01. 
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Table 7. Baseline neuropsychological battery scores. Means reported are marginal means, controlling for sex, IQ, and alcohol use.  
 Control (n = 35) Cannabis user (n = 36)    
Cognitive Measure M (SE) M (SE) F p ηp
2 
Finger Tapping Test      
Dominant hand (# taps) 42.11 (1.71)  46.98 (1.68)  3.25 .076^ .05 
Non-dominant hand (# taps) 41.92 (1.50)  44.85 (1.48)  1.52 .222 .02 
Grooved Pegboard      
Dominant hand time (s) 65.48 (1.44)  63.83 (1.42)  0.52 .473 .01 
Non-dominant hand time (s)
b 
72.86 (2.00)  71.40 (2.00)  0.21 .650 <.00 
Digit Symbol      
Total correct 87.61 (2.64)  89.33 (2.60)  0.17 .682 <.00 
Letter Cancellation      
Time (s) 112.09 (3.45)  96.33 (3.39)  8.31 .005** .11 
Total omissions
a
 1.49 (0.15)  1.53 (0.14)  0.02 .881 <.00 
Total commissions
a
 0.81 (0.04)  0.72 (0.04)  1.61 .209 .02 
COWAT      
Total correct words generated 43.09 (1.80)  50.66 (1.77)  7.07 .010** .10 
Total set-loss errors
a
 0.82 (0.08)  1.10 (0.08)  4.16 .045* .06 
Total perseverative errors
a
 1.03 (0.08)  0.96 (0.08)  0.28 .602 <.00 
Digit Span      
Digits forward (# recalled) 7.66 (0.22)  7.16 (0.21)  2.14 .148 .03 
Digits backward (# recalled) 5.94 (0.26)  5.25 (0.25)  2.84 .097 .04 
RAVLT      
Trial 1 7.07 (0.34)  6.62 (0.33)  0.72 .401 .01 
Trial 2 9.92 (0.43)  9.72 (0.42)  0.09 .764 <.00 
Trial 3 11.78 (0.38)  11.33 (0.37)  0.57 .451 .01 
Trial 4 12.75 (0.4)  11.69 (0.39)  2.78 .100^ .04 
Trial 5 13.38 (0.36)  12.36 (0.35)  3.25 .076^ .05 
Total words: Trial 1-5 54.90 (1.46)  51.71 (1.43)  1.92 .171 .03 
Trial 1-5 total intrusions
a
 1.02 (0.11)  1.32 (0.11)  2.77 .100^ .04 
Trial 1-5 total perseverative errors
a
 1.94 (0.18)  1.85 (0.18)  0.10 .752 <.00 
Total words: Interference trial list 7.37 (0.33)  5.92 (0.32)  7.74 .007** .10 
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 Control (n = 35) Cannabis user (n = 36)    
Cognitive Measure M (SE) M (SE) F p ηp
2 
Total words: Immediate recall 12.22 (0.41)  10.54 (0.40)  6.87 .011* .09 
Total words: Delayed recall 12.01 (0.45)  9.68 (0.44)  10.61 .002** .14 
Spatial Working Memory
b 
     
Total between search errors 13.65 (1.93)  12.40 (1.93)  0.16 .686 <.00 
Strategy Score: 6-8 30.30 (1.05)  28.90 (1.05)  0.69 .410 .01 
Spatial Delayed Response Task 2.45 (0.16)  2.53 (0.16)     
Error: No delay (mm) 6.45 (0.44)  7.71 (0.43)  0.10 .752 <.00 
Error: 500 ms delay (mm) 9.89 (0.60)  11.92 (0.59)  3.29 .074^ .05 
Error: 8,000 ms delay (mm) 1816.66 (100.77)  1981.98 (98.98)  4.61 .036* .07 
Mean reaction time: No delay  1653.57 (74.05)  2070.81 (72.73)  1.08 .304 .02 
Mean reaction time: 500 ms delay  1723.02 (82.39)  2268.63 (80.93)  12.69 .001** .16 
Mean reaction time: 8,000 ms delay   17.52 <.000** .21 
Tower of London
b
      
% Perfect Solutions 83.47 (0.03)  74.15 (0.03)  5.11 .027* .07 
Average moves: 2-move 2.00 (0.00)  2.00 (0.00)     
Average moves: 3-move 3.00 (0.06)  3.29 (0.06)  9.34 .003* .13 
Average moves: 4-move 4.93 (0.18)  5.16 (0.18)  0.64 .428 .01 
Average moves: 5-move 5.67 (0.21)  6.20 (0.21)  2.54 .116 .04 
First move initiation time: 2-move 3180.33 (195.14)  3704.75 (195.14)  2.85 .096^ .04 
First move initiation time: 3-move 5508.33 (414.31)  5504.90 (414.31)  < 0.00 .996 <.00 
First move initiation time: 4-move 8269.05 (845.16)  8518.35 (845.16)  0.03 .854 <.00 
First move initiation time: 5-move 12989.62 (1185.74)  8930.44 (1185.74)  4.62 .035* .07 
First move initiation time: Average 7486.83 (586.33)  6664.61 (586.33)  0.78 .382 .01 
Iowa Gambling Task
c
      
Good Choices-Bad Choices: Block 1 -1.25 (1.69)  -3.37 (1.63)  0.64 .426 .01 
Good Choices-Bad Choices: Block 2 3.01 (1.75)  -1.78 (1.69)  3.06 .085^ .05 
Good Choices-Bad Choices: Block 3 3.59 (1.83)  -1.39 (1.77)  3.02 .087^ .04 
Good Choices-Bad Choices: Block 4 9.41 (1.92)  -1.00 (1.85)  11.98 .001** .16 
Good Choices-Bad Choices: Block 5 9.47 (2.05)  0.45 (1.97)  7.93 .006** .11 
Deck 1 choices 15.51 (1.62)  21.49 (1.56)  5.607 .021* .08 
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 Control (n = 35) Cannabis user (n = 36)    
Cognitive Measure M (SE) M (SE) F p ηp
2 
Deck 2 choices 22.38 (2.31)  32.06 (2.23)  7.183 .009** .10 
Deck 3 choices 22.73 (2.06)  17.28 (1.98)  2.872 .095^ .04 
Deck 4 choices 39.38 (3.48)  29.17 (3.36)  3.507 .066^ .05 
a
Square root transformed.
 b
Data unavailable for 1 cannabis user (n = 35). 
c
Data unavailable for 1 control (n = 34). 
^p ≤ .1. *p ≤ .05. **p ≤ .01. 
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Table 8. Partial correlations between baseline cognitive performance and substance use variables in cannabis users (n = 36). 
 
Age of regular 
cannabis use 
Past Year: 
Total # hits Alcohol use
 
Tobacco use 
Non-cannabis 
drug use 
Substance Use Measures
a 
     
Age of regular cannabis use − -.100 -.055 -.111 -.221 
Past Year: Total # hits  − .030 -.074 .164 
Alcohol use   − .126 .208 
Tobacco use    − -.073 
Non-cannabis drug use     − 
Cognitive Measures
b 
Age of regular 
cannabis use
c
 
Past Year: 
Total # hits
c
 Alcohol use
d
 
Tobacco 
use
e
 
Non-cannabis 
drug use
f
 
Processing Speed Composite -.040 -.050 -.002 .121 -.299^ 
Verbal Learning and Memory Composite .030 .136 .504** -.185 .143 
Letter Cancellation      
Time .278 .153 .104 -.112 .290 
COWAT – Verbal Fluency      
Total words -.043 .226 -.128 -.157 .020 
Total set-loss errors
g
 -.295 -.014 -.173 -.050 -.318^ 
RAVLT      
Total words: Interference trial list .147 -.338^ .455** .102 .009 
Total words: Immediate recall -.162 .118 .551** -.208 .028 
Total words: Delayed recall -.060 .268 .457** -.131 .326^ 
% Recalled after consolidation -.279 .153 .242 -.100 .457** 
Spatial Delayed Response Task      
Error: 8,000 ms delay -.177 .426* -.390* .073 .180 
Mean reaction time: 500 ms delay -.429* .018 -.293 -.272 .054 
Mean reaction time: 8,000 ms delay -.453* .004 -.308^ -.192 .039 
Tower of London
g
      
% Perfect Solutions .026 .113 .344^ .033 .013 
Average moves: 3-move -.414* .028 -.390* -.301 -.200 
First move initiation time: 5-move .089 -.387* .215 -.205 -.375* 
Iowa Gambling Task      
Good Choices-Bad Choices: Block 2 .024 -.155 -.015 -.135 -.095 
Good Choices-Bad Choices: Block 4 -.182 -.137 .194 .061 -.072 
Good Choices-Bad Choices: Block 5 -.287 -.100 -.053 .099 -.141 
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Deck 1 choices .013 .159 .087 -.056 -.027 
Deck 2 choices .297 -.058 -.198 -.011 .210 
Notes. Tobacco use, non-cannabis drug use, past year: total # hits, and COWAT total set-loss errors were square root transformed. 
a
Partial correlations with sex 
controlled. 
b
Partial Correlations with sex and IQ controlled. 
c
Also controlled for alcohol, tobacco, and non-cannabis drug use. 
d
Controlling for tobacco and non-
cannabis drug use. 
e
Controlling for alcohol and non-cannabis drug use. 
f
Controlling for alcohol and tobacco use. 
g
Data unavailable for 1 participant (n = 35).  
^p ≤ .1. *p ≤ .05. **p ≤ .01.  
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Table 9. Baseline demographic and substance use characteristics between participants who returned for follow-up assessment and those who dropped out of the 
study at follow-up, separated by controls and cannabis users. 
 
Control 
M (SD)  
Cannabis User 
M (SD)  
Variable Follow-up Sample 
Lost to Follow-
up F or χ2 Follow-up Sample 
Lost to Follow-
up F or χ2 
n  29 6  26 10  
Age 19.29 (0.93) 19.93 (0.80) 2.412 19.43 (0.65) 19.73 (0.44) 1.820 
#Male/#Female 10/19 3/3 χ2 = 0.513 19/7 6/4 χ2 = 3.425^ 
#Caucasian/#Other Ethnicity 23/6 4/2 χ2 = 0.451 22/4 9/1 χ2 = 0.175 
Years of education 13.00 (1.19) 14.50 (0.55) 9.007** 13.28 (0.98) 13.20 (0.92) 0.049 
Estimated Full Scale IQ 114.79 (9.57) 114.17 (9.37) 0.021 114.77 (10.41) 114.00 (11.15) 0.038 
Vocabulary T-Score 62.10 (6.93) 60.50 (6.92) 0.267 61.38 (8.21) 60.10 (9.12) 0.167 
Matrix reasoning T-Score 54.52 (6.09) 55.67 (5.89) 0.179 55.38 (5.74) 55.80 (5.35) 0.039 
Alcohol use average -.58 (0.74) -0.65 (0.35) 0.044 0.71 (0.76) 0.30 (0.68) 2.217 
ASR substance use       
Past 6 months: Tobacco use per day 0.00 (0.00) 0.00 (0.00) – 1.02 (1.62) 0.60 (1.58) 0.487 
Past 6 months: Days drunk 5.28 (9.44) 5.83 (9.00) 0.018 28.58 (19.83) 21.30 (16.16) 1.068 
Past 6 months: Days using drugs 0.10 (0.41) 0.33 (0.82) 1.081 136.20 (43.44) 174.70 (10.26) 7.558** 
Cannabis use
b
       
Age first used (years)    15.42 (1.15)  14.75 (1.36)  2.259 
Past year: Days used – – – 324.9 (48.48)  357.18 (24.73)  3.983^ 
Past 30 days: Days used – – – 26.79 (4.21)  29.36 (2.02)  3.384^ 
Past year: Total # hits – – – 3234.65 (2482.38)  3314.99 (1891)  0.009 
Past 30 days: Total # hits – – – 257.19 (211.02)  276.98 (179.39)  0.069 
Notes. Group comparisons using chi-square or one-way analysis of variance are reported. ASR = Adult Self-Report. 
a
Variables only included for cannabis users.  
^p ≤  .10. **p ≤ .01.  
  
 143 
Table 10. Baseline and follow-up neuropsychological cognitive composite scores for participants who completed the follow-up 
assessment (controls n = 29) and (cannabis users n = 26). Cognitive composite scores are average z-scores from component test 
variables with higher performance indicating better performance. Means reported are marginal means, controlling for sex, IQ, and 
average alcohol use within time point. Marginal means calculated for each time point separately. 
Cognitive Composite Baseline Follow-up Repeated Measures ANCOVA 
 Control  
(n = 29) 
Cannabis user 
(n = 26) 
Control  
(n = 29) 
Cannabis user 
(n = 26) 
Group Group × Time 
 M (SE) M (SE) M (SE) M (SE) F (p)/ ηp
2
 F (p)/ ηp
2
 
Motor Speed -0.441 (0.230)  0.285 (0.253)  0.004 (0.177)  0.131 (0.191)  0.63 (.430)/.013 0.49 (.487)/.010 
Motor Dexterity -0.249 (0.202)  -0.091 (0.223)  0.259 (0.185)  0.051 (0.199)  0.13 (.723)/.003 0.67 (.416)/.014 
Processing Speed -0.411 (0.148)  0.316 (0.163)  -0.136 (0.155)  0.355 (0.167)  5.88 (.019*)/.107 1.67 (.202)/.033 
Verbal Learning and Memory 0.242 (0.183)  -0.408 (0.202)  0.304 (0.191)  -0.094 (0.206)  3.41 (.071^)/.065 0.67 (.416)/.014 
Spatial Working Memory & Planning 0.032 (0.145)  -0.324 (0.160)  0.302 (0.175)  0.049 (0.189)  3.09 (.085^)/.060 1.64 (.207)/.033 
*p ≤ .05.  
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Table 11. Baseline and Follow-up neuropsychological battery scores for participants who completed the follow-up assessment (controls n = 29) and (cannabis 
users n = 26). Means reported are marginal means, controlling for sex, IQ, and average alcohol use within time point. Marginal means calculated for each time 
point separately. 
Cognitive Measure Baseline Follow-up Repeated Measures ANCOVA 
 Control 
(n = 29) 
Cannabis user 
(n = 26) 
Control 
(n = 29) 
Cannabis user 
(n = 26) 
Group Group × Time 
 M (SE) M (SE) M (SE) M (SE) F (p)/ ηp
2
 F (p)/ ηp
2
 
Finger Tapping Test       
Dominant hand (# taps) 41.03 (1.96)  47.80 (2.11)  44.68 (1.52)  47.22 (1.64)  1.54 (.22)/.031 0.21 (.648)/.004 
Non-dominant hand (# taps) 41.14 (1.75)  45.44 (1.88)  43.94 (1.33)  43.49 (1.44)  0.09 (.768)/.002 0.77 (.385)/.015 
Grooved Pegboard       
Dominant hand time (s) 65.42 (1.70)  64.38 (1.83)  59.86 (1.49)  63.96 (1.60)  0.60 (.442)/.012 2.94 (.093^)/.057 
Non-dominant hand time (s)
 
73.46 (2.38)  71.67 (2.56)  70.54 (2.31)  69.32 (2.50)  0.01 (.913)/<.000 0.10 (.758)/.002 
Digit Symbol       
Total correct 86.44 (3.07)  91.28 (3.31)  91.52 (2.98)  95.57 (3.21)  1.15 (.289)/.023 0.12 (.733)/.002 
Letter Cancellation       
Time (s) 113.27 (3.66)  93.13 (3.94)  109.19 (4.09)  95.82 (4.41)  7.72 (.008**)/.136 1.85 (.180)/.036 
Total omissions
a
 1.44 (0.15)  1.52 (0.16)  1.56 (0.15)  1.27 (0.16)  0.02 (.897)/ < .000 2.86 (.097^)/.055 
Total commissions
a
 0.81 (0.05)  0.73 (0.06)  0.73 (0.04)  0.80 (0.04)  0.08 (.775)/.002 1.63 (.208)/.032 
COWAT       
Total correct words generated 42.99 (2.14)  50.47 (2.30)  45.69 (2.33)  50.27 (2.51)  2.03 (.161)/0.04 0.28 (.597)/.006 
Total set-loss errors
a
 0.85 (0.08)  1.03 (0.09)  1.11 (0.10)  1.01 (0.10)  0.01 (.939)/ < 0.000 0.49 (.486)/.010 
Total perseverative errors
a
 1.08 (0.08)  0.82 (0.08)  1.04 (0.11)  1.11 (0.12)  0.12 (.733)/0.002 1.80 (.186)/.035 
Digit Span
c 
      
Digits forward (# recalled) 7.67 (0.23)  7.21 (0.25)  7.46 (0.24)  7.20 (0.25)  1.45 (.235)/0.029 0.46 (.503)/.009 
Digits backward (# recalled) 5.89 (0.30)  5.20 (0.32)  5.64 (0.30)  5.81 (0.31)  0.34 (.560)/0.007 2.59 (.114)/.051 
RAVLT        
Total words: Trial 1 7.13 (0.38)  6.63 (0.41)  8.30 (0.29)  6.70 (0.31)  3.69 (.060^)/.070 3.13 (.083^)/.060 
Total words: Trial 2 10.22 (0.48)  9.91 (0.52)  10.50 (0.38)  10.75 (0.41)  0.01 (.905)/ < .000 0.82 (.370)/.016 
Total words: Trial 3 11.68 (0.47)  11.59 (0.50)  12.40 (0.41)  11.44 (0.44)  0.34 (.565)/.007 1.92 (.172)/.038 
Total words: Trial 4 12.73 (0.46)  11.88 (0.50)  13.03 (0.43)  12.62 (0.47)  1.17 (.285)/.023 0.35 (.558)/.007 
Total words: Trial 5 13.40 (0.39)  12.52 (0.42)  13.13 (0.43)  12.70 (0.47)  1.38 (.246)/.027 0.40 (.529)/.008 
Total words: Trial 1-5 55.15 (1.72)  52.53 (1.85)  57.36 (1.45)  54.21 (1.56)  1.20 (.278)/.024 0.11 (.744)/.002 
Trial 1-5 total intrusions
a
 1.06 (0.10)  1.18 (0.11)  0.73 (0.11)  1.33 (0.11)  11.05 (.002**)/.184 1.80 (.186)/.035 
Trial 1-5 total perseverations
a
 2.04 (0.21)  1.88 (0.22)  1.77 (0.22)  2.00 (0.24)  0.14 (.714)/.003 0.20 (.659)/.004 
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Cognitive Measure Baseline Follow-up Repeated Measures ANCOVA 
 Control 
(n = 29) 
Cannabis user 
(n = 26) 
Control 
(n = 29) 
Cannabis user 
(n = 26) 
Group Group × Time 
 M (SE) M (SE) M (SE) M (SE) F (p)/ ηp
2
 F (p)/ ηp
2
 
Total words: Interference trial 7.39 (0.38)  5.88 (0.41)  6.73 (0.38)  6.46 (0.41)  2.67 (.109)/.052 1.43 (.238)/.028 
Total words: Immediate recall 12.22 (0.45)  10.64 (0.49)  11.81 (0.51)  11.10 (0.55)  3.17 (.081^)/.061 1.11 (.298)/.022 
Total words: Delayed recall 12.05 (0.52)  9.64 (0.56)  11.92 (0.53)  10.74 (0.57)  5.21 (.027*)/.096 1.85 (.180)/.036 
Spatial Working Memory
b,c 
      
Total between search errors
a 
13.03 (2.10)  13.05 (2.31)  9.09 (2.58)  11.82 (2.71)  0.46 (.502)/.010 < 0.00 (.988)/ < .000 
Strategy Score: 6-8 30.49 (1.13)  29.96 (1.25)  27.5 (1.28)  27.38 (1.35)  < 0.00 (.989)/ < .000 0.03 (.855)/.001 
Spatial Delayed Response Task       
Error: No delay (mm) 2.33 (0.14)  2.46 (0.15)  2.24 (0.25)  2.69 (0.27)  1.20 (.278)/.024 0.45 (.505)/.009 
Error: 500 ms delay (mm) 6.60 (0.50)  7.55 (0.54)  7.79 (0.59)  6.85 (0.63)  0.01 (.941)/ < .000 2.27 (.138)/.044 
Error: 8,000 ms delay (mm) 10.17 (0.70)  12.04 (0.76)  11.43 (0.91)  12.50 (0.99)  1.71 (.196)/.034 0.62 (.437)/.012 
Mean reaction time: No delay  
1876.57 
(109.45)  
1977.55 
(117.64)  
1919.95 
(135.20)  
1965.74 
(145.74)  0.09 (.765)/.002 < 0.00 (.978)/ < .000 
Mean reaction time: 500 ms 
delay  
1623.18 
(79.43)  
2127.61 
(85.37)  
1634.68 
(70.50)  
1784.82 
(75.99)  8.94 (.004**)/.015 4.46 (.040*)/.08 
Mean reaction time: 8,000 ms 
delay 
1701.68 
(94.14)  
2268.38 
(101.19)  
1862.74 
(93.03)  
2041.93 
(100.28)  7.85 (.007**)/.138 5.30 (.026*)/.098 
Tower of London
b
       
% Perfect Solutions
d 
84.79 (2.89)  72.98 (3.19)  87.07 (3.3)  79.45 (3.38)  7.43 (.009**)/.139 1.72 (.197)/.036 
Average moves 2-move 2.00 (0.00)  2.00 (0.00)  2.00 (0.00)  2.00 (0.00)  - - 
Average moves 3-move 3.02 (0.06)  3.28 (0.07)  3.03 (0.04)  3.18 (0.05)  11.75 (.001**)/.197 5.58 (.022*)/.104 
Average moves 4-move 4.96 (0.21)  5.17 (0.23)  4.59 (0.20)  4.94 (0.21)  1.95 (.169)/.039 0.02 (.891)/ < .000 
Average moves 5-move 5.62 (0.23)  6.22 (0.26)  5.98 (0.24)  5.83 (0.26)  0.74 (.393)/.015 3.02 (.089^)/.059 
First move initiation time 2-
move
d
 
3047.22 
(188.46)  
3783.47 
(207.75)  
3766.62 
(246.93)  
3884.28 
(253.35)  1.76 (.191)/.037 1.78 (.189)/.037 
First move initiation time 3-
move
d
 
5188.61 
(466.35)  
5618.77 
(514.08)  
6767.39 
(696.40)  
5608.14 
(714.51)  0.18 (.672)/.004 1.67 (.202)/.035 
First move initiation time 4-
move
d
 
7494.03 
(814.22)  
8890.52 
(897.57)  
9979.34 
(703.40)  
7533.22 
(721.69)  0.65 (.426)/.014 3.83 (.056^)/.077 
First move initiation time 5-
move
d
 
12119.97 
(1219.36)  
9817.20 
(1344.18)  
14868.04 
(2090.80)  
10742.39 
(2145.16)  2.54 (.118)/.052 0.10 (.757)/.002 
First move initiation time: 
Average
d
 
6962.46 
(584.97)  
7027.49 
(644.84)  
8845.35 
(777.26)  
6942.01 
(797.47)  1.24 (.272)/.026 1.30 (.260)/.028 
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Cognitive Measure Baseline Follow-up Repeated Measures ANCOVA 
 Control 
(n = 29) 
Cannabis user 
(n = 26) 
Control 
(n = 29) 
Cannabis user 
(n = 26) 
Group Group × Time 
 M (SE) M (SE) M (SE) M (SE) F (p)/ ηp
2
 F (p)/ ηp
2
 
Iowa Gambling Task
e 
      
Good-Bad Choices: Block 1 -2.02 (1.91)  -3.52 (2.05)  -1.51 (2.61)  5.17 (2.69)  0.74 (.395)/.016 4.53 (.039)/.091 
Good-Bad Choices: Block 2 3.49 (2.02)  -2.05 (2.17)  2.77 (2.63)  3.04 (2.70)  < 0.00 (.978)/ < .000 1.57 (.216)/.034 
Good-Bad Choices: Block 3 4.24 (1.95)  -1.65 (2.1)  5.04 (2.35)  5.56 (2.41)  0.48 (.494)/.010 2.66 (.110)/.056 
Good-Bad Choices: Block 4 9.82 (2.11)  -3.80 (2.26)  7.37 (2.82)  3.78 (2.90)  5.38 (.025*)/.107 6.00 (.018*)/.118 
Good-Bad Choices: Block 5 10.83 (2.3)  -0.62 (2.47)  8.51 (2.72)  8.99 (2.79)  1.65 (.206)/.035 11.01 (.002**)/.197 
Deck 1 choices 15.39 (1.83)  21.49 (1.97)  13.66 (2.32)  17.08 (2.38)  2.43 (.126)/.051 2.081 (.156)/.044 
Deck 2 choices 21.44 (2.57)  34.32 (2.76)  25.26 (3.60)  19.65 (3.70)  0.84 (.773)/.002 10.90 (.002**)/.195 
Deck 3 choices 23.12 (2.23)  14.95 (2.40)  15.01 (5.97)  34.07 (6.13)  1.36 (.250)/.029 10.90 (.002**)/.195 
Deck 4 choices 40.06 (3.78)  29.24 (4.07)  46.08 (5.68)  29.20 (5.84)  4.12 (.048*)/.084 0.34 (.565)/.007 
Notes. Baseline and follow-up statistics for the follow-up sample (control n = 29, cannabis user n = 26). Marginal means and standard errors are presented for 
the, controlling for time to follow-up interval, sex, IQ, and average alcohol use during baseline and follow-up. 
a
Square root transformed
 b
Data unavailable for 1 
cannabis user (n = 25) at baseline.
 c
Data unavailable for 1 control at follow-up (n = 28). 
 d
Data unavailable for 2 controls (n = 27) at follow-up. 
e
Data unavailable 
for 1 cannabis user (n = 25) and 3 controls (n = 26) at follow-up 
^p ≤ .1. *p ≤ .05. **p ≤ .01. 
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Table 12. Partial correlations between follow-up cognitive performance and cannabis use measures in 
cognitive measures in cannabis users(n = 26). Partial correlations controlling for baseline cognitive 
performance, time to follow-up interval, sex, IQ, and average alcohol use during baseline and follow-up. 
Cognitive Measures 
Baseline Past 
Year Total # hits 
Past Year: 
Total # hits 
Age of regular 
cannabis use 
Cognitive Composites    
Motor Speed  -.277 -.174 .237 
Motor Dexterity  -.017 .276 .155 
Processing Speed  -.310 .328 -.154 
Verbal Learning and Memory  -.326 -.083 .507* 
Spatial Working Memory & Planning -.077 .259 .334 
    
Finger Tapping Test    
Dominant hand (# taps) -.210 -.243 .158 
Non-dominant hand (# taps) -.327 -.066 .295 
Grooved Pegboard    
Dominant hand time (s) -.096 -.168 -.274 
Non-dominant hand time (s)
 
.120 -.279 -.038 
Digit Symbol    
Total correct -.113 .274 -.274 
Letter Cancellation    
Time (s) .350 -.268 .158 
COWAT    
Total correct words generated -.190 .357 .158 
Digit Span
 
   
Digits forward (# recalled) -.183 .072 .479* 
Digits backward (# recalled) .325 .089 -.218 
RAVLT     
Total words: Trial 1-5 -.514* -.101 .530* 
Total words: Interference trial .152 -.153 .061 
Total words: Immediate recall -.210 -.053 .344 
Total words: Delayed recall -.186 -.063 .560** 
% Recalled after consolidation -.088 -.021 .503* 
Spatial Working Memory
a 
   
Total between search errors
 
-.211 -.347 -.065 
Strategy Score: 6-8 -.125 -.197 .145 
Spatial Delayed Response Task    
Error: No delay (mm) -.150 .028 -.071 
Error: 500 ms delay (mm) .033 -.230 .141 
Error: 8,000 ms delay (mm) .127 .042 .273 
Mean reaction time: No delay  -.016 .067 .006 
Mean reaction time: 500 ms delay  -.040 -.035 -.081 
Mean reaction time: 8,000 ms delay -.128 -.228 -.050 
Tower of London
a
    
% Perfect Solutions
 
-.218 -.121 .366 
Average moves 3-move .032 -.311 .317 
Average moves 4-move .182 .004 -.346 
Average moves 5-move .269 -.162 -.313 
First move initiation time 2-move
d
 -.158 .117 .287 
First move initiation time 3-move
d
 .363 -.347 .175 
First move initiation time 4-move
d
 .360 .094 -.130 
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Cognitive Measures 
Baseline Past 
Year Total # hits 
Past Year: 
Total # hits 
Age of regular 
cannabis use 
First move initiation time 5-move
d
 -.121 .192 .014 
Iowa Gambling Task
b 
   
Total Good-Bad Choices .053 .263 -.351 
Deck 1 choices -.064 -.411 .126 
Deck 2 choices -.051 -.072 .406^ 
Deck 3 choices -.083 .010 -.324 
Deck 4 choices .14y6 .045 .217 
Notes Total # hits square root transformed. 
a
Data unavailable for 1 cannabis user (n = 25) at baseline.
 b
Data 
unavailable for 1 cannabis user (n = 25) at follow-up 
^p ≤ .1. *p ≤ .05. **p ≤ .01. 
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Table 13. Hierarchical multiple regression analyses: Cannabis use at baseline assessment 
predicting follow-up RAVLT Trial 1-5 performance within cannabis users. 
Model Adj. R
2 
F p b* t p 
Dependent variable: RAVLT Trial 1-5 
Step/Model 1 .349 3.786 .013*    
Baseline Trials 1-5 Words    .476 2.894 .009** 
Interval    .220 1.387 .180 
Sex    -.064 -0.393 .698 
IQ    .273 1.706 .103 
Alcohol use    .234 1.427 .168 
Step/Model 2 .497 5.278 .002**    
Baseline Trials 1-5 Words    .487 3.369 .003** 
Interval    .281 1.990 .060^ 
Sex    -.149 -1.022 .319 
IQ    .312 2.209 .039* 
Alcohol use    .208 1.440 .165 
Baseline Past Year Total # Hits     -.389 -2.678 .014* 
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Table 14. Hierarchical multiple regression analyses: Age of cannabis use initiation 
predicting follow-up forward digit span performance within cannabis users. 
 
Model Adj. R
2 
F p b* t p 
Dependent variable: Digit Span Digits forward (# recalled) 
Step/Model 1 .133 1.765 .166    
Baseline Digits forward    .287 1.513 .146 
Interval    .179 0.960 .348 
Sex     -.239 -1.266 .220 
IQ    .315 1.673 .110 
Alcohol use    .153 0.798 .434 
Step/Model 2 .297 2.760 .042*    
Baseline Digits forward    .242 1.405 .176 
Interval    .034 0.189 .852 
Sex     -.326 -1.875 .076^ 
IQ    .304 1.792 .089^ 
Alcohol use    .147 0.848 .407 
Age cannabis use initiated    .438 2.381 .028* 
^p ≤ .1. *p ≤ .05.  
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Table 15. Hierarchical multiple regression analyses: Age of cannabis use initiation 
predicting learning and memory performance within cannabis users. 
Model Adj. R
2 
F p b* t p 
Dependent variable: Verbal Learning and Memory composite 
Step/Model 1 .506 4.094 .010**    
Baseline Verbal learning 
and memory 
   .438 2.514 .021* 
Interval    .201 1.274 .217 
Sex    .086 0.538 .597 
IQ    .183 1.105 .282 
Alcohol use    .285 1.689 .107 
Step/Model 2 .633 5.462 .002**    
Baseline Verbal learning 
and memory 
   .337 2.122 .047* 
Interval    .060 0.402 .692 
Sex    .005 0.036 .972 
IQ    .198 1.352 .192 
Alcohol use    .302 2.028 .057^ 
Age cannabis use initiated    .401 2.566 .019* 
Dependent variable: RAVLT Trial 1-5 total words 
Step/Model 1 .452 4.964 .004**    
Baseline Trial 1-5 words    .506 3.071 .006** 
Interval    .250 1.579 .130 
Sex    -.047 -0.290 .775 
IQ    .267 1.675 .109 
Alcohol use    .208 1.266 .220 
Step/Model 2 .523 5.386 .002**    
Baseline Trial 1-5 words    .361 2.360 .029* 
Interval    .098 0.662 .516 
Sex    -.116 -0.814 .426 
IQ    .259 1.862 .078^ 
Alcohol use    .228 1.588 .129 
Age cannabis use initiated    .435 2.723 .013* 
Dependent variable: RAVLT Delayed Recall 
Step/Model 1 .470 5.437 .003**    
Baseline Trial 7    .504 2.946 .008** 
Interval    .206 1.397 .178 
Sex    .080 0.537 .597 
IQ    .205 1.306 .206 
Alcohol use    .243 1.505 .148 
Step/Model 2 .617 7.716 < .000**    
Baseline Trial 7    .454 3.099 .006** 
Interval    .067 0.497 .625 
Sex     -.004   -0.028 .978 
IQ    .210 1.574 .132 
Alcohol use    .248 1.808 .086^ 
Age cannabis use initiated    .400 2.946 .008** 
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Model Adj. R
2 
F p b* t p 
Dependent variable: RAVLT % Recalled after consolidation 
Step/Model 1 .286 3.004 .035*    
Baseline % after consol.    .381 1.874 .076^ 
Interval     -.004   -0.023 .982 
Sex    .050 0.276 .785 
IQ    .301 1.639 .117 
Alcohol use    .222 1.203 .243 
Step/Model 2 .438 4.253 .007**    
Baseline % after consol.    .505 2.706 .014* 
Interval     -.125   -0.778 .446 
Sex    .002 0.012 .991 
IQ    .248 1.507 .148 
Alcohol use    .165 1.001 .329 
Age cannabis use initiated    .430 2.535 .020* 
^p ≤ .1. *p ≤ .05. **p ≤ .01.  
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Table 16. Hierarchical multiple regression analyses: Age of cannabis use initiation 
predicting Iowa Gambling Task performance within cannabis users. 
Model Adj. R
2 
F p b* t p 
Dependent variable: IGT Deck 2 Choices 
Step/Model 1 .224 2.387 .077^    
Baseline Deck 2 choices    .141 0.729 .475 
Interval    .532 2.870 .010* 
Sex     -.113   -0.620 .543 
IQ     -.252   -1.324 .201 
Alcohol use    .250 1.336 .197 
Step/Model 2 .487 2.848 .040*    
Baseline Deck 2 choices    .102 0.556 .585 
Interval    .528 3.030 .007** 
Sex     -.212   -1.180 .253 
IQ     -.303   -1.676 .111 
Alcohol use    .203 1.147 .266 
Age cannabis use initiated     .342 1.884 .076^ 
^p ≤ .1. *p ≤ .05. **p ≤ .01. 
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Table 17. Study 2: Demographic and substance use characteristics of cannabis users and controls at baseline and follow-up.  
Variable Control Cannabis User F, U, χ2  p 
n 23 23   
T1: Baseline characteristics      
Age 19.19 (2.31) 19.45 (0.66) 0.27 .61 
#Male/#Female 16/7 16/7 χ2 = 0.00 1.00 
#Caucasian/#Other Ethnicity 21/2 19/4 χ2 = 0.77 .38 
Years of education 13.09 (2.07)  13.26 (0.92) 0.14 .71 
Estimated Full Scale IQ 115.65 (9.46) 115.17 (11.02) 0.03 .88 
Vocabulary T-Score 62.09 (5.43) 61.83 (8.34) 0.02 .90 
Matrix reasoning T-Score 55.65 (7.06) 55.35 (5.58) 0.03 .87 
Alcohol use, past 12 months (Mdn PEI rating) 1 4 U = 54.00 < .00** 
0: Never (n) 9 1 –  – 
1: 1-5 times (n) 7 0 – – 
2: 6-20 times (n) 3 3 –  –  
3: 21-49 times (n) 3 6 –  –  
4: 50-99 times (n) 1 8 –  –  
5: 100+ times (n) 0 5 –  –  
Cannabis use, past 12 months (Mdn PEI rating) 0 5 U = 0.00 < .00** 
0: Never (n) 21 0 –  –  
1: 1-5 times (n) 2 0 –  –  
2: 6-20 times (n) 0 0 –  –  
3: 21-49 times (n) 0 0 –  –  
4: 50-99 times (n) 0 0 –  –  
5: 100+ times (n) 0 23 –  –  
Age of regular cannabis use onset
a – 15.35 (1.16) – – 
Past year: Days used
a
  323.07 (49.55)   
Past 30 days: Days used
a
  26.37 (4.31)   
Past year: Total # hits
a
  3032.55 (2395.31)   
Past 30 days: Total # hits
a – 241.17 (209.71) – – 
T2: Follow-up characteristics      
Years between assessments 2.12 (0.66) 2.34 (0.31) 2.18 .15 
Age at follow-up 21.31 (2.43) 21.79 (0.82) 0.82 .37 
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Variable Control Cannabis User F, U, χ2  p 
Age range at follow-up 17.2 – 26.0 20.6 – 23.3 –  –  
Alcohol use, past 12 months (Mdn PEI rating) 3 4 U = 84.5 < .00** 
0: Never (n) 2 1 –  –  
1: 1-5 times (n) 3 0 –  –  
2: 6-20 times (n) 6 1 –  –  
3: 21-49 times (n) 8 2 –  –  
4: 50-99 times (n) 3 11 –  –  
5: 100+ times (n) 1 8 –  –  
Cannabis use, past 12 months (Mdn PEI rating) 0 5 U = 0.00 < .00** 
0: Never (n) 14 0 –  –  
1: 1-5 times (n) 7 0 –  –  
2: 6-20 times (n) 2 0 –  –  
3: 21-49 times (n) 0 1 –  –  
4: 50-99 times (n) 0 6 –  –  
5: 100+ times (n) 0 16 –  –  
Past year: Days used
a 
 253.94 (118.69)   
Past 30 days: Days used
a 
 18.73 (11.04)   
Past year: Total # hits
a 
 2637.92 (2203.77)   
Past 30 days: Total # hits
a – 183.15 (190.88) – – 
Notes. Values represent means and standard deviation units, unless otherwise specified. Group comparisons were conducted using chi-square, Mann-Whitney U, 
and one-way analysis of variance. PEI = personal Experience Inventory. 
a
Variables only included for cannabis users. 
*p ≤  .05. **p ≤ .01. 
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Table 18. DSM-IV-TR Diagnoses at baseline and follow-up, as assessed by the K-SADS-PL. The number of participants who met criteria for each 
disorder is reported. 
 Control  Cannabis 
 Baseline (n = 23) Follow-up (n = 23)  Baseline (n = 23) Follow-up (n = 23) 
 Current 
 
Partial 
Remission Past Current 
Partial 
Remission Past 
 
Current 
Partial 
Remission Past Current 
Partial 
Remission Past 
Cannabis Dependence 0 0 - 0 0 -  13 0 - 15 3 - 
Cannabis Abuse 0 - 0 0 - 0  7 - 8 2 - 5 
Alcohol Dependence 0 0 - 0 0 -  2 0 - 3 1 - 
Alcohol Abuse 0 - 0 0 - 1  5 - 8 4 - 7 
Major Depressive 
Disorder 
0 - 2 0 - 2  0 - 0 0 - 1 
Bipolar NOS 0 - 0 0 - 0  1 - 0 1 - 1 
Social Phobia 0 - 0 1 - 1  0 - 0 0 - 0 
Specific Phobia 0 - 0 0 - 0  0 - 1 0 - 0 
Generalized Anxiety 
Disorder 
0 - 0 0 - 0  0 - 0 0 - 1 
Notes. NA = not assessed at follow-up. Current ratings are based on previous 6 months for substance use disorders, and on the previous 2 months for other 
diagnoses. At baseline, past ratings are based on lifetime symptom expression for cannabis users. At baseline for controls and follow-up for controls and cannabis 
users, past ratings are based on symptoms during follow-up interval.
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Table 19. Other drug usage in cannabis users and controls at baseline and follow-up. Number of 
participants who used each drug at different usage levels. Count includes use in past 12 months 
at baseline and follow-up 
 
Control Cannabis 
Baseline Follow-up Baseline Follow-up 
 
n = 23 n = 23 n = 23 n = 23 
Psychedelics 
    No use 23 22 12 8 
1-5 times - 1 10 13 
6-20 times - - 1 2 
Cocaine 
    No use 23 22 22 15 
1-5 times - 1 1 8 
Amphetamines 
    No use 23 23 19 17 
1-5 times - - 3 1 
6-20 times - - 1 5 
Barbiturates 
    No use 23 23 21 23 
1-5 times - - 2 - 
Tranquilizers 
    No use 23 23 20 23 
1-5 times - - 3 - 
Heroin 
    No use 23 23 23 23 
Other narcotics 
    No use 23 23 18 19 
1-5 times - - 5 4 
Steroids 
    No use 23 23 23 23 
Inhalants 
    No use 23 23 23 23 
Prescription drugs 
    No use 23 22 18 20 
1-5 times - 1 5 3 
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Table 20. Baseline group differences in fractional anisotropy (FA) and radial diffusivity (RD). 
Measure Contrast 
Max 
Z-stat 
Cluster 
Size 
(mm
3
) 
CWP X  Y  Z Hemisphere Anatomical Region 
FA Controls < CU 4.18 2584 
 
0.012 4 26 4 Right Genu, forceps minor of CC 
RD Controls > CU 3.86 1640 0.102 2 26 6 Right Genu, forceps minor of CC 
Notes. Results from voxelwise multiple regression analyses of FA and RD at baseline. Multiple regression covariates were group, sex, age, and baseline alcohol 
use. Cluster-level statistical thresholding was p<e.05 after family-wise error correction for multiple comparisons; trend-level results (FWE p ≤ .10) are included 
as well. CC = corpus callosum. 
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Table 21. Partial correlations between cognitive and substance use variables and mean FA in cannabis users > controls baseline cluster. 
Measure 
R Genu, Forceps minor CC 
(4, 26, 4) 
Past Year: total# hits
a 
-.152 
Age first regular cannabis use
a 
-.070 
Past Year: total # drinks
b 
-.577** 
Tobacco use
a 
-.017 
Cognitive Composites
a 
 
Motor Speed  .291 
Motor Dexterity  .282 
Processing Speed  .299 
Verbal Learning and Memory  .054 
Spatial Working Memory & Planning  .042 
Iowa Gambling Task
a 
 
Deck 1 choices -.155 
Deck 2 choices -.477* 
Deck 3 choices -.239 
Deck 4 choices
 
.194 
Good deck choices .258 
Notes. Past year: total # hits, past year: total # drinks, and tobacco use were square root transformed. 
a
Controlling for sex and baseline alcohol use. 
b
Controlling 
for sex.  
^p ≤ .1. *p ≤ .05. **p ≤ .01.  
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Table 22. Analysis of 2-year change in fractional anisotropy and radial diffusivity. 
Measure Contrast 
Max 
Z-stat 
Cluster 
Size 
(mm
3
) 
CWP X  Y  Z Hemisphere Anatomical Region 
Fractional 
Anisotropy 
Controls > Cannabis 5.80 3864  0.001 32 -32  40 Right 
SLF, extending to junction 
with CST 
Fractional 
Anisotropy 
Controls > Cannabis 4.12 1632  0.017 -38 -44 24 Left 
SLF, extending to CC 
forceps major 
Fractional 
Anisotropy 
Controls > Cannabis 3.88 1464  0.030 -18 16 42 Left 
White matter adjacent to 
superior frontal gyrus 
Fractional 
Anisotropy 
Controls > Cannabis 4.46 1232  0.065 -16 -28 50 Left 
CST, adjacent to pre- and 
postcentral gyri 
Fractional 
Anisotropy 
Controls > Cannabis 4.25 1208  0.071 26 16 12 Right 
ATR; superior FOF; adjacent 
to frontal operculum 
Fractional 
Anisotropy 
Cannabis > Controls 4.49 1808  0.010 -14 16 26 Left Anterior CC 
Fractional 
Anisotropy 
Cannabis > Controls 3.75 1696  0.014 -10 -24 -6 Left 
White matter adjacent to 
posterior thalamus 
Radial 
Diffusivity 
Controls < Cannabis 4.54 6848  0.001 16 -36 38 Right 
CST; SLF; posterior 
cingulum  
Radial 
Diffusivity 
Controls > Cannabis 3.97 2368  0.006 -24 -18  4 Left CST 
Notes. Results from voxelwise multiple regression analysis of FA and RD 2-year change values (i.e., residuals from regression of each participant‟s follow-up 
FA or RD volume on the corresponding baseline FA or RD volume). Multiple regression covariates were group, sex, age at baseline, time interval between 
baseline and follow-up assessments, and average alcohol use. Cluster-level statistical thresholding was p < .05 after family-wise error correction for multiple 
comparisons; trend-level results (FWE p < .10) are included as well. ATR = anterior thalamic radiation; CC = corpus callosum; CST = corticospinal tract; FOF = 
fronto-occipital fasciculus; SLF = superior longitudinal fasciculus
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Table 23. Correlations between cognitive and substance use variables and mean FA-change cluster values. 
 Control > CU Cannabis > Control 
 
R SLF/CST 
(32, -32, 40) 
L SLF/CC 
forceps major  
(-38, -44, 24) 
L SFG WM 
(-18, 16, 42) 
L CST  
(-16, -28, 50) 
R ATR  
(26, 16, 12) 
L Ant CC 
(-14, 16, 26) 
L Thalamic 
WM 
(-10, -24, -6) 
BL Past Year: total # hits
a
 .246 -.081 .218 -.127 .400^ -.189 -.054 
Past Year: total# hits
a 
-.083 -.479* -.290 -.461* -.149 .276 .092 
Age first regular cannabis use
a 
.245 -.018 .012 -.007 -.008 -.253 -.024 
Past Year: total # drinks
b 
.039 .167 .239 -.019 -.095 .114 -.074 
Tobacco use
a 
-.129 .120 .249 -.043 .021 -.286 .125 
Cognitive Composites
a 
       
Motor Speed  .039 .139 .126 .151 .473* .138 .316 
Motor Dexterity  .046 -.066 .263 .224 -.084 -.003 .061 
Processing Speed  -.040 -.310 -.323 -.123 -.320 .142 -.083 
Verbal Learning and Memory  -.094 .123 -.078 -.064 -.306 -.321 -.073 
Spatial Working Memory & 
Planning  .038 -.187 -.094 -.074 -.204 .072 -.141 
Iowa Gambling Task
a 
       
Deck 1 choices .211 .189 .496* .207 .181 .126 -.005 
Deck 2 choices .128 .110 .348 .167 -.139 -.010 .125 
Deck 3 choices -.322 .161 .078 .352 .150 -.101 -.095 
Deck 4 choices
c 
.085 -.252 -.394^ .136 -.116 .071 .040 
Good deck choices -.174 -.150 -.443* -.198 .018 -.046 -.080 
Notes. Past year: total # hits, past year: total # drinks, and tobacco use were square root transformed. 
a
Controlling for baseline value, sex, interval between 
assessments, and average alcohol use at baseline and follow-up. 
b
Controlling for baseline value, sex, and interval between assessments. 
^p ≤ .1. *p ≤ .05. **p ≤ .01.  
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